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ABSTRACT 
 
 
In this study, the effect of the amino acid residues at positions 40 and 407 on the catalytic activity of 
porcine CYP17A1 was investigated. Porcine cofactor CYB5 was cloned from porcine liver tissue and 
its effect on the catalytic activity of porcine CYP17A1 was determined. The influence of rat, human 
and angora CYB5 on the lyase activity of porcine CYP17A1 was subsequently determined and 
compared to the influence of porcine CYB5. Wt porcine CYP17A1, which has residues Val40 and 
His407, catalysed the conversion of prog efficiently with ~50% prog converted to 17OHprog (~40%) 
and A4 (~10%) after 3 hr. After 24 hr, negligible levels prog remained with ~71% 17OHprog and 
~25% A4 being produced. Low levels of 16OHprog were formed (~9%). The Leu105Ala mutation 
reduced wt 17α-hydroxylase activity, with 70% prog remaining after 24 hr while 16OHprog (~10%) 
levels remained unchanged. Porcine CYP17A1 with residues Leu40 and His407, exhibited similar 
catalytic activity towards prog as did wt porcine CYP17A1 (Val40 and His407 residues), while porcine 
CYP17A1 with residues Leu40 and  Leu407 increased the formation of A4 2-fold to 54% at 24 hr and 
porcine CYP17A1 with residues Val40 and Leu407 resulted in the highest formation of A4 (90%). Wt 
porcine CYP17A1, while having converted 95% of the prog substrate, produces only ~16% A4 after 24 
hr. In the presence of porcine CYB5, however, the lyase activity was stimulated with 85% of prog 
being converted to A4 and only 13% 17OHprog remaining. The lyase activity was also stimulated by 
CYB5 from other species, resulting in an increase in A4 production of 60.6%, 24% and 11.6% by rat, 
angora and human CYB5, respectively. The degree of lyase stimulation correlated to the percentage 
identity of the CYB5 amino acid sequences to porcine CYB5. While the Val and Leu residues at 
position 40 do not appear to influence the lyase activity of porcine CYP17A1 as prominently as the 
residue at position 407, it is the charged residue at 407 that plays a significant role in the production of 
A4, decreasing A4 production irrespective of the Val and the Leu residues at position 40. It would, 
furthermore, appear that the stimulation of lyase activity of CYP17A1 is the greatest when assaying 
this activity in the presence of CYB5 of the same species as was detected when co-expressing porcine 
CYP17A1 and porcine CYB5.   
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OPSOMMING 
 
 
 
In hierdie studie is die invloed van die aminosuurresidue by posisies 40 en 407 op die katalitiese 
aktiwiteit van vark CYP17A1 ondersoek. Vark CYB5 is geklooneer vanuit vark lewer weefsel en die 
effek van hierdie kofaktor op die katalitiese aktiwiteit van vark CYP17A1 is bepaal. Die invloed van 
rot, mens en angora CYB5 op die liase aktiwiteit van vark CYP17A1 is daarna bepaal en vergelyk met 
die invloed van vark CYB5. Vark CYP17A1-VH, (kodeer Val40 en His407), kataliseer die 
omskakeling van prog doeltreffend met ~50 % prog wat omgeskakel word na 17OHprog (~40%) en A4 
(~10%) na 3 uur. Na 24 uur, is feitlik alle prog omgeskakel, met ~71% 17OHprog en ~25% A4 
geproduseer. Lae vlakke 16OHprog is ook gevorm (~9%). Die Leu105Ala mutasie verminder 17α-
hidroksilase aktiwiteit, met 70% prog wat na 24 uur nie omgesit is nie, terwyl 16OHprog (~10%) 
vlakke onveranderd gebly het. Vark CYP17A1-LH (kodeer Leu40 en His407), en CYP17A1-VH het 
diselfde katalitiese aktiwiteit teenoor prog getoon, terwyl vark CYP17A1-LL (kodeer Leu40 en 
Leu407) die vorming van A4 2-voudig verhoog het tot 54% na 24 uur. Vark CYP17A1-VL (kodeer 
Val40 en Leu407) se katalitiese aktiwiteit het gelei tot die hoogste vorming van A4 (90%). Alhoewel 
CYP17A1-VH, 95% van die prog substraat omgeskakel het is slegs ~16% A4 geproduseer na 24 uur. 
In die teenwoordigheid van vark CYB5 is die liase aktiwiteit egter gestimuleer, en is 85% van die prog 
substraat omgeskakel na A4 met slegs 13% 17OHprog teenwoordig na 24 uur. Die liase aktiwiteit is 
ook gestimuleer deur CYB5 van ander spesies, wat lei tot 'n toename in A4 produksie van 60,6% , 24% 
en 11,6% deur rot, angora en menslike CYB5, onderskeidelik. Daar is gevind dat daar’n sterk 
korrelasie is tussen die stimulering van die liase aktiwitieit en die persentasie aminosuur volgorde 
identiteit van CYB5 afkomstig vanaf die verskillende spesies. Terwyl die Val en die Leu 
aminosuurresidu op posisie 40 wel die liase aktiwitiet tot ‘n mate beȉnvloed, blyk dit uit die data dat die 
potitief gelaaide residue by 407 'n belangrike rol speel in die produksie van A4, en  A4 produksie 
verlaag ongeag van die Val en die Leu residu by posisie 40. Dit wil ook verdermeer voorkom asof die 
stimulering van die liase aktiwiteit van CYP17A1 die hoogste is wanneer die ensiem gekataliseerde 
reaksie deurgevoer word in die teenwoordigheid van CYB5 en CYP17A1 afkomstig vanaf dieselfde 
spesies. 
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CHAPTER 1 
INTRODUCTION 
The study and understanding of steroid biosynthesis is pertinent to areas of physiology, medicine, and 
pharmacology. Investigating disorders confined to rare genetic lesions and the contributuon of altered 
steroidogenic regulation in common clinical disorders have contributed greatly towards our present 
knowledge of steroid hormone biosynthesis. Major developments have led to a comprehensive 
understanding of steroid biosynthesis — the cloning of the steroidogenic acute regulatory protein 
(StAR) and ensuing studies pertaining to the intracellular transport of cholesterol; the expanding 
anthology of cytochrome P450s (P450) hydroxysteroid dehydrogenases (HSD); the increasing roles of 
electron transfer proteins and other cofactors associated with disease; and the illumination of additional 
steroidogenic pathways in classical and extra-glandular steroidogenic tissues have added substantial 
intricacies to the understanding of molecular steroidogenesis.  
Steroid hormones are produced from the metabolism of cholesterol. There structures are, therefore, 
directly related and all contain the characteristic cyclopentanophenanthrene or gonane 4-ring structure 
present in cholesterol (Miller and Auchus, 2011). Steroid hormones are important in that they regulate 
numerous developmental and physiological progression from fetal life through to adulthood. 
Glucocorticoids and mineralocorticoids are secreted by the adrenal glands and are vital in carbohydrate 
metabolism and the perpetuation of blood volume and the regulation of sodium levels, respectively. 
Androgens are mandatory for gametogenesis, secondary sexual characteristics and reproduction and are 
generally synthesized by the testes and ovaries. Adrenal glands do secrete the weaker androgens, 
dehydroepiandrosterone (DHEA), DHEA-sulphate (DHEA-S) and androstenedione (A4) but neither 
DHEA nor DHEA-S can activate the androgen receptor (AR). In peripheral tissues, C19 weak 
androgens serve as metabolic precursors for the synthesis of the potent C19 androgens, testosterone and 
dihydrotestosterone (DHT).  
The adrenal C19 steroids are catalysed by cytochrome P450 17α-hydroxylase/17,20 lyase (CYP17A1), 
an enzyme which functions at a key branch point in steroidogenesis with its two core activities 
determining which class of steroid hormones a given cell may produce. CYP17A1 catalyses the 17α-
hydroxylation of both pregnenolone (preg) and progesterone (prog), as well as C17-C20 cleavage of 
their 17α-hydroxy derivatives 17α-hydroxypregnenolone (17OHpreg) and 17α-hydroxyprogesterone 
Stellenbosch University  http://scholar.sun.ac.za
2 
(17OHprog) respectively, in a common active site. In the absence of CYP17A1 activities, only prog, 
mineralocorticoids (11-deoxycorticosterone and aldosterone) and the weak glucocorticoid, 
corticosterone, can be formed. The 17α-hydroxylase activity is required for formation of the 
glucocorticoid cortisol and both 17α-hydroxylase and 17,20-lyase activities are needed for C19 steroid 
production (in adrenal or gonads). Cytochrome P450 oxidoreductase (CPR) is the classical redox 
partner of CYP17A1 and other microsomal P450s and relies on the assistance of an electron transfer 
flavoprotein to shuttle electrons between reduced NADPH and the P450s heme center. In the adrenal 
glands, CYP17A1 17,20-lyase activity is reliant on CPR to facilitate the reaction (Yanagibashi and 
Hall, 1986). Furthermore, there is substantial evidence supporting the understanding that the interaction 
of CYP17A1 with cytochrome b5 (CYB5) profoundly increases the rate of 17,20-lyase activity, 
approaching that of the 17α-hydroxylase reaction, by facilitating the transfer of the second electron 
(Lee-Robichaud et al., 1995a).  
CYP17A1 protein from different species exhibits similar catalytic activities in the ∆5 and ∆4 pathways 
towards preg and prog, respectively. However, the kinetics of the 17,20-lyase reaction have been 
shown to be remarkably different for the two hydroxylated substrates. In some species, the secretion of 
C19-steroids is not restricted only to the gonads. Lower vertebrate animals (i.e. rat, hamster) do not 
express adrenal CYP17A1 and thus are incapable of synthesizing adrenal C19-steroids. The guinea-pig 
adrenal favours C19-steroid production from 17OHprog via the ∆4 pathway. Human adrenal CYP17A1 
(as well as bovine, sheep, porcine and other primates) favours the ∆5 pathway with the 17,20-lyase 
activity towards 17OHpreg producing DHEA, which is subsequently converted to A4 by 3βHSD (Lee-
Robichaud et al., 1995a; Katagiri et al., 1995; Auchus et al., 1998). Porcine CYP17A1 is unique in the 
fact that although it leads to rapid DHEA production from 17OHpreg, when expressed in the adrenal, it 
is also highly capable of producing significant levels of A4 from 17OHprog. The lyase activities are 
amplified when porcine CYP17A1 is expressed in the presence of CYB5. However, together with 
hydroxylase and lyase catalytic activities, porcine CYP17A1 exhibits an additional species-dependent 
activity in the catalysis of C16-steroids (androstenes) when expressed in the presence of elevated levels 
of CYB5, which is characteristic of the porcine testes. It is due to the versatility of porcine CYP17A1s 
catalytic activity, along with the efficiency at forming both ∆5 and ∆4 steroid products, that makes this 
species enzyme a suitable model for the manipulation of the primary protein structure to investigate the 
enzyme. Since the enzyme already favours the ∆5 pathway and DHEA formation, the ∆4 pathway will 
be studied to determine the influence of CYB5 on enzyme activity. 
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Chapter 2 presents an overview of steroidogenesis in which the catalytic roles of the P450 enzymes, 
together with the HSDs, with respect to the biosynthesis of adrenal steroid hormones, are discussed. 
The dual hydroxylase and lyase activities of CYP17A1 and the influence of CYB5 on the modulation 
of the lyase activity in the biosynthesis of adrenal androgens will be presented. 
Chapter 3 and Chapter 4 describe the study into the catalytic activity of porcine CYP17A1 in which the 
following aims are addressed: 
• to investigate the effect of the amino acid residues at positions 40 and 407 on the catalytic activity of 
porcine CYP17A1  
• to clone porcine CYB5 form porcine liver tissue 
• to investigate the effect of porcine CYB5 on the catalytic activity of porcine CYP17A1 
• to compare the influence of porcine CYB5 to that of human, rat and angora CYB5 on the lyase 
activity of porcine CYP17A1 
The investigation into the influence of mutations, at amino acid residue positions 40 and 407 in porcine 
CYP17A1, on the catalytic activity of the enzyme is described in Chapter 3. The amino acid sequence 
of porcine wild-type (wt) CYP17A1 cDNA (wt pCYP17A1), available in our laboratory, differed from 
the published amino acid sequences for CYP17A1 protein previously isolated from the adrenal (Chung 
et al., 1987) and translated from the testes mRNA (Conley et al., 1992). Sequence analysis of porcine 
wt CYP17A1 identified Val40 and His407 (designated -VH) amino acid residues, while the adrenal 
protein has Leu40 and His407 (designated -LH) residues and the testicular protein has Leu40 and 
Leu407 (designated -LL) residues.  
Mutant constructs were thus prepared, using porcine wt CYP17A1 (Val40 and His407) to incorporate 
residues Leu40 and His407 (pCYP17A1-LH), as well as residues Leu40 and Leu407 (pCYP17A1-LL), 
to represent both the porcine adrenal and the testicular proteins, respectively. A single CYP17A1 gene 
is expressed in both human adrenal and testes and an amino acid sequence comparison of the translated 
protein with porcine CYP17A1 shows that human CYP17A1 exhibits Leu40 and His407 residues. 
Furthermore, human CYP17A1 has an Ala105 residue, which is associated with the 16α-hydroxylase 
activity (Swart et al., 2010). Porcine wt CYP17A1, as well as the adrenal and testes protein sequences, 
have a Leu residue at position 105. As porcine CYP17A1 catalyses low levels of 16α-
hydroxyprogesterone (16OHprog), the mutation Leu105Ala was also constructed (pCYP17A1-LA) to 
investigate the 16α-hydroxylase activity. Constructs were transiently expressed in a non-steroidogenic 
mammalian (COS-1) cell line and the activities of wt and mutated constructs were investigated. 
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Chapter 4 presents an investigation into the influence of porcine, human, rat and angora CYB5, which 
all share a high degree of amino acid sequence identity, on the catalytic activity of porcine CYP17A1. 
Data, which will be presented and discussed, include the cloning of porcine cDNA encoding CYB5 by 
RT-PCR of total RNA isolated from porcine liver. CYB5 constructs were co-expressed in COS-1 cells 
with porcine adrenal CYP17A1 (wt pCYP17A1-VH) and pCYP17A1-LL (mutant construct 
representing testicular protein) and the influence of CYB5 on the conversion of prog was assayed to 
determine the influence of the different species of CYB5s on the catalytic activity of porcine 
CYP17A1.   
Chapter 5 concludes the thesis with an overview of the results obtained in this study. Inferences 
pertaining to the structure/function relationship of porcine CYP17A1, without and in the presence of 
CYB5, will be presented. 
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CHAPTER 2  
STEROID BIOSYNTHESIS AND THE ROLE OF CYP17A1 AND CYB5 
2.1 The endocrine system 
The endocrine system is one of the body’s two main communications systems, the nervous system 
being the second. Communication within the nervous system is expeditious, while the signals sent by 
the endocrine system may be delayed and last for longer periods of time. The endocrine system consists 
of glands that are not anatomically connected. These ductless glands secrete hormones, chemical 
messengers, which enter the blood stream and are carried away from the endocrine gland to the target 
cells upon which they purposefully act. A single gland may secrete multiple hormones due to different 
types of endocrine cells in the same gland or single cell may excrete more than one hormone 
(Widmaier et al., 2004). 
From a chemical standpoint, hormones fall into three chemical classes. Amines include the thyroid 
hormones, including follicle stimulating hormone (FSH) and leutenizing hormone (LH), the 
catecholamines: epinephrine and norepinephrine, which are produced by the adrenal medulla and 
dopamine, which is produced by the hypothalamus. There are a wide range of peptide hormones, 
including gonadotropin releasing hormone (GnRH) and adrenocorticotrophic hormone (ACTH), which 
are all synthesized by specific endocrine glands, including the gastrointestinal tract, heart, kidneys, 
liver and pancreas. Peptide hormones are synthesised within endocrine cells by the ribosomes, rough 
ER and Golgi apparatus, where they are finally stored in secretory vesicles in the active hormone form, 
waiting for cell stimulation. A single endocrine cell may synthesize, store and secrete multiple peptide 
hormones that differ in their effects on target cells. The classical steroid-producing endocrine glands 
are the adrenal glands (adrenal cortex), gonads (ovary and testis), placenta (during pregnancy) and the 
brain. All steroid hormones are synthesized from cholesterol. Unlike the hydrophilic amine and peptide 
hormones, upon synthesis, the lipid-soluble steroid hormones diffuse across the plasma membrane, 
enter the interstitial fluid and then enter the blood (Widmaier et al., 2004). 
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2.2 The adrenal gland: a historical perspective on its function 
A recent publication provides an informative historical overview of the scientists involved in the first 
discoveries of the adrenal gland as an endocrine gland, as well as the earliest documentations of 
steroids (Miller, 2013). 
In 1563, Professor Eustachius was the first to correctly describe the anatomy of the adrenal, but due to 
political and religious sequestration his work was only published in 1714. In 1805, Cuvier 
distinguished the cortex and the medulla. Brown-Sequard later speculated that the adrenals secreted the 
“life-sustaining factors” referred to as hormones. He proved that a gland was indispensable for life and 
was the first who attempted hormonal replacement therapy (HRT). Many diseases associated with 
adrenal malfunction were identified and documented during the 1700s and 1800s. In 1912, Glynn 
correctly concluded that the adrenal medulla and cortex developed differently, were functionally 
different to each other and distinguished between sexual characteristics and blood pressure. Further 
advancements in understanding the adrenal and adrenocortical hormones were established with respect 
to symptoms of Addison and Cushing disease. In 1946, Seyle studied the stress response and 
conceptualized the hypothalamic-pituitary-adrenal axis (HPA-axis) of control and coined the terms 
‘mineralocorticoid’ and ‘glucocorticoid’. In 1927, Wieland and Wiedaus set the baseline for identifying 
the molecular structure of cholesterol. However, the correct cyclopentanophenanthrene structure (see 
Figure 2-1) was resolved by Rosenheim and King in 1932 and thereafter estrone, androsterone and prog 
were isolated. This set the stage for studies on adrenal steroids. Amongst other researchers, Kendall, 
Reichstein and Hench contributed in the identification and isolation of 29 distint steroids, including 
cortisone, corticosterone and cortisol. In 1950, they received the only Nobel Prize, ever awarded, for 
work pertaining to adrenal steroid hormones, which lead to the administration of cortisone as a 
“miracle cure” for severely arthritic patients (Hench et al., 1949; Miller, 2013).  
The 1930s yielded fundamental characterisations as well as identified the precursor/product 
relationships, which ultimately led to the general understanding of steroidogenesis (Kendall et al., 
1934). Early studies from the 1950s revealed that steroid 21-hydroxylation by bovine adrenal 
microsomes was inhibited in the presence of carbon monoxide and was reversible by light, which led to 
the most important breakthrough: that steroid 21-hydroxylation was P450-mediated (Ryan and Engel, 
1956; Miller, 2013). The following years revealed key discoveries concerning steroidogenic reactions 
being associated with P450 enzymes. The cloning of the cDNA encoding key steroidogenic enzymes 
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from a variety of animal sources proposed that there were less steroidogenic enzymes than there were 
steroidogenic reactions (Miller, 1988; 2013). It was concluded that generally, in different tissues, the 
same enzyme would catalyze one particular steroidogenic reaction. 
 
Figure 2-1: Cyclopentanophenanthrene 4-ring structure is common to all steroids. According to the standard convention of 
nomenclature, numbers indicate carbon atoms and letters designate rings. Methyl groups may be present at C10 and C13, 
hydroxyl groups may be present at C17, C16 or C3 and an alkyl side chain may be present at C17. The major C21 steroid 
precursors to steroid hormone biosynthesis, derived from cholesterol with an 8-C side-chain at C17, are preg (double bond 
between C5-C6) and prog (double bond between C4-C5), both possessing a 2-C side-chain at C17. 3βHSD isomerase 
activity is responsible for shifting double bonds between rings B and A. Steroids derived from preg follow the Δ5 pathway 
and possess C5-C6 double bonds and steroids derived from prog follow the Δ4 pathway and generally possess C4-C5 
double bonds. For steroids with this basic structure, functional groups and hydrogen molecules are labelled as either α or β, 
according to whether they are situated behind or in front of the plane of the page, respectively (reproduced from Moss, 
1989). 
2.3 Steroid hormones 
Steroids are essential for vertebrate physiology during pre- and postnatal life. They are required for 
normal reproductive function and body homeostasis. In humans, there are five central groups of steroid 
hormones: progestagens (prog), androgens (testosterone), estrogens (estradiol), glucocorticoids 
(cortisol/corticosterone) and mineralocorticoids (aldosterone). Testosterone, and its potent derivative 
DHT, prog and estradiol are together referred to as the sex steroids while cortisol, corticosterone and 
aldosterone are collectively referred to as corticosteroids (Widmaier et al., 2004). Figure 2-2 shows the 
metabolic pathway, which produces the three classes of steroid hormones, namely sex steroids and the 
mineralo-and glucocorticosteroids. 
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Figure 2-2: Overview of the biosynthesis of mineralocorticoids, glucocorticoids, estrogens and androgens in the adrenals, 
testes and ovaries. The steroidogenioc enzymes, P450 and HSD, are shown at the reactions, which they catalyse, as well as 
the electron transfer proteins involved in the reaction: CPR (or POR) and ferredoxin/ferredoxin reductase (fdx/fdr). Cofactor 
CYB5 (or b5) may amplify specific enzyme activities. The formation of the weaker androgens, DHEA and A4, may take 
place in adrenals or not at all. Levels of androgens produced by adrenal glands are highly species-specific and dependent on 
the 17,20-lyase activity of CYP17A1. Complete conversion of androgens to estrone and estradiol take place only in the 
ovaries (reproduced from Miller and Auchus, 2011).  
Although present during other phases of the estrous and menstrual cycles, progestagens are defined by 
their ability to maintain pregnancy. Synthetic progestagens (or progestins) are used as HRTs and in 
contraception (Voet and Voet, 2004). The progestagens (prog, 17OHprog and 17OHpreg) are the major 
precursors to the mineralocorticoids (prog), glucocorticoids (17OHprog), estrogens and androgens 
(17OHprog or 17OHpreg) (Miller and Auchus, 2011). Progestagens have anti-gonadotropic effects and 
at adequate concentrations inhibit the formation of prog and other sex steroids (Raudrant and Rabe, 
2003). To avoid sex hormone levels from increasing beyond normal concentrations, the presence of 
prog inhibits the secretion of FSH and LH by negative feedback on the hypothalamic-pituitary-gonadal 
axis (HPG-axis), which is triggered by prog binding to and activating the prog receptor (PR). All 
steroidogenic tissues are in general capable of producing progestagens (Miller and Auchus, 2011). In 
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certain tissues, enzymes required for the formation of the final steroid product are not all found in a 
single cell. Theca cells, in the ovarian follicles, convert cholesterol to the androgen A4, which is 
subsequently converted to estrogen in the granulosa cells. The sex steroids are crucial for sexual 
development, sexual behaviour and reproduction and bind to their respective steroid receptors, AR and 
estrogen receptor (ER), in target tissues (Couse and Korach, 1998). The major postnatal production of 
these steroids commences at the onset of puberty and declines after menopause in females.  
Glucocorticoids perform essential roles in regulating glucose metabolism. They are synthesised in the 
adrenal cortex and bind to the glucocorticoid receptor (GR) in target cells (Miller and Auchus, 2011). 
Glucocorticoids form part of the feedback mechanism in the immune system, which reduces 
inflammation (Rhen and Cidlowski, 2005). Thus, in medicine, they are utilised for properties assisting 
in the treatment of diseases that are associated with an overactive immune system, including asthma, 
allergies and autoimmune diseases. They also have inhibitory effects on lymphocyte proliferation and 
thus are involved in the treatment of lymphomas and leukemias (Pazirandeh et al., 2002). Cortisol is 
the most important glucocorticoid in humans and regulates or assists a variety of important 
cardiovascular, metabolic, immunologic and homeostatic systems (Chrousos, 2009). Cortisol is 
synthesised from corticosterone (the inactive form) and its synthesis is triggered in response to stress or 
when blood glucocorticoid levels are low. Corticosterone also possesses glucocorticoid activity and is 
the predominant glucocorticoid in rodents.  
Aldosterone binds to the mineralocorticoid receptor (MR) and its principle effects include the 
reabsortion of water and the induction and expression of epithelial sodium channels and the 
sodium/potassium ATPase in the distal convoluted tube and collecting duct of the nephron, hence 
regulating sodium reabsorption  and potassium reuptake. Aldosterone action is a key determinant in 
blood pressure (Williams and Williams, 2003). Other steroids are also present in steroidogenic organs 
and in the circulation. These are referred to as steroid precursors as they need to be converted into the 
active steroid hormones in their target tissues. Table 2-1 shows a summary of the major steroids, site of 
production, trophic hormone responsible for regulation and their physiological functions. 
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Table 2-1: Major steroid hormones and their physiological functions (Hu et al., 2010). 
 
Steroid hormones are synthesised from cholesterol via a common precursor steroid, preg, which is the 
product of a single reaction catalysed by the first rate-limiting P450 (see Figure 2-2). All steroids 
possess the gonane skeleton (cyclopentanophenanthrene) or a skeleton derived there from. The basic 
structure has 17 carbons that consists of three 6-C rings to which a 5-C ring is attached, see Figure 2-1 
(Moss, 1989). Carbons 10 and 13 both have attached methyl groups. Each carbon has one or two 
hydrogens attached.  
Steroids are divided into groups according to the parent compound and the number of carbons that they 
possess. Cholestane (cholesterol) has 27 carbons, including the 17-C gonane structure. Pregnanes 
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contain 21 carbons and are referred to as C21 steroids, these include preg, prog and the corticosteroids. 
Androstanes have 19 carbons and include the androgens (C19 steroids). Estranes consist of 18 carbons 
and include the estrogens (C18 steroids). Steroid compounds differ in characteristics because of the 
occurrence of different functional groups attached to the basic steroid structure. Ketones and hydroxyl 
groups, double bonds, methyl- or ethyl groups attached to the four rings and the oxidation state of the 
carbon atoms in the rings, are typical functional groups common to all steroids (Moss, 1989). Preg is 
the first steroid produced: an essential intermediate in steroid synthesis and is therefore the cornerstone 
for synthesis of each class of steroid hormone. The molecular structure of preg is shown in Figure 2-3, 
as well as various active steroid hormones.  
 
Figure 2-3: (a) Molecular structure of preg, a common steroid precursor. Numbers refer to carbon atoms in the steroid 
molecule and the nomenclature of the steroidogenic reactions and associated enzymes are derived from the number of the 
affected carbon atom. (b) Molecular structure of active steroid hormones: the mineralocorticoid aldosterone (C21), the 
glucocorticoid cortisol (C21), the androgen testosterone (C19) and the estrogen estradiol (C18).  
The multitude of biochemical steps which occur during steroid synthesis from cholesterol each 
incorporate small molecular changes to each formed steroid and are exquisitely mediated by specific 
enzymes. The steroids produced by a particular cell therefore depend on the types and concentrations of 
enzymes present. 
2.4 Cholesterol synthesis and delivery to steroidogenic tissue 
Steroidogenic cells have the potential to acquire cholesterol from multiple sources. Cholesterol 
synthesis can be achieved de novo from acetate in the ER of all steroidogenic cells (Mason and Rainey, 
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1987). Furthermore, using receptor-mediated uptake methods, intracellular cholesterol can be acquired 
from plasma low-density lipoprotein (LDL) and high-density lipoprotein (HDL) (Gwynn and Strauss, 
1982). Even though all major steroidogenic organs are capable of synthesizing cholesterol de novo; the 
adrenal and ovaries preferentially utilize cholesterol supplied by LDL and HDL, while testicular 
Leydig cells rely essentially on endogenously synthesized cholesterol. In contrast to human adrenals 
preferring LDL-derived cholesterol, rodent adrenals prefer synthesis from HDL via a receptor termed 
scavenger receptor B1 (SRB1) (Azhar et al., 2003).  
Intracellular cholesterol levels are controlled by a collection of transcription factors referred to as sterol 
response binding proteins (SREBPs). These proteins regulate the expression of genes, which are 
implicated in the biosynthesis of cholesterol, as well as fatty acids (Horton et al., 2002). ACTH 
stimulates LDL receptors, which causes the uptake of LDL cholesterol, as well as stimulating the rate 
limiting enzyme of cholesterol synthesis: 3-hydroxy-methylglutaryl co-enzyme A reductase. Adequate 
concentrations of LDL suppress this enzyme. After receptor-mediated endocytosis, intracellular LDL 
cholesterol esters are either stored in endosomes or converted to free cholesterol, which are used in 
steroid hormone synthesis (Brown et al., 1979). Figure 2-3 shows the main features of cholesterol 
delivery intracellular and into the mitochondria. 
 
Figure 2-3: Cellular cholesterol economy and delivery to the mitochondria for steroid hormone synthesis (Miller and 
Auchus, 2011). 
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Enzymes of the acyl-coenzyme A: cholesterol acyltransferase (ACAT) family can esterify free 
cholesterol, which is stored as cholesterol esters in lipid vesicles. Furthermore, activation of hormone-
sensitive lipase (HSL) allows access to this free cholesterol. Finally, free cholesterol can be bound by 
StarD4 for transport through the cytosol to target membranes, including the outer mitochondrial 
membrane (OMM) (Soccio and Breslow, 2003). However, StarD4 mediated transcytoplasmic transport 
is not the only means by which free cholesterol or cholesterol from intracellular lipid droplets can reach 
the OMM. Movement and fusion of adjacent cholesterol containing vesicles (Soccio and Breslow, 
2004) as well as nonspecific bindings with sterol-carrier proteins (Gallegos et al., 2001) can transport 
the nearly insoluble free cholesterol to the OMM. StAR protein is responsible for the swift 
translocation of cholesterol from the OMM to the inner mitochondrial membrane (IMM) (Miller, 
2007a). Transport of cholesterol into the IMM initiates the start of steroidogenesis with the first 
catalytic reaction, mediated by P450scc and the production of the first C21 steroid precursor, preg. 
2.5 Steroid hormone biosynthesis by endocrine tissues 
Steroidogenesis in the adrenal, ovaries and testes is predominantly under the regulation and control by 
tissue-specific trophic hormones; however the availability of sufficient levels of cholesterol, as a 
substrate, is a key determining factor in optimal production of steroid hormones. Only the adrenals can 
synthesize corticosteroids. The ovaries and testes, but not the adrenals, can synthesize estrogens. The 
adrenals, ovaries and testes can all synthesis progestagens and androgens though the amounts of 
androgens produced by the adrenals depend greatly on the species and the concentration and expression 
of steroidogenic enzymes (Miller and Auchus, 2011).  
2.5.1 The biosynthesis pathway 
The comprehensive metabolic pathway for the biosynthesis of active steroid hormones from cholesterol 
commences with the mediated transport of cholesterol into the mitochondria of a steroidogenic cell. A 
side chain cleavage reaction yields the steroid precursor, preg, which is systematically and 
enzymatically transformed via a cascade of reactions to produce biologically active steroid hormones 
(see Figure 2-2).  
Stellenbosch University  http://scholar.sun.ac.za
14 
The collection of enzymes controlling each reaction in the pathway, are referred to as steroidogenic 
enzymes and exist in two distinct groups of proteins: P450s and HSDs. Reactions, which are mediated 
by P450 enzymes, are irreversible with regards to mechanism and physiology (Hall, 1986). HSD-
mediated reaction mechanisms are reversible and can proceed bi-directionally, although each HSD 
contributes to steroid flux by either oxidative or reductive mechanisms in vivo (Goosen et al., 2012).  
Steroidogenic enzymes are only expressed in certain cell types. This cell-specific level of expression 
determines the capabilities of each cell to synthesize different steroid hormones. Table 2-2 shows a 
summary of the sites of steroid enzyme expression in steroidogenic tissues and the major steroid 
hormones produced. 
Table 2-2: Specific expression of steroidogenic enzymes in various cell types in the adrenal cortex, ovary and testes 
(Hanukoglu, 1992). 
 
2.5.2 Cytochrome P450s 
P450 steroid enzymes are all members of a protein superfamily represented in all kingdoms (bacteria, 
fungi, plants and mammals) with expression in the majority of species. They all contain a single heme 
group and are comprised of ~500 amino acids (Aguiar et al., 2005). When P450s are complexed in 
vitro with exogenous carbon monoxide, and are reduced, they absorb light at 450 nm, hence the name 
P450 (pigment 450) (Nelson et al., 1996). Over 3000 enzymes have been identified in nature and the 
human genome project has identified 57 human enzymes with critical physiological roles. The 
development of various diseases and disorders have been linked to P450s, including cancer and 
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cardiovascular- and endocrine dysfunction. Numerous levels of regulation contribute to maintaining the 
proper function of P450s, which include transcription, translation and posttranslational modifications of 
the proteins (Tee et al., 2008).  
Mammals express multiple enzymes concurrently in an array of tissue types, cell types and subcellular 
compartments (Guengerich, 2001). Mammalian P450s are all membrane bound. The first reported 
mammalian P450 structure offered insight into the comprehensive understanding of the flexibile nature 
of P450s, which allows them to accommodate a range of substrates with different shapes and sizes 
(Williams et al., 2000a; Williams et al., 2000b). This is particularly true of the xenobiotic P450 
enzymes, which are involved in the metabolism of drugs and carcinogens, while a second group of 
P450 enzymes have high substrate specificity, catalysing the biosynthesis and metabolism of 
endogenous compounds, including cholesterol, steroids, vitamins and eicosanoids.  
One of the most central discoveries that emerged from molecular studies is that almost every P450 
enzyme protein is encoded by a single gene (Miller and Auchus, 2011). A second notable finding is 
that some enzymes catalyse more than one reaction in the pathway. In general, P450s are capable of 
hydroxylating substrates as well as cleaving carbon-carbon bonds within steroid substrates. All P450s 
function as monooxygenases. Their heme centres activate molecular oxygen and incorporate one 
hydroxyl group into substrates by reducing two atoms of dioxygen to one hydroxyl group and one 
water molecule, together with the concomitant oxidation of the electron donor NADPH.  
There are two biochemical classifications of P450 enzymes and they are classified according to their 
intracellular locations and the mechanisms by which they acquire electrons from NADPH (Miller, 
2005). Type 1 P450s are associated with the IMM (including certain bacterial systems), where they 
receive two electrons from the reduction of NADPH via an electron transfer chain of two proteins: fdr, 
a flavoprotein also referred to as adrenodoxin reductase (adr) and fdx, an iron-sulfur protein also 
referred to as adrenodoxin (adx). Type 2 P450s are present in the ER, where they receive electrons 
from NADPH via membrane-bound CPR and are sometimes assisted by CYB5 (Pandey and Flück, 
2013). Figure 2-5 shows these electron transfer mechanisms. 
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Figure 2-5: P450 electron transfer from NADPH. (a) In the mitochondrial system, two high potential electrons are 
transferred from NADPH to a flavoprotein Adr (or fdr) via its coenzyme flavin adenine dinucleotide (FAD). The electrons 
are shuttled one at a time by Ad (adx or fdx), a non-heme iron-sulfur protein, to the Type 1 P450 enzyme to hydroxylate or 
cleave the substrate (s). (b) The microsomal electron transfer system involves only one protein, CPR containing two flavin 
prosthetic groups: FAD and flavin mononucleotide (FMN). Electrons are transferred from NADPH, via the two flavin 
domains, to the type 2 P450 enzymes to modify the substrate (Payne and Hales, 2004).  
2.5.2.1 Mitochondrial (type 1) P450 enzymes 
Mitochondrial enzymes include cholesterol side-chain cleavage (P450scc or CYP11A1), P450 11β-
hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2).  
The predominant sites of P450scc expression are in the adrenal cortex (all three zones), ovary (theca 
and granulosa cells), testes (Leydig cells) and placenta (Ishimura and Fujita, 1997). P450scc catalyses 
the rate limiting step of steroid hormone biosynthesis. It converts cholesterol to preg via three distinct 
reactions: 22-hydroxylation, 20α-hydroxylation, and scission of C20-C22 bond. Figure 2-6 shows these 
sequential reactions. 
Figure 2-6: Three sequential reactions catalysed by P450scc in the formation of preg from cholesterol, via two hydroxylated 
cholesterol intermediates, utilizing one molecule of oxygen and one molecule NADPH per reaction (reproduced from Payne 
and Hales, 2004).  
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The rate limiting nature of this reaction is dependent on access of cholesterol (delivery and transport 
into the mitochondria) to the substrate-binding site of P450scc (Stocco, 2001). The hydroxylated 
intermediates are tightly bound to P450scc, whereas the dissociation constant of final product preg is 
40 to 600-fold more than that of the hydroxylated intermediates (Orme-Johnson, 1990). Preg diffuses 
out of the mitochondria for further enzyme modifications by type 2 P450 enzymes. 
CYP11B1 and B2 are located in the IMM. They are essential in final product formation of 
mineralocorticoids and glucocorticoids. Steroid products produced by type 2 enzymes diffuse back into 
the mitochondria for corticoid synthesis. CYP11B1 catalyses 11β-hydroxylation of 11-
deoxycorticosterone and 11-deoxycortisol yielding corticosterone and cortisol, respectively (Payne and 
Hales, 2004). CYP11B1 can also hydroxylate C18 of 11-deoxycorticosterone or corticosterone to form 
18-hydroxycorticosterone, although it is incapable of catalysing the oxidation of the 18-hydroxy group 
to form aldosterone. CYP11B2, also known as aldosterone synthase, catalyses aldosterone synthesis 
from 11-deoxycorticosterone. CYP11B2 catalyses three sequential reactions, utilizing one molecule of 
oxygen and one molecule of NADPH per reaction and the mitochondrial electron transfer system. 
CYP11B1 and 2 expression is restricted to the adrenal cortex; B2 is solely expressed in the zona 
glomerulosa and B1 is expressed in the zona fasciculata and zona reticularis (Ishimura and Fujita, 
1997). 
2.5.2.2 Microsomal (type 2) P450 enzymes 
The P450 enzymes that target the ER include CYP17A1, P450 aromatase (CYP19) and P450 21-
hydroxylase (CYP21A2).  
CYP17A1 is expressed in all classical steroidogenic tissues, with some species-related differences in 
the adrenal glands, ovaries and placenta (Ishimura and Fujita, 1997). In the adrenal gland, CYP17A1 is 
only expressed in the zona reticularis and zona fasciculata, but not in the zona glomerulosa (Hyatt et 
al., 1983). CYP17A1 is essential for either directing the Δ5- and Δ4 pathways towards glucocorticoid 
(cortisol) synthesis, via its 17α-hydroxylase activity. Its subsequent 17,20-lyase activity results in the 
pathway producing the precursors for sex steroids synthesis.  
Sites of CYP19 are abundant, which includes the ovaries, testes and placenta, however, levels of 
expression have species-dependent differences and more so during pregnancy (Simpson et al., 1994). 
CYP19 catalyses the conversion of the C19 androgens (A4 and testosterone) to the C18 estrogens 
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(estrone and estradiol, respectively). The reaction involves CPR, with three molecules of oxygen and 
three molecules of NADPH involved in hydroxylation and peroxidation reactions, resulting in the 
signature benzene structure.  
Steroid hormone synthesis may occur in peripheral tissues but not from cholesterol. Alternatively, they 
are produced as products of metabolism of circulating precursor steroids, previously formed in the 
endocrine glands. Adipose tissue is capable of the conversion of androgens to estrogens and the 
conversion of testosterone to the androgen derivative, DHT, occurs in the skin (Auchus, 2004). 
Adipose tissue has substantial aromatase activity and adequately transforms A4 to estrone and 
testosterone to estradiol, with less efficiency and serves as the principle mechanism of estrogen 
production in postmenopausal women (Simpson et al., 2002). 
Aromatase excess syndrome is as a result of a defunct CYP19A1 gene, which causes the over-
expression of aromatase and an increase is estrogen production leading to gynecomastia in males and 
gigantomastia in females (Kamat et al., 2002). Aromatase deficiency may lead to the inhibition of 
estrogen production, resulting in virilization of a female at birth and in both sexes, the lack of 
epiphyseal closure resulting in tall stature of the individuals (Herrmann et al., 2002). 
CYP21A2 expression is localized to the adrenal cortex and is mandatory for the synthesis of gluco- and 
mineralocorticoids (Rice et al., 1990). CYP21A2 is responsible for C21 hydroxylation of Δ4 steroids, 
prog and 17OHprog, yielding 11-deoxycorticosterone and 11-deoxycortisol, respectively, as corticoid 
precursors (Payne and Hales, 2004). One molecule of oxygen and one molecule of NADPH are utilized 
in the reaction and catalysis takes place in the ER. As the adrenal zona glomerulosa cells do not express 
CYP17A1, prog cannot be typically 17α-hydroxylated thus prog is the sole substrate for CYP21A2 in 
these cell types. Furthermore, because CYP11B2 is also expressed in these zona glomerulosa, 
CYP21A2 is essential for providing the steroid precursors for aldosterone synthesis.  
A defect within the CYP21A2 gene causes an interruption in the normal development of the enzyme, 
termed congenital adrenal hyperplasia (CAH) or 21-hydroxylase deficiency. Abnormal CYP21A2 
activity reduces cortisol synthesis and a concomitant reduction in cortisol levels. Hyperplasia of the 
adrenal cortex results in the elevation of ACTH levels. ACTH initiates the transport of cholesterol into 
the mitochondria and the synthesis of preg. Steroid precursors prog, 17OHpreg and especially 
17OHprog, accumulate in the adrenal cortex and in circulating blood. 21-Hydroxylase activity is not 
involved in the synthesis of androgens; however, 21-hydroxylase deficiency leads to a considerable 
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amount of 17OHpreg being diverted to the synthesis of DHEA, A4 and testosterone in the first 
trimester of fetal life in both sexes (Lee, 2001). 
2.5.3 Hydroxysteroid dehydrogenases  
HSDs are essential to steroid synthesis and include 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-
isomerases (3βHSD), 17β-hydroxysteroid dehydrogenase (17βHSD) and 11β-hydroxysteroid 
dehydrogenase (11βHSD). They have a molecular mass of ~35-45 kDa and do not possess heme 
groups. In contrast to the single gene expression system for P450s, multiple isoforms exist for 3βHSD 
and multiple isozymes exists for 17β- and 11βHSD, which are all products of distinct genes (Bellemare 
et al., 2005). The number of isoforms/isozymes differ among species with regards to tissue distribution, 
catalytic activity (dehydrogenase or reductase), substrate and cofactor specificity and subcellular 
localization (Miller and Auchus, 2011). All isoforms (except type 5 17βHSD) belong to the same 
phylogenetic protein family, namely the short-chain alcohol dehydrogenase reductase superfamily 
(Miller and Auchus, 2011). Type 5 17βHSD belongs to the aldo-ketosteroid reductase superfamily 
(Bellemare et al., 2005). All HSDs are involved in the reduction and oxidation of steroid hormones.  
2.5.3.1 3βHSD 
3βHSD isoforms exhibit a high degree of amino acid sequence identity and are classified according to 
two functional groups: dehydrogenase/isomerase or 3-ketosteroid reductase, the latter not taking part in 
active steroid hormone synthesis. 3βHSD/isomerases play a pivotal role in synthesising all classes of 
active steroids and are expressed in all steroidogenic tissues in a cell- and tissue-specific manner. Two 
distinct forms have been identified in humans, 3βHSD1 and 2 (Penning, 1997). Type 1 expression 
occurs in the placenta, skin and breast tissue and type 2 occurs in the adrenal gland, ovary and testis 
(Simard et al., 1996). 3βHSD/isomerases are mitochondrial or microsomal membrane bound enzymes, 
depending on the type of cell in which they are expressed (Rheume et al., 1991). They function at key 
branch points, converting progestagens and androgens of the Δ5 pathway to progestagens and 
androgens of the Δ4 pathway (see Figure 2-2) or more specifically, 3β-hydroxy-5-ene steroids into 3-
keto-4-ene steroids through sequential dehydrogenase and isomerase reactions.  
In the first dehydrogenation reaction of the steroid substrate, NAD+ is reduced to NADH with the 
production of a Δ5-3 ketosteroid intermediate and together with NADH, remains in complex with the 
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protein. Bound NADH induces a conformational change within the enzyme. This results in the ensuing 
isomerisation of the adjacent carbon-carbon double bond from the Δ5 position (between carbons 5 and 
6) to the Δ4 position (between carbons 4 and 5) of the bound steroid intermediate, ultimately yielding 
the corresponding Δ4 steroid (Thomas et al., 2003). Substrates are preg, 17OHpreg and DHEA and 
steroid products are prog, 17OHprog and A4, respectively. Figure 2-7 shows the two-step conversion 
of Δ5 androgen 5-androsten-3β-ol-17-one (DHEA) via the Δ5-3 keto intermediate 5-androstene-3,17-
dione to Δ4 androgen 4-androstene-3,17-dione (A4). 3βHSD is also capable of converting 5-
androstene-3β,17β-diol (androstenediol), a product of DHEA metabolism by 17βHSD, to testosterone 
(Payne and Hales, 2004).  
 
Figure 2-7: 3βHSD-mediated conversion of a 3-hydroxy-5-ene steroid (DHEA) to a 3-keto-4-ene steroid (A4). This 
conversion involves (1) a dehydrogenation reaction via NAD+ reduction and (2) a second isomeration reaction due to 
enzyme-bound NADH. The steroid intermediate formed is 5-androstene-3,17-dione (Thomas et al., 2003).  
Steroid 5α-reductases are usually grouped with HSDs however they reduce alkenes with single carbon-
carbon bonds to their saturated state (Miller and Auchus, 2011). Testosterone is converted to DHT by 
two forms of steroid 5α-reductase (encoded by genes SRD5A1 and SRD5A2. 5α-Reductase type 1 is 
found especially in liver and skin and type 2 predominates in urogenital tissues. In men, ~5% of 
testosterone undergoes 5α-reduction to form DHT. DHT has 2-3-fold greater affinity for ARs than 
testosterone and has 15-30-fold greater affinity than adrenal androgens. The dissociation rate of 
testosterone from the receptor is 5-fold faster than for DHT (Grino et al., 1990). Idiopathic hirsutism 
occurs in hyperandrogenic women associated with increased 5α-reductase activity and the concomitant 
increase in levels of DHT (Azziz et al., 2000).  
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2.5.3.2 17βHSD 
17βHSDs, also known as 17-ketosteroid reductase, catalyze the final reaction in active gonadal steroid 
hormone biosynthesis, but are not involved in active hormone synthesis in the adrenal; however, they 
do produce precursors that are transported to the gonads. There are several different 17βHSD isoforms, 
functioning either as oxidases or reductases. They differ in substrate preferences and sites of 
expression. There are at least 14 human 17βHSD isoforms; these isoforms vary widely in size, 
structure, substrate specificity, cofactor utilization, subcellular localization and physiological functions 
(Peltoketo et al., 1999). While the 3βHSDs exhibit a high degree of amino acid sequence identity the 
17βHSD isozymes do not.  
17βHSDs catalyze the reversible conversion of the inactive 17-keto (reduction) to the active 17β-
hydroxy (oxidation) groups in androgens and estrogens (Payne and Hales, 2004). These reactions 
include the interconversions of A4 and testosterone; DHEA and androstenediol; estrone and estradiol; 
androsterone and 5α-androstane-3α,17β-diol (androstanediol), and 5α-androstane-3,20-dione 
(androstanedione) and DHT. They use NADH/NADPH as the cofactor in the conversion of estrone to 
estradiol and A4 to testosterone (Luu-The, 2001; Peltoketo et al., 1999). Figure 2-8 shows the activities 
of steroidogenic 17βHSD types 1 and 3 catalysing reactions in estradiol and testosterone formation, 
respectively. 
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Figure 2-8: Enzymatic reactions catalyzed by 17βHSD isozymes. Human forms 1 and 3 act as reductases. Type 1 converts 
estrone to estradiol and type 3 converts A4 to testosterone with the reversible reactions catalysed by type 2 (Payne and 
Hales, 2004).  
In humans, DHEA accounts for the majority of androgen secreted from the adrenal gland. 17βHSDs are 
expressed in several cell types, including the prostate epithelials. Type 1 is responsible for the 
conversion of DHEA to androstenediol, another significant precursor steroid in the formation of 
testosterone and or the estrogens (Miller and Auchus, 2011). Type 2 is responsible for the 
transformation of androstenediol back to DHEA. An important field of research is the influence of 
androgens on prostate and ovarian cancer. A study showed that orchiectomy reduces plasma 
concentration of testosterone by more than 90% but reduces plasma androstenediol by only 50% 
(Belanger et al., 1986). Although androstenediol is a major metabolite of DHEA metabolism in human 
prostate homogenates (catalysed by prostate 17βHSDs), it has not yet been reported whether prostate 
cancer cells, postorchiectomy, are capable of forming androstenediol (Mitamura et al., 2002). 
Mizokami et al. (2004) found that adrenal androstenediol is present in prostate cancer tissue even after 
androgen deprivation therapies (Mizokami et al., 2004). Furthermore, androstenediol activates mutant 
ARs in cancer cells and is more efficient at activating these receptors than activation by DHT, inducing 
more cell proliferation, more expression of prostate-specific antigen (PSA) mRNA and more PSA 
promoter (Mizokami et al., 2004). Plaza et al. (2010) reported increased conversion of DHEA to 
Stellenbosch University  http://scholar.sun.ac.za
23 
androstenediol in endometria from untreated women with polycystic ovarian syndrome (Plaza et al., 
2010).  
17βHSD type 2 converts testosterone to A4 but after 5α-reduction of testosterone, type 2 is responsible 
for the conversion of DHT to androstanedione interconverted by 17βHSD type 6 (RODH) to 
androsterone. 17βHSD type 6 also exhibits modest 3-C isomerase activity between androstanediol and 
androsterone isomers ((Miller and Auchus, 2011). 17βHSD type 5 (AKR1C3) forms part of the aldo-
keto reductase family and can also convert DHT to androstanediol, where 17βHSD type 2 converts it to 
androsterone. Androsterone is ultimately an inactive metabolite of testosterone breakdown, though it 
can be an effector on its own by being converted back to DHT via 17βHSD type 3 and 6. Table 2-3 
shows the types of 17βHSD isoforms involved in steroidogenic reactions. 
Table 2-3: Principle oxidase and reductase steroidogenic reactions catalysed by 17βHSDs (reproduced from Miller and 
Auchus, 2011). 
 
2.5.3.3 11βHSD 
Although classical steroid hormones are classified as either gluco- or mineralocorticoids, the cloning 
and subsequent expression of MR demonstrated that these receptors had equivalent affinities for both 
aldosterone and cortisol (Arriza et al., 1987). In mineralocorticoid-receptive tissues, cortisol is 
catalytically converted to a metabolically inactive steroid, cortisone (Funder et al., 1988). The 
reversible reactions between the active and inactive forms are mediated by two 11βHSD isozymes 
(White et al., 1997). 11βHSD type 1 (11βHSD1), a 34 kDa dimer, is expressed mostly in 
glucocorticoid-receptive tissues such as the liver, testis, lung, adipose tissue and proximal convoluted 
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tubule (Seckl et al., 2004). Type 1 catalyzes the oxidation of cortisol to cortisone, which involves 
cofactor NADP+, and the reduction of cortisone to cortisol, which involves cofactor NADPH, with 
cortisone reduction being the dominant reaction. Catalysis is dependent on which cofactor is available; 
however, the enzyme can only function in the presence of elevated steroid substrate concentrations 
(Moore et al., 1993). 11βHSD type 2 (11βHSD2) is a 41 kDa protein and only has 21% amino acid 
sequence identity with 11βHSD1, whereas 11βHSD2 and 17βHSD2 share 37% identity and both 
favour steroid oxidation in vivo. 11βHSD2 catalyzes only the oxidation of cortisol to cortisone using 
NAD+. 11βHSD2 expression occurs in mineralocorticoid-receptive tissues and therefore, serves to limit 
MR activation to the effects of “true” mineralocorticoids, aldosterone or deoxycorticosterone (Miller 
and Auchus, 2011).  
2.5.4 Regulation of steroid synthesis and enzyme expression 
Chemical regulation of steroidogenesis is predominantly under the control of pituitary trophic 
hormones and the second rate-limiting step of steroid synthesis is the cleavage of cholesterol side 
chains by P450scc, during the first committed reaction in steroid biosynthesis. This reaction is 
stimulated in steroidogenic cells of the adrenal cortex by ACTH, which initiates glucocorticoid 
production, while LH stimulates steroidogenic cells in the ovary and testes, to release steroid hormones 
(Purves et al., 2001).  
The expression of P450scc proteins occurs in all steroidogenic cells and is regulated by the trophic 
hormonal system, which is cell-type specific (Hanukoglu, 1992; Guo et al., 2003). In the zona 
fasciculata of adrenal cortex cells, the expression of mRNA encoding for P450scc is induced by ACTH 
(Hanukoglu et al., 1990). ACTH is released into the bloodstream from the anterior pituitary, as a 
biological reaction to stress situations. Trophic hormones increase CYP11A1 gene expression through 
transcription factors (SF1) and by the α isoform of activating protein 2 (AP2) (Lavoie and King, 2009). 
P450scc is active at all times; however, its activity is first and foremost restricted by the supply of 
cholesterol from the OMM to the IMM. The supply of cholesterol is considered to be the true rate-
limiting step in steroidogenesis and is facilitated predominantly by StAR or STARD1, a putative 
regulator and cholesterol-shuttling protein (Stocco, 2001). Within P450scc tertiary structure, the start 
domain contains the cholesterol-binding hydrophobic tunnel (Stocco, 2001).  
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In response to cellular stimulation for the synthesis of particular steroids, the amount of StAR available 
to transfer cholesterol to the IMM, confines the rate of the reaction (in acute regulation). With chronic 
or prolonged cell stimulation, the capacity of the system to synthesise the steroid becomes 
questionable. Congenital lipoid adrenal hyperplasia is a disease associated with mutations in the StAR 
gene, where steroid hormone biosynthesis is compromised (Hashemipour et al., 2012). 
Trophic hormone stimulation of any steroidogenic cell results in G-protein activation, which stimulate 
adenylate cyclase activity; elevates intracellular cAMP levels and the concomitant activation of protein 
kinase A (PKA). Activation of PKA signalling pathways is a mode of regulation acting either 
independently or synergistically with other forms of regulation. PKA action involves the 
phosphorylation of proteins (cholesteryl ester hydrolase), as well as transcription factors and cAMP 
response-element binding proteins. The expression of StAR protein is regulated by the cAMP/PKA 
signalling cascade. Regulation of steroidogenesis can also be modulated through signal transduction 
pathways which do not require cAMP and or protein (StAR) synthesis. The PKA-independent 
signalling pathways, as well as the protein kinase C pathway, arachidonic acid metabolites, growth 
factors, chloride ions and the calcium messenger system, regulate or modulate steroid hormone 
biosynthesis (Stocco et al., 2005).  
Chronic regulation includes the over-transcription and translation of genetic sequences encoding for 
enzymes of the steroid biosynthesis pathways (Simpson and Waterman. 1988). A nuclear DNA-binding 
protein, termed SF-1 or Ad4BP, is a key nuclear component, which determines cell-specific expression 
of P450 and some HSD steroidogenic enzymes in the gonads and adrenals (Lala et al., 1992; 
Morohashi et al., 1992). This protein recognizes and binds variations of an AGGTCA sequence motif 
found in the proximal promoter. Other factors are also necessary for determining maximal expression, 
namely tissue-specific expression with cell-specific elements located within the enzymes gene 
sequence.  
ACTH stimulates adrenal zona reticularis and -fasciculata cells; LH stimulates ovarian theca, corpus 
lutea and testicular Leydig cells and FSH stimulates ovarian granulosa cells. Peptide hormones perform 
via G protein-coupled receptors, which activate adenylate cyclase and increases cAMP levels. 
Increased cAMP levels initiates the synthesis of steroidogenic P450 and 3βHSD enzymes, specific to 
those cells. cAMP responsive sequences are located in the promoter sequence regions of genes 
encoding steroidogenic P450s. These sequences may differ among multiple P450 encoding genes and 
between genes in different species. CYP11B2 gene expression is amplified by angiotensin II and 
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potassium ions, which increases intracellular calcium ions rather than the regulation of SF-1. 
Regulation and expression of 17βHSDs exhibit species-specific differences, due to distinct mechanisms 
controlling cell- and tissue- specific regulation (Payne and Hales, 2004). 
2.5.5 Transport of synthesized steroid hormones 
Newly synthesised steroids are secreted directly into circulation where they are bound to specific 
proteins. Some hormone transport proteins in plasma are highly selective by having substrate specific 
characteristics. Sex hormone binding globulin (SHBG) transports estradiol, testosterone and DHT. 
Corticosteroid binding globulin (CBG) transports the major corticosteroid precursors, prog and 
17OHprog. SHBG and CBG have high binding affinities with low binding capacities for their steroids. 
Albumin, the abundant plasma protein found in vertebrates, as well as other transport proteins, are 
comparatively non-selective and transport nearly all lipophilic molecules entering the bloodstream. 
Albumin is not strongly attracted to any one molecule in particular, therefore having low binding 
affinities but it does have a high binding capacity for steroids. (Baker, 2002). 
All circulating steroids are mostly bound to transport proteins but a small group are unbound or free. 
Free steroids are available to act on target cells and are also serve as substrates for steroid metabolism 
in the peripheral tissues. SHBG and CBG contribute to the regulation and availability of steroid 
hormones for biological actions and their clearance (Baker, 2002). 
2.6 CYP17A1: an exquisite regulator of steroidogenesis  
CYP17A1 catalyses two mixed-function oxidase reactions and therefore functions as a key branch 
point in steroidogenesis, determining which class of steroid hormones a given cell can produce (Miller 
and Auchus, 2011). The 17α-hydroxylase activity is essential for the biosynthesis of C21-
glucocorticoids, while both the 17α-hydroxylase and 17,20-lyase activities are required for the 
production of  C19-androgens. CYP17A1 is expressed in the zona fasciculata and -reticularis of the 
adrenal cortex. Zona glomerulosa lacks CYP17A1 and therefore, as a result, produces 
mineralocorticoids. 
Several factors play a role in modulating CYP17A1 hydroxylase and lyase activity, which include 
levels of gene expression, the availability of different endogenous substrates and most importantly, the 
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presence of redox partners CPR and CYB5 (Gower and Cooke, 1983; Matteson et al., 1986; Couch et 
al., 1986).  
2.6.1 The classic dual reactions 
It was first believed that the dual reactions were carried out by two different enzymes (Nakajin et al., 
1981a); however, the authors demonstrated that a particular purified protein catalysed both 17α-
hydroxylation and C17-20 cleavage (Nakajin et al., 1981b). This was confirmed by Zuber et al. (1986), 
by the subsequent cloning of CYP17A1 from bovine cDNA and its expression in COS-1 cells 
catalyzing both C21 and C21 17α-hydroxylated steroids (Zuber et al., 1986). 
In adrenal steroidogenesis, the first CYP17A1 catalysed reaction is the 17α-hydroxylation of the Δ5- 
and Δ4 C21 steroids, preg and prog, yielding their hydroxylated intermediates 17OHpreg and 
17OHprog, respectively. Sequentially, the second reaction of CYP17A1 follows with the scission of the 
C17-20 bond to form the C19 steroids, DHEA and A4, respectively. The favoured substrate for 17,20-
lyase activity is, however, species-specific. Each reaction involves one molecule of NADPH and one 
molecule of molecular oxygen (Payne and Hales, 2004). Figure 2-9 shows an overview of general 
CYP17A1 catalysed reactions. 
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Figure 2-9: CYP17A1 catalysed reactions of the Δ5- and Δ4 pathway. Preg and prog are two intermediates vital to synthesis 
of mineralocorticoids, glucocorticoids and androgens. CYP17A1 exhibits 17α-hydroxylase activity in the conversion of C21 
steroids, preg and prog, to hydroxylated intermediates and 17,20-lyase activity involving the scission of the C17-C20 bond 
of the hydroxy intermediates to produce DHEA and A4, respectively. Acetaldehyde is released as a by-product of the lyase 
reaction (Miller and Auchus, 2011). 
The dual reactions catalysed by CYP17A1 are differentially regulated in a cell- and tissue-specific 
manner. Like all P450s, CYP17A1 requires CPR to shuttle electrons from NADPH to its heme centre 
(Auchus and Rainey, 2004). Using the microsomal methods derived from Nakajin et al. (1981a), Hall 
and colleagues demonstrated that by increasing the molar ratio of CPR to CYP17A1, a concomitant 
increase in the ratio of 17,20-lyase to 17α-hydroxylase activity was observed in porcine testicular 
microsomes (Nakajin et al., 1981a; Yanagibashi and Hall, 1986). They also illustrated, when compared 
to adrenal expression, that CPR was more plentiful in testes, where 17,20-lyase activity is required for 
the production of testosterone. These findings indicated that sufficient levels of CPR are essential for 
optimal 17,20-lyase activity. Throughout development, CPR is expressed in all three of the human 
adrenal zones, though the highest expression is in the zona reticularis and is dependent on the 17,20-
lyase reaction for the production of  C19 androgen precursors (Suzuki et al. (2000).  
In humans and chimpanzee, there is a prepubertal increase in adrenal secretion of C19-steroids (onset 
referred to as adrenarche). Principally, production of DHEA and its sulphate ester continually increases 
to levels exceeding cortisol secretion rates, reaching maximal levels at age 25-30 and slowly declining 
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thereafter (adrenopause) (Orentreich et al., 1984). Adrenarche is independent of the gonads. 
Throughout life, most other mammals, including canine, equine, bovine, porcine, caprine and guinea 
pig species, all have relatively low DHEA-S serum concentrations and both old world and new world 
monkeys have rather high DHEA-S concentrations, which do not fluctuate as a function of age (Cutler 
et al., 1978). Baboon and rhesus monkey DHEA-S concentrations are high at birth and decline shortly 
after (Sapolsky et al., 1993). Although adrenarche has only been documented in humans and 
chimpanzees, fragmentary data suggests it may also occur in gorillas and orangutans (Cutler et al., 
1978). Adrenarche is thus characterized by the important feature of an increased conversion of 
17OHpreg to DHEA, which is resultant of increased 17,20-lyase activity. At adrenarche, CPR 
expression increases in all zones of the adrenal. This in turn increases both activities of the CYP17A1 
enzyme system, particularly the 17,20-lyase, enhancing the overall capacity of DHEA production 
(Auchus and Rainey, 2004). However, increased CYB5 expression in the zona reticularis during 
adrenarche is one of the major contributors to increased lyase activity. 
Abnormal CYP17A1 function has been linked to a several diseases, including polycystic ovary 
syndrome (Qin and Rosenfield, 1998; Strauss, 2003), Cushing’s syndrome (Ogo et al., 1991), CAH 
(Maitre and Shirwalkar, 2003) and prostate cancer (Lunn et al., 1999; Madigan, 2003). 17α-
Hydroxylase deficiency is a rare form of CAH. According to the P450 single gene expression system, 
the adrenals and gonads share the same CYP17A1 defect. The lack of adrenal 17α-hydroxylase activity 
is characterized by weakened cortisol production and resultant hypersecretion of ACTH, which drives 
massive overproduction of the 17-deoxysteroids, deoxycorticosterone and corticosterone. Excess 
deoxycorticosterone suppresses the regulatory renin-angiotensin system, consequently, suppressing 
aldosterone synthesis causing hypertension and hypokalemia (Costa-Santos et al., 2004). Defunct 
CYP17A1, exhibiting no hydroxylase activity is deficient of lyase activity as well, suppressing sex 
steroid formation. An absence of CYP17A1 lyase activity in humans, due to preferential congenital 
mutations, leads to the development of abnormal secondary sex characteristics, sexual infantilism in 
females and failure of virilization in males (Suzuki et al., 1998). The 17,20-lyase activity is particularly 
sensitive to alterations in the interactions between CYP17A1 and its cofactors proteins CPR and CYB5 
(Gupta et al., 2001). 
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2.6.2 Species-specific CYP17A1 activities 
The mechanism of action of these enzymes in the steroid metabolic pathway is complex and steroid 
metabolism in different species in the adrenal is continuously being investigated. Various species 
CYP17A1 show different selectivities towards substrates of steroid precursors and intermediates. A 
major difference between species CYP17A1 functions, is attributed to the lyase activity towards Δ5- 
and Δ4 hydroxylated intermediates and the fact that in some species the secretion of C19-steroids is not 
restricted only to the gonads. Humans and higher primates can form DHEA and A4 in the adrenals. 
Lower vertebrates, such as rats, are incapabale of synthesizing adrenal C19-steroids, as CYP17A1 is 
not expressed in the adrenals (Miller and Auchus, 2011). 
Transfections in non-steroidogenic COS-1 cell lines, demonstrated that the initial hydroxylase reaction 
catalysed by human, bovine or rat CYP17A1 shows equal Δ5- and Δ4 activities and that these species 
proteins can be differentiated on the basis of lyase activity (Fevold et al., 1989). Human, bovine and 
porcine CYP17A1 favours 17OHpreg as the substrate for the lyase reaction (Miller, 1988), while the 
rat enzyme favours 17OHprog (Fevold et al., 1989). 
Human and baboon CYP17A1 cDNA share 96% amino acid sequence identity. Sequence analysis 
showed that there are 28 different amino acid residues between human and baboon CYP17A1, 
primarily in the F and G helices and the F-G loop (Swart et al., 2002). Human and chimpanzee 
CYP17A1 differ by two amino acids, sharing more than 99% amino acid sequence identity (Arlt et al., 
2002). Baboon CYP17A1 has a significantly higher activity for prog hydroxylation relative to preg, 
whereas human and chimpanzee CYP17A1 favours preg hydroxylation (Arlt et al., 2002). Baboon 
CYP17A1 has no 17,20-lyase activity for 17OHprog and although A4 forms part of the major 
androgens secreted by the human adrenal, human CYP17A1 17,20-lyase activity primarily converts 
17OHpreg to DHEA via the Δ5 pathway. Adrenal A4 is produced by the subsequent conversion of 
DHEA to A4 by 3βHSD2 (Swart et al., 2002; Nakamura et al., 2011). In species such as the rat and 
trout, testosterone synthesis is dependent on the Δ4 pathway, while humans rely on the Δ5 pathway 
(Brock and Waterman, 1999). Guinea pig CYP17A1 favours Δ4 hydroxylase and -lyase activities and 
is incapable of converting 17OHpreg to DHEA (Tremblay et al., 1994). Porcine and hamster CYP17A1 
catalyse both Δ5- and Δ4 hydroxylase and -lyase reactions (Zhang et al., 1992; Cloutier et al., 1995).  
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2.6.2.1 16α-hydroxylase activity  
In addition to 17α-hydroxylase and 17,20-lyase activities, CYP17A1 also exhibits species-specific 
steroid hydroxylase activities. In some species, CYP17A1 exhibits 16α-hydroxylase activity towards 
prog. In 1965, Sharma et al. (1965) first detected high levels of 16OHprog using microsomal studies 
involving testicular tissue incubated with prog (Sharma et al., 1965). It was subsequently shown, that 
the 16OHprog produced from prog in human testicular microsomes, was not metabolized further and 
that it had an inhibitory effect on CYP17A1 lyase activity (Inano and Tamaoki, 1978). Further studies 
showed the conversion of prog to 16OHprog in the fetal adrenal (Yamasaki and Shimizu, 1973) and 
human ovaries (Sano et al., 1981).  
Both the human and chimpanzee enzymes convert striking amounts of prog to 16OHprog (Swart et al., 
1993; Arlt et al., 2002). The C16 hydroxylation is catalysed in a common active site with the 17α-
hydroxylase and 17,20-lyase reactions. This enzyme does not hydroxylate preg at the C16 position 
(Swart et al., 1993).  
 
Human CYP17A1 has been shown to produce a 16OHprog to 17OHprog ratio of 1:4 when expressed in 
COS-1 cells (Swart et al., 1993) and 1:2 when expressed in yeast (Storbeck et al., 2008a). Even though 
the physiological importances of mineralocorticoids, glucocorticoids and sex steroids have been well 
established, the precise function of 16OHprog is yet to be determined. 
16α-Hydroxylase activity has been reported in other primate and mammalian species, although levels 
of 16OHprog are substantially lower than in human and chimpanzee (Swart et al., 1993; Arlt et al., 
2002). Artl et al. (2002) demonstrated the ratio, of 16α-hydroxylase to17α-hydroxylase activities of 
human and chimpanzee CYP17A1, to be 8-fold higher than that of baboon CYP17A1 and 2-fold higher 
than rhesus monkey CYP17A1 (Arlt et al., 2002). Storbeck et al. (2008a) developed a sensitive UPLC-
coupled atmospheric pressure chemical ionization mass spectrophotometry assay, which enabled the 
detection of 16OHprog, produced by the angora goat CYP17A1 expressed in COS-1 cells (Storbeck et 
al., 2008a). The authors concluded that although some species did produce small amounts of 
16OHprog, the levels were below the previous limits of detection. 
A study involving site-directed mutagenesis and prog conversion assays in COS-1 cells, identified a 
single amino acid residue responsible for conferring 16α-hydroxylase activity in human CYP17A1, 
namely Ala at position 105 (Ala105) (Swart et al., 2010). They demonstrated that introducing the 
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mutation Ala105Leu into the human enzyme significantly increased the ratio of 17OHprog to 
16OHprog when compared to the wt enzyme. Conversely, introducing the Leu105Ala mutation into the 
baboon, caprine and porcine enzymes resulted in a decreased ratio of 17OHprog to 16OHprog when 
compared to the respective wild-types (Swart et al., 2010). 
2.6.2.2 16-ene synthase activity 
CYP17A1 possesses the ability to catalyse the formation of a third class of active steroids, referred to 
as 16-unsaturated steroids or 16-androstenes, via its 16-ene synthase activity (Soucy et al., 2003). 
Synthesis of 16-ene steroids are highly species-specific and are based on the nature and functions of 
these steroids. These steroids are sex pheromones and are produced predominantly by the gonads in 
humans and porcine (Weusten et al., 1989). Two types of 16-androstenes, 5α-androst-16-en-3-one 
(androstenone) and 5α-androst-16-en-3α(or β)-ol (androstenols), have aroused considerable interest as 
they elicit both primer and releaser pheromonal effects in porcine, predominantly androstenone, which 
is stored in adipose tissue of mature boars (Pattersen, 1968). 16-Androstenes are present in neonatal 
porcine testis and the quantities increase progressively with age, particularly after 18 weeks (Booth, 
1975).  
Production of 16-androstene steroids is catalysed by CYP17A1s 16-ene synthase activity, which 
requires the presence of CYB5: together CYP17A1 and CYB5 are referred to as the andien-β synthase 
system (Katkov and Gower, 1970). In species producing androstene steroids, the CYP17A1-CYB5 
enzyme system is capable of cleaving the C17,20 carbon bond of steroid substrates without prior 17α-
hydroxylation. Overproduction of 16-androstene steroids by the testis can be attributed to the high 
levels of CYB5 found in testicular tissue (Robic et al., 2008).  
Lin et al. (2005a) developed a sensitive and flexible single-stranded conformational polymorphism 
(SSCP) technique, which is capable of detecting a single nucleotide polymorphism (SNP) (Lin et al., 
2005a). They used this method to assess the result of a tyrosine to adenosine nucleotide substitution at 
1317 bp of porcine CYP17A1 nucleotide gene sequence. The mutation caused a Leu439 to His439 
amino acid substitution and no changes were observed in CYP17A1 enzyme activity in the biosynthesis 
of androstenone or sex steroids. Other polymorphisms (formerly suggested to be imperative for the 
functional interaction of CYP17A1 with CYB5 in human) were not observed (Lin et al., 2005a). The 
synthesis of androstenone in porcine testis was not affected by any polymorphisms in the coding region 
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of the porcine CYP17A1 gene. The authors also identified a guanine/tyrosine SNP in porcine CYB5 
mRNA at base 8, upstream to the ATG in the 5’-untranslated region (Lin et al., 2005b). Of the total 
229 testis samples tested, 84.8% were homozygous for the guanine variant, 12.4% were heterozygous, 
and 2.8% were homozygous for the tyrosine variant. The latter demonstrated significantly lower CYB5 
activity than variant guanine, as well as a subsequent reduction in androstenone production.  
Studies by Kwan et al. (1985) showed C21 steroids are substrates for 16-ene activity and the first 
metabolites formed are androstadienol (andien-β), synthesized from preg and androstadienone, 
synthesized from prog (Kwan et al., 1985). The 16-ene synthesis pathway in immature porcine 
testicular microsomes is shown in Figure 2-10 together with the key steroid enzymes, CYP17A1, 
CYB5, 17β-, 3βHSD and 5α-reductase, which are involved in 16-ene biosynthesis. 
CYP17A1 appears to be capable of cleaving the C17,20 bond of prog directly in a species-specific 
manner and requires the assistance of CYB5. Prog can be converted into androstadienone but not via 
17OHprog or 16-dehydroprog as intermediates (Kwan et al., 1984). Neither 17OHpreg (Katkov and 
Gower, 1970) nor 17OHprog (Ahmad and Gower, 1968) can be converted to 16-androstenes directly. 
Kwan et al. (1984) found DHEA and A4 present from the typical 17,20 cleavage of 17OHpreg and 
17OHprog, respectively (Kwan et al., 1984). The concentration of A4 was 31 times higher than the 
control incubation. The high proportion of 17OHprog being metabolized by 17,20-lyase, may explain 
why it is not available for the conversion to 16-dehydroprog and androstadienone. The authors base the 
validity of such an explanation on the assumption that CYP17A1 is active and capable of catalyzing the 
direct conversion of prog to the 16-androstene precursors in neonatal porcine testis (Kwan et al., 1984). 
No androstenes were formed when 16OHprog was used as a putative precursor (Kwan et al., 1985). A 
similar conclusion was reported by Matsui and Fukushima (1970) who used 16OHprog and boar testis 
preparations (Matsui and Fukushima, 1970). 
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Figure 2-10: CYP17A1 16-ene synthase activity in neonatal porcine testicular microsomes. CYB5 and 3βHSD are essential 
for 16-ene steroid synthesis. Species-specific 17,20-lyase activity, in the presence of high levels of CYB5, is responsible for 
conferring andien-β synthase activity. Preg and prog are the major substrates for andien-β synthase action; they produce the 
first 16-ene precursor steroids, andien-β and androstadienone, respectively. It appears that a single direct side-chain 
cleavage reaction of prog is responsible for androstadienone formation, while 17OHpreg and 16-dehydropreg are 
intermediates in andien-β synthesis. 5α-reductase and 3β-HSD are involved in formation of final 16-androstene products 
(adapted from Kwan et al., 1984). 
Mason et al. (1979) first proposed that preg is converted into andien-β via a pathway first involving 
17α-hydroxylation of preg, then a dehydration reaction forming 16-dehydropreg with andien-β 
synthase subsequently catalyzing the side-chain cleavage (Mason et al., 1979). Kwan et al. (1984) 
confirmed this and added that the final androstenol products androsten-3α-ol (An-α) and androsten-3β-
ol (An-β) are formed by andien-β metabolism; see Figure 2-11 (Kwan et al., 1984).  
Loke and Gower (1972) suggested that 5-pregnene-3β,20β-diol was also an intermediate in andien-β 
synthesis from preg in boar testicular microsomes (Loke and Gower, 1972). However, when 5-
pregnene-3β,20β-diol was given as a substrate, 17OHpreg and 16-dehydropreg were found as well as 
andien-β. They suggested/concluded that the diol was converted back to preg by 20β-hydroxysteroid 
dehydrogenase (20βHSD) and then metabolized to andien-β (Loke and Gower, 1972).  
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Figure 2-11: Andien-β metabolism and the formation of 16-androstene steroids. The 16-ene synthase complex, porcine 
CYP17A1 and CYB5, transforms preg into andien-β and prog into androstadienone. 
Andien-β is transformed via 3βHSD activity, yielding the steroid intermediate androstadienone, which 
is then reduced by 5α-reductase to yield androstenone (Kwan et al., 1984). Androstenone is finally 
reduced to α-or β-androstenol, by 3α- or 3βHSD, respectively (Robic et al., 2008). 3βHSD is active in 
both the liver and testis but the expression of the hepatic form is negatively correlated with 
androstenone levels in adipose tissue. In comparison with other species, variations detected in the 
promoter region of porcine HSD3B gene do not show any relationship with androstenone formation but 
are associated more with the type of breed (Cue et al., 2007). Cue et al. (2007) speculated that 
transcription factors, responsible for the liver-specific regulation of the HSD3B expression, may be 
crucial for regulating the manner in which androstenone is deposited in porcine adipose tissue (Cue et 
al., 2007).  
It is clear that CYP17A1 together with CYB5, as well as 3βHSD are crucial to the production of 16-ene 
steroids. 
2.7 Cytochrome b5: a precise modulator of steroid enzyme activity 
In mammals, CYB5 exists as a soluble cytosolic protein (also found in erythrocytes) or as a membrane-
bound protein, the latter acting as either a modifier or an essential component of P450 or non-P450 
enzyme catalysed reactions in steroid biosynthesis (Schenkman and Janssom, 2003). Membrane-bound 
CYB5 are classified as two types, according to primary structure and sub-cellular localization. The first 
type is a 134 amino acid protein, localized to the ER and the second type is the 146 amino acid protein, 
localized to the OMM (Ito, 1980; Lederer et al., 1983). The expression of both CYB5 isoforms have 
been detected in a variety of tissues, including the adrenals, gonads, kidney, liver, fat and brain 
(Giordano and Steggles, 1991; Giordano and Steggles, 1993).  
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Two genes express human CYB5. The first gene on chromosome 18q23 has 6 exons that undergo 
alternative splicing: exons 1-4 encode a 98 amino acid soluble form and exons 1-3 and 5-6 encode the 
widely expressed 134 amino acid CYB5 form bound to the ER (Giordano et al., 1993). The second 
gene on chromosome 16q22.1 oncorporates 5 exons, which encode the 146 amino acid OMM-bound 
form (Kuroda et al., 1998). The 134 amino acid ER-bound protein is the only form known to have 
significant affects on adrenal steroidogenesis. It is the most dominant CYB5 isoform present in the 
adrenal and is localized to the zona reticularis, the site of adrenal androgen production, where its 
expression coincides with the onset of adrenarche (Miller and Auchus, 2011). 
The 134 amino acid ER-bound form of CYB5 is a 16 kDa electron transfer protein consisting of three 
structural domains: the N-terminal and heme-containing soluble domain, a C-terminal membrane 
anchor and a linker region, which connects the two domains (Renthal, 2010). The amino acid sequence 
of the truncated catalytic heme domain is highly conserved throughout all species, although the full-
length protein shows over 80% amino acid sequence identity in mammals (Ozolz, 1989). The heme 
domain (~90 amino acids) is responsible for electron transfer and possesses several negatively charged 
residues, which are involved in the binding of CYB5 to its redox partners (Im and Waskell, 2011). Of 
the 28 amino acids comprising the N-terminal tail, 23 are hydrophobic. It is unclear whether the tail 
domain interacts with P450s of if they are only necessary for the appropriate positioning of the heme 
group. The last 10 residues of the C-terminal are essential for targeting the ER and for membrane 
insertion (Mitoma and Ito, 1992). A study showed that the insertion of additional residues in this region 
caused the protein to be transported to the plasma membrane of COS-1 cells (Honsho et al., 1998). The 
linker domain (~15 amino acids) is highly flexible and is crucial for heme positioning in the optimal 
orientation to stimulate the P450. Proteolytic cleavage before or after the linker domain disassociates 
the soluble catalytic domain from the membrane anchor. Soluble CYB5 cannot modify the activities of 
the microsomal steroidogenic enzymes, with only the membrane bound forms being able to perform 
this function (Schenkman and Janssom, 2003).  
2.7.1 An allosteric regulator of 3βHSD 
During the biosynthesis of steroid hormones, 3βHSD competes with CYP17A1 for Δ5 steroid 
intermediates. The ratio of the enzyme activities and substrate specificities are critical in determining 
the level of production of steroid intermediates through the pathway (Conley and Bird, 1997). This 
competition is significantly altered by CYB5, which selectively stimulates CYP17A1 lyase activity and 
Stellenbosch University  http://scholar.sun.ac.za
37 
consequently increases C19 steroid production substantially (Katagiri et al., 1982). Goosen et al. 
(2011) investigated the influence of CYB5 on 3βHSD activity and showed in COS-1 cells, co-
transfected with 3βHSD and CYB5, that the latter significantly increased both caprine and ovine 
3βHSD activity towards preg, 17OHpreg and DHEA in a substrate and species-specific manner (Swart 
et al., 1995; Goosen et al., 2011). Although the Km values remained unchanged, CYB5 increased the 
apparent Vmax values of the enzyme for all substrates. In a follow up study, Goosen et al. (2012) 
showed that CYB5 augments 3βHSD activity via an allosteric mechanism by increasing the affinity of 
the enzyme for cofactor NAD+ (Goosen et al., 2012).  
2.7.2 An amplifier of 17,20-lyase activity 
CYP17A1 lies at the junction of androgen and corticoid biosynthesis: hydroxylation being common to 
both pathways and the carbon-carbon bond cleavage only necessary for androgen formation (Nakajin et 
al., 1981b). Under normal physiological conditions, there must be precise control mechanisms 
preventing the hydroxysteroids from undergoing increased carbon-carbon bond cleavage as observed in 
excessive androgen production in the adrenal gland contributing to virilization (Miller and Auchus, 
2011). A remarkable positive correlation is shown between DHEA production and the significant co-
localization of CYB5 and CYP17A1 in the ER of the gonads and the adrenal zona reticularis and 
implicated the involvement of CYB5 as a potential modulator of the cleavage activity of CYP17A1 (Lu 
et al., 1974).  
There is a significant amount of research dedicated to demonstrating what a profound influence CYB5 
has on CYP17A1 activity. Many sources data show (especially for species with minimal to no lyase 
activity), that optimal molar ratios of CYB5 to CYP17A1 increases the rate of the 17,20-lyase reaction, 
to the extent that that it approaches the rate of the hydroxylase reaction (Katagiri et al., 1982; 
Kominami et al., 1992; Lee-Robichaud et al., 1995b; Auchus et al., 1998).  
In 1982, Hall and colleagues were the first to show the dramatically enhanced 17,20-lyase activity of 
CYP17A1 in the presence of purified CYB5 protein (Onoda and Hall, 1982). Katagiri et al. (1982) 
demonstrated the selective stimulation of CYP17A1 lyase activity in the presence of CYB5, which was 
stimulated up to 10-fold, with insignificant stimulation of the hydroxylase activity (Katagiri et al., 
1982). The authors concluded that the degree of side-chain cleavage was dependent on the 
concentration of CYB5.  
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Auchus et al. (1998) established that CYB5 increases 17,20-lyase activity by acting as an allosteric 
effector on the CYP17A1-CPR complex and facilitating optimal electron transfer from CPR to 
CYP17A1 (Auchus et al., 1998).  
Lee-Robichaud et al. (1995b) showed that human CYP17A1 differs from other mammalian enzymes 
with the carbon-carbon bond cleavage activity exhibiting an absolute requirement for CYB5 (Lee-
Robichaud et al., 1995b). They concluded that the low levels of CYB5 found in the adrenal cortex 
should be an important factor in limiting the formation of androgens by this tissue. In the same study, 
the authors made use of NADPH-CPR as the electron donor and showed that homogenous porcine 
CYP17A1 catalysed the conversion of preg and prog to their 17α-hydroxylated counterparts, which 
were subsequently cleaved into androgens through the enzyme’s lyase activity. The study showed that 
CYB5 stimulated both these activities; however it is most noticeable effect was in the formation of 16-
ene steroids, which require CYB5 for their production (Lee-Robichaud et al., 1995b).  
2.7.3 CYB5 structure-function model 
CYB5 belongs to a group of widespread integral proteins with a monotopic membrane topology with 
the N-terminal of the protein presenting itself on the cytosolic side of the membrane and the C-terminal 
incorporated within the membrane layers (Khaderbhai et al., 2003).  
Lee-Robichaud et al. (1997) determined the significance of the membrane-anchoring domain in 
altering CYP17A1 lyase activity using modified forms of rat CYB5 protein: i) native, wt (core-tail, 
residues 1-134); ii) globular, soluble domain (core, residues 1-99); iii) wt attached to an alkaline 
phosphatase signal sequence at the N-terminal (signal-core-tail, residues 21-134) and iv) the globular 
core attached to the alkaline phosphates signal sequence (signal-core, residues 21-99) (Lee-Robichaud 
et al., 1997). The authors proposed a topology-based membrane model of CYB5 with CYP17A1 and is 
shown in Figure 2-12. Each variant of CYB5 was constructed in such a manner that when anchored in 
the membrane, the variant would impose a different orientation of the globular domain for its 
interaction with CYP17A1. Native CYB5 is favourably positioned for optimal interaction with 
CYP17A1 (Figure 2-12a). Signal-core-tail variants were able to adopt three topological states (Figure 
2-12c and d), though only one could provide dynamic interactions with CYP17A1 (Figure 2-12c, 
right). Core and signal-core variants (Figure 2-12b and c, left) were unsuitably orientated with respect 
to CYP17A1.  
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Figure 2-12: Model depicting the possible topologies of membrane bound variants of CYB5 and CYP17A1. (a) Native (wt) 
CYB5 anchored to the membrane via a C-terminal domain (core-tail) shows optimal interaction with CYP17A1. (b) No 
positive interaction is achieved between CYP17A1 and the globular, core. Signal-core variant does not possess the C-
terminal membrane anchor and is N-terminally attached to membrane via alkaline phosphatase signal sequence. Signal-
core-tail variants can present in three topological states: the first state (c, left) allows for no interaction; the second state (c, 
right) allows for a functional interaction and the last state (d) allows for a weak interaction. The authors excluded CPR from 
this model for clarification purposes (reproduced from Lee-Robichaud et al., 1997). 
Native rat CYB5 stimulates maximum lyase potential (Katagiri et al., 1982; Auchus et al., 1998) and it 
was postulated to be as a result of optimal interaction and/or binding between CYB5 and CYP17A1 
(Lee-Robichaud et al., 1997). The C-terminal orientates the globular portion in the favoured position 
with the associated binding site in CYP17A1, therefore ensuring optimal activity. The signal-core-tail 
CYB5 variant exhibited a 2-fold lower affinity for CYP17A1 and ~55% of the lyase stimulatory 
activity by native CYB5. Signal-core and core variants of CYB5 were incapable in promoting lyase 
activity due to an inadequate orientation with respect to CYP17A1. The authors concluded that the 
decreased catalytic competencies, imposed by CYB5 variants with modified tail domains, were 
attributed to their modified interactions with CYP17A1. The incapacity of the soluble heme core to 
stimulate the lyase reaction is corroborated by other reconstituted CYP-CPR-CYB5 studies (Lamb et 
al., 2001; Clarke et al., 2004). This suggests that the membrane anchor domain provides the 
appropriate membrane-integrated topology of CYB5 for maximum interaction in a quaternary complex 
with CYP17A1, as well as contributing to the stability of the protein-protein interface through amino 
acid residue charge-based pairings and non-specific hydrophobic interactions (Mulrooney et al., 2004). 
2.8 Mechanism of CYP17A1 activity 
2.8.1 Redox partners, electron transfer and heme reduction 
The first oxidation reaction catalysed by CYP17A1 requires the transfer of two electrons, via a redox 
partner, for the fundamental reduction of the proteins oxyheme group. CPR is the typical redox partner 
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for P450s and is abundant in mammalian cells, contributing to the transfer of both electrons from 
NADPH to CYP17A1.  
Auchus et al. (1998) investigated the amplification of CYP17A1 activity in reconstituted assays by 
means of variable molar ratios of CYB5 to CYP17A1 while CPR concentration were maintained 
(Auchus et al., 1998). The authors observed maximum stimulation of the lyase reaction when ratios 
between CYB5 and CYP17A1 varied from 10:1 to 30:1. CYB5 in excess, rapidly and considerably 
decreases augmentation of the lyase reaction, which suggests that at these high levels of CYB5, 
electron scavenging from CPR occurs, reducing the potential of the initial electron to reduce 
CYP17A1. They investigated the function of CYB5, using genetically modified CYB5 protein that was 
devoid of heme (apo-CYB5). The expressed recombinant apo-protein, exhibited a similar stimulatory 
effect on CYP17A1 lyase activity, when compared to the holo-protein. The lyase activity was not 
repressed when the ratio of apo-CYB5 to CYP17A1 concentrations exceeded the optimal ratio of 30:1 
for expressed holo-CYB5 (Auchus et al., 1998). Estabrook (1999) proposed that during the reduction 
of CYP17A1 in the second catalytic reaction, the second electron can be derived from CYB5, where 
CYB5 functions as a substitute redox partner to the conventional CPR (Estabrook, 1999). The quicker 
rate at which the second electron is transferred from CYB5 to CYP17A1 is thought to reduce the 
possibility of spontaneous decay of iron-oxygen complex during the P450 oxidoreduction cycle 
(Estabrook, 1999). 
However, in accordance with the findings from Auchus et al. (1998), additional studies led to the 
understanding that CYB5 does not play a role in electron donation or transfer but rather possesses 
remarkable allosteric capabilities in modulating CYP17A1 activity (Auchus et al., 1998; Lee-
Robichaud et al., 1998; Schenkman and Jansson 2003). It was proposed that CYB5 serves as an 
allosteric modulator, which induces a conformational change within the enzyme that is sufficient in 
promoting optimal interaction between CPR and CYP17A1, thus enhancing the flow of electrons 
within the system via CPR-flavin domains, as well as to promote the disassembly of the CYP-substrate 
complex in the catalytic cycle (Schenkman and Jansson, 2003).  
2.8.2 Redox partners and complex formation are essential for CYP17A1 activity 
CPR, a diflavin reductase, is a ~82 kDa membrane-bound protein, which constitutes 680 amino acids 
and utilizes both flavins, FMN and FAD, as cofactors. They bind to different domains in CPR and 
Stellenbosch University  http://scholar.sun.ac.za
41 
serve as intermediates in the transfer of electrons from NADPH (Narayanasami et al., 1995; Shephard 
et al., 1989). Human and other species CPR, share highly conserved binding domains for FMN, FAD 
and NADPH.  FAD and NADPH domains are similar to the FAD and NADPH binding domains of fdr. 
The cofactor binding domains are connected by a flexible, hinge region consisting of ~10-12 amino 
acid residues (Pandey and Flück, 2013). Comparable to microsomal P450s, CPR is membrane-bound to 
the ER by a N-terminal hydrophobic anchor, which consists of ~55 amino acids. Earlier studies showed 
that recombinant CPR devoid of the membrane anchor, was unable to support P450-mediated reactions 
as the removal of this N-terminal sequence led to a loss of interaction with P450s (Lu et al., 1969). This 
emphasized the importance of the membrane anchor for the interaction with P450s.  
Two mechanisms are suggested in playing a role in the association between redox partners and 
CYP17A1, namely electrostatic interactions between the anionic residues of CPR pairing up with 
cationic amino acid residues on the surface of the CYP17A1 molecule, as well as through non-specific 
interactions of the hydrophobic membrane regions of both proteins (Kurian et al., 2004).  
CYP17A1 complexes with CPR during the first hydroxylation reaction. Two electrons are received 
from NADH/NADPH and CPR facilitates the transfer by accommodating these two electrons and 
transferring them, separately and sequentially via FAD and FMN, to the P450. The CPR-P450 complex 
assumes a molecular alignment with respect to the substrate, which allows for oxidative attack by 
CYP17A1, which hydroxylates the substrate at C17 position (Akhtar et al., 2005). CYB5 may either 
facilitate conventional CPR redox reactions (in CYP17A1 catalysed reactions) or as a donator of 
second electron to P450s (drug metabolizing P450s) (Shimada et al., 2005). During the second catalytic 
round, species- and tissue-dependent, CYB5 may interact with the CYP17A1/CPR complex and induce 
a conformational change at the active site in CYP17A1s, which expedites an oxidative attack at C20 of 
the hydroxylated substrate intermediate, resulting in the dissociation of the bond between C17 and C20 
(Lee-Robichaud et al.,1998). No apparent or remarkable conformational changes were observed by 
CYB5 physically interacting with CYP17A1s active site, it was subsequently proposed that there are 
rather understated structural modifications that occur in the interior active sites of CYP17A1 (Akhtar et 
al., 2005). Lee-Robichaud et al. (1998) proposed that the substrate intermediate, whilst still 
maintaining its affinity for the enzyme, was reorientated to a position, which favoured C17-C20 
cleavage (Lee-Robichaud et al., 1998). Mutations in CPR cause a complex set of disorders that often 
resemble defects in steroid metabolizing enzymes CYP17A1, CYP21A2 and aromatase (Flück et al., 
2007). Figure 2-13 shows allosteric modulation by CYB5 promoting CYP17A1 cleavage activity. 
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Figure 2-13: Model proposing CYB5-mediated changes in CYP17 (CYP17A1) 17,20-lyase activity. Two electrons are 
acquired from NADP and transferred by CPR and/or CYB5, which interact with CYP17A1 via electrostatic interactions 
between oppositely charged amino acid residues. Non-specific interactions between the membrane-anchoring regions and 
membrane facilitates the formation of the complex. (a) The CPR-CYP17A1 complex generates a molecular alignment that 
is sufficient for the oxidative attack of CYP17A1 to hydroxylate a steroid substrate at the C17 position and not at the C20. 
(b) CYB5 may interact with this complex during the second round of catalytic cycle and can induce a conformational 
change in CYP17A1 at the active site. The change will induce an oxidative attack by the oxyheme intermediate (*) of 
CYP17A1 and redirect it towards the C20 of the hydroxylated substrate intermediate and is observed by the scission of the 
C17-C20 bond. Fe-O-O is suggested to be the attacking oxyheme intermediate (reproduced from Akhtar et al., 2005). 
In the CYP17A1-redox partner complex, C17 is in closer proximity with the activated oxyheme 
intermediate and hydroxylation is generally favoured at this carbon position; however it has been 
reported that this attack may also take place at the C16 position (Swart et al., 1993). The CYP17A1-
CPR-CYB5 complex alters CYP17A1 orientation by bringing the oxyheme intermediate into alignment 
with the C20 position of hydroxylated substrate intermediate, either through repositioning of the heme 
group or substrate intermediate. A consequent nucleophillic attack (cleavage) is directed towards the 
carbonyl group of the substrate to form a shorter steroid product and acetic acid (Lee-Robichaud et al., 
1998). In species with 16-androstene steroid production, the oxyhemeprotein-CYB5 complex causes a 
unique realignment of certain steroid substrates facilitating 16-ene synthase activity of CYP17A1 in 
bypassing prog hydroxylation and cleaving prog directly to yield androstadienol or in the formation of 
andien-β from 16-dehydropreg cleavage (Soucy et al., 2003). These reaction takes place at a rate 10-
fold faster when in the presence of high amounts of CYB5 and occurs in Leydig cells.  
2.9 Summary 
The biochemical pathway that comprises all active adrenal and gonadal steroid hormone biosynthesis is 
exquisitely controlled. Steroidogenic enzymes are responsible for catalyzing the formation of each 
steroid intermediate and product and the extent of their activities are facilitated by electron transfer 
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and/or redox partner proteins. These enzymes are tightly regulated under HPA-axis control, as well as 
on levels of gene transcription, post-translational modifications and cell-, tissue- and species-specific 
expression patterns.  
Cholesterol and its immediate C21 metabolite, preg, are the parent steroids from which all steroid 
intermediates are derived. P450s and HSDs play pivotal roles in steroid hormone biosynthesis. They 
have unique and specialized functions based solely on the substrates that they can catalyse. Preg 
initiates the Δ5 steroid pathway in androgen and corticoid formation. Dehydrogenation/isomerisation of 
preg yields prog, which initiates the Δ4 pathway in androgen and corticoid formation. Δ5- and Δ4 
androgen formation vary greatly in the adrenals among different species, particularly with A4 
formation.  
The enzyme CYP17A1 plays an essential role in both adrenal and gonadal steroidogenesis in 
mammals. CYP17A1 functions at intersections in competition with 3βHSD for substrates. CYP17A1 
exhibits dual activity of hydroxylation of C17 and side-chain cleavage of the carbon-carbon bond 
between C17,20 of C21 steroids, the latter reaction being strongly amplified by CYB5 in a species-
specific manner. 3βHSD and 17βHSD exist as multiple isoforms and are crucial components in the 
biosynthesis of all steroids. 3βHSD catalyses the transition between Δ5- and Δ4 C21 steroids and 
together with the 17βHSDs catalyze vital steps in C19 steroid formation. Recent publications have 
placed new emphasis on the steroid synthesis pathway through the allosteric interaction between 
3βHSD isoforms and CYB5 which augments the activity of 3βHSD thus creating a highly competitive 
environment with CYP17A1 for substrates (Goosen et al., 2011; 2012).   
In addition to the conventional reactions of CYP17A1, CYP17A1 has species-specific 16α-hydroxylase 
and 16-ene-synthase activity. A recent publication has attributed 16α-hydroxylase to amino acid 
residue Ala105 (Swart et al., 2010). CYP17A1, together with high levels of CYB5, also has the ability 
to cleave the C17,20 side chain of C21 steroids without prior 17α-hydroxylation and form pheromonal 
16-androstenes. This initial lyase reaction is greatly species- and tissue-specific and purely dependent 
on CYB5. 3βHSD is equally essential in this pathway and is responsible for final product formation. It 
is clear that CYP17A1 together with CYB5, as well as 3βHSD are crucial to the regulation and 
formation of major steroids. 
In the following chapter, sequence comparisons of the cDNA encoding two wt porcine CYP17A1’s and 
the consequences of point mutations, assessed in terms of the catalytic activity towards prog, will be 
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presented. The influence of porcine CYB5, cloned from liver mRNA, as well as that of CYB5 from 
various other species on wt porcine CYP17A1 activity, will also be presented in subsequent chapters.   
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CHAPTER 3 
THE INFLUENCE OF VAL40LEU, HIS407LEU AND LEU105ALA 
SUBSTITUTIONS ON 17α-HYDROXYLASE/17,20-LYASE AND 16α-
HYDROXYLASE ACTIVITIES OF PORCINE CYP17A1 
3.1. Introduction 
CYP17A1 cDNA, 1527 bp, encodes a protein of 509 amino acids and has a predicted molecular weight 
of 56 kDa (Chung et al., 1987). This enzyme catalyses both the 17α-hydroxylase and 17,20-lyase 
reactions, essential to steroidogenesis in the adrenal and gonads (Miller and Auchus, 2011). CYP17A1 
also has the ability to catalyse the 16α-hydroxylation of prog with Ala105 being the key residue in 
conferring this activity in humans (Swart et al., 2010). CYP17A1 from various species exhibit 
markedly different activities because of structural variations, differences in redox partner binding and 
differences in the contribution of CYB5 to the lyase activity. The reactions are catalysed in a common 
active site (Miller and Auchus, 2011). Mutations in the gene encoding this protein result in the loss of a 
functional protein eliminating either the 17,20-lyase activity (Biason-Lauber et al., 1997), 17α-
hydroxylase (Fardella et al., 1994) or both activities (Suzuki et al., 1998). Mutations with such 
consequences usually fall within conserved domains of the proteins three-dimensional (3D) structure 
(Chung et al., 1987). Research has identified key amino acid residues within the CYP17A1 sequence, 
which are solely responsible for- or that have considerable influence on enzyme activity and essentially 
steroid product formation (Swart et al., 2010; Gupta et al., 2001).  
The obstacles in structural studies of membrane-bound proteins are generally attributed to their high 
level of hydrophobicity, which makes them susceptible to misfolding and aggregation and their 
insolubility does not allow for obtaining adequate quality crystals using X-ray crystallography. 
Furthermore, their large size and slow reorientation does not make them suitable for structure 
determination using solid-state NMR spectroscopy (Lacapère et al., 2007). However, since the first 
published structure in 1965, the number of structures determined for membrane proteins, have grown 
exponentially (Deisenhofer et al., 1985; White, 2004). Additional methods have been developed in 
ascertaining 3D structures, one widely used technique is homology, comparative or molecular 
modelling (Kirton et al., 2002). It has been observed that proteins with similar amino acid sequences 
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have a tendency to adopt similar 3D structures (Chothia and Lesk, 1986). Therefore, it is possible to 
predict the 3D structure (though inherently less accurate than those derived experimentally) of a protein 
based exclusively on knowledge of its amino acid sequence and the 3D structures of proteins with 
similar sequences.  
Much has been learnt in terms of structure/function through enzyme deficiencies brought about by 
specific mutations occurring in patients as well as site-directed mutagenesis. The structure of human 
CYP17A1 has been modelled using computational chemistry in order to understand the information 
about naturally occurring mutations and to provide a rational basis for designing alterations in the 
enzyme that probe functional domains of the protein (Auchus and Miller, 1999). The crystal structure 
of human CYP17A1, in complex with inhibitors abiraterone and TOK-001, has also been determined 
clarifying previous misconceptions regarding CYP17A1 structure (Nahri et al., 1986) as well as preg 
and prog substrate specificity (DeVore and Scott, 2012).  
3.2 Structural domains of CYP17A1  
The P450 moiety (P450BMP) of the distinct bacterial microsomal enzyme P450BM-3 has been 
crystallized (Boddupalli et al., 1992) and its structure solved (Ravvichandran et al., 1993). This 
distantly related bacterial P450 was the template for molecular modelling and the first 3D structure for 
human CYP17A1 was established in 1999, with protein data bank identification number (pdb-id) 2C17 
(Auchus and Miller, 1999). Subsequently, the crystallization and structure of the more closely related 
mammalian P450, cytochrome P450 2C5 (CYP2C5) pdb-id 1DT6, has been determined and is also 
used as a template for structural modelling of other human and mammalian P450s (Williams et al., 
2000b).  
Figure 3-1 shows the alignment of core elements of human CYP17A1 with bacterial P450 class 2 
enzymes (P450BMP), the principle template upon which the human CYP17A1 structural model is 
based (Auchus and Miller, 1999). Residues that form part of core helices and sheets are shown in bold. 
The most conserved residues are underlined. Among various species CYP17A1, conserved residues 
include: Trp121 in the C-helix; catalytic Thr306 in the I-helix; the Glu359xxArg362 sequence in the K-
helix and the heme-liganding Cys442 (Auchus and Miller, 1999). 
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Figure 3-1: Alignments of core elements of human CYP17A1 (C17) and P450BMP (BMP). Residues forming part of core 
structures are shown in boldface type and the conserved residues are underlined (reproduced from Auchus and Miller, 
1999). 
Recently, the first X-ray crystal structures of CYP17A1 have been obtained (DeVore and Scott, 2012), 
in complex with two CYP17A1 inhibitors, abiraterone or TOK-001. Both inhibitors are involved in 
treatments of prostate- and or breast cancer (Attard et al., 2008) and bind with heme Fe, which orients 
the structure above the heme plane at an angle of 60º, as well as being positioned against the central I 
helix. Asp202 (F helix) interacts with the β-hydroxyl group of C3 (3β-OH) and differs from the 
predicted by homology models and from steroids in other P450 enzymes with identified structures.  
The global structure of CYP17A1 provides the groundwork for understanding mutations found in 
patients with steroidogenic diseases, the active site exposes multiple spatial arrangements and hydrogen 
bond characteristics, which justify for a superior understanding of the enzyme’s dual catalytic potential. 
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Human CYP17A1 protein was engineered to exhibit a mutation that eliminated the N-terminal 
transmembrane helix (truncated) and was subsequently expressed in E. coli. CYP17A1 bound with 
either abiraterone or TOK-001, resulted in a type II difference spectra, which is consistent with the 
binding of nitrogen to the heme Fe with dissociation constant (Kd) values of <100 nM.  
CYP17A1 bound to prog or preg results in a type I substrate-induced difference spectra, which is 
indicative of the ligand displacing water from the heme. This modified human CYP17A1 bound preg 
more tightly than prog, with Kd values of <100 nM and 229 nM, respectively. Full-length CYP17A1 
has a 3-fold higher Km (11.4 µM) compared to the truncated form (Km 3.7 µM).  
Although inhibitors reside in the majority of the roofed active site, the void extends beyond these 
ligands in several directions. The 3β-OH group of the inhibitors is the most prominent extension of the 
active site cavity, spanning the top of the I helix and along the underside of the F and G helices. The 
cavity is lined by mostly hydrophobic residues (Ile198, Leu243 and Phe300), although several polar 
residues (Tyr201, Asn202 and Arg239) of the F and G helices, border at the top of the cavity and 
interact with- or are located near water molecules. A single direct hydrogen bond exists between the 
inhibitors and CYP17A1 and it forms part of a larger hydrogen bond network linking with residues 
Asn202, Glu305, Arg239, the backbone carbonyl of Gly297, conserved water molecules and for some 
proteins, Tyr201 (DeVore and Scott, 2012).  
These interactions strongly resemble interactions conserved in steroid hormone receptors, where in 
each deep receptor pockets, the 3β-OH group of steroids forms hydrogen bonds with Gln or glutamate, 
Arg and often a conserved water molecule. These interactions are vital for ligand recognition by 
hormone receptors and may also contribute to CYP17A1 selectivity for preg, prog and their 17α-
hydroxy counterparts. When preg and prog were substituted into the CYP17A1-abiraterone structure 
model (see Figure 3-2), prog maintained the hydrogen bond with residue Asn202. The distances from 
C17 and C16 to the catalytic heme oxygen were 3.7Å and 3.9Å, respectively, which was consistent 
with the data regarding the major 17OH- and minor 16OHprog metabolites (DeVore and Scott, 2012). 
Aromatase (Ghosh et al., 2009), P450scc (Mast et al., 2011) and cholesterol 24-hydroxylase 
(CYP46A1) (Mast et al., 2008) proteins maintain the characteristic folding of the cytochrome P450 
structure and CYP17A1 can be compared to these reported steroid complex structures. However, 
aromatase, P450scc and CYP46A1 orientates steroid substrates in an opposite direction, as was 
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determined for CYP17A1, so that the steroid ligands are positioned over the K–L loop directed towards 
the B1 sheet instead of oriented towards helices F and G as with CYP17A1 (see Figure 3-2). 
 
Figure 3-2: CYP17A1 structure compared to the AR and P450scc. (a) Hydrogen bond network near 3β-hydroxyl group of 
abiraterone involving Asn202, Arg239 and water. (b) The AR (pdb-id 3L3X) has a similar hydrogen bond network with 
Arg752 and Glu711 with several waters interacting with DHT ketone. (c) The structure of CYP17A1, bound with 
abiraterone (yellow), superimposed on CYP11A1 structure with 20,22-dihydrocholesterol (pink). Different steroid 
orientations are observed for both structures (reproduced from DeVore and Scott, 2012). 
3.2.1 Heme and its binding site 
Heme is a chemical compound and a prosthetic group on numerous proteins permitting their cellular 
functions. The basic structure of heme consists of a ferrous (Fe++) ion contained in the center of a 
heterocyclic organic porphyrin ring, which constitutes up to four pyrolic groups joined together by 
methane bridges (Voet and Voet, 2004). Various types of heme exist, differing by their side groups. 
However, most forms are derived from heme b (Figure 3-3), where each pyrole ring has one methyl 
group side-chain; two of the pyrole rings have a vinyl group side-chain, while the other two rings have 
a propinoic acid side-chain (propionate group). Many porphyrin-containing metalloproteins (including 
Stellenbosch University  http://scholar.sun.ac.za
50 
cytochromes) have heme as their prosthetic group and are thus known as hemeproteins. In addition to 
the chemical properties of their environment, each hemeprotein has a precise amino acid sequence and 
structure that coordinates which heme it associates with, if it can associate and how.  
The heme has four covalent bonds to nitrogen counterparts of pyrole rings with p electrons contributing 
to its stability when the Fe is attached to the heme. The 5th available ligand of the Fe molecule is 
occupied by the thiolate side-chain of a cysteine residue in microsomal cytochrome P450s and the 6th 
site is occupied by dioxygen (Shimizu et al., 1988). During electron transfer in P450 catalytic 
reactions, the Fe molecule cycles between Fe++ and Fe+++ states as it activates dioxygen for 
hydroxylation reactions. 
 
Figure 3-3: Chemical structure of heme b (C34H32O4N4Fe). In all cytochrome P450s, the 5th and 6th ligands of the central Fe 
molecule in heme b are occupied by the thiolate side-chain of a cysteine residue (blue) and dioxygen (red), respectively 
(reproduced from Shimizu et al., 1988). 
The heme-binding domain of CYP17A1 is highly conserved among species and consists of residues 
Pro434-Ile443 with the Cys442 residue functioning as the axial ligand of the heme Fe. Residue Arg440 
forms a hydrogen bond with the propionate moiety and is a constant observation in all P450 structures 
(Ravichandran et al., 1993). The amino acid substitution Arg440Cys causes complete 17α-hydroxylase 
deficiency in P450s (Fardella et al., 1994). The substitution His373Leu renders the P450 enzyme 
incapable of binding with heme and causes 17α-hydroxylase deficiency (Monno et al., 1993). Residue 
His373 does not interact with heme but forms a hydrogen bond with the carboxylate group of residue 
Glu391 in the neighbouring strand of a β-sheet near the membrane attachment-site. Therefore, 
His373Leu appears to alter the general structure of the P450, which indirectly forbids heme binding 
(Monno et al., 1993).  
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3.2.2 The substrate-binding pocket 
Human CYP17A1 does not possess a bi-lobed substrate binding pocket, as was previously predicted by 
CYP17A1 models based on bacterial P450s (Nahri et al., 1986; Lin et al., 1994), which was 
carroborated by DeVore and Scott (DeVore and Scott, 2012). Miller and Auchus (1999) define this 
pocket by: the heme-group, which forms the floor of the pocket; the I-helix, which runs along the edge 
of the heme ring; strands 4 and 5 of β-sheet 1, which is opposite the I-helix; residue Ile112, which is in 
the B’-C’-loop on the one side; the loop after the K-helix on the other side and lastly, by residues 
Val482 and Val483, which forms a turn in β-sheet 3 forming the top of the substrate binding pocket 
(Auchus and Miller, 1999). Multiple residue interactions are found to limit the extent of the pocket 
above the heme. Figure 3-4 shows the structural model of human CYP17A1 binding pocket occupied 
with a steroid substrate.  
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Figure 3-4: A model of steroid-bound CYP17A1 (pdb-id 2C17). Heme is shown in red; the iron-oxy in green; Thr306 (-
OH) group in orange; CYP17A1 hydrophobic residues in gray and hydrophilic residues in cyan. The steroid (preg) is shown 
in yellow with C17 and its attached hydrogen (C17-H) in blue. (a) A stick diagram shows that the entire substrate-binding 
pocket of CYP17A1 is defined by hydrophobic residues and that the two hydrophilic residues do not contribute to the 
surface boundary of the pocket. (b) A comparison of crystal structures for P450cam (cyan), P450BMP (yellow) and 
CYP17A1 (gray) show that β-sheet 3 extends closer towards the heme and occupies more steroid-binding space in 
P450BMP and CYP17A1, than in P450cam, thus restricting the size of the substrate-binding pocket. Although modelling 
core elements initially positioned the α-carbons of CYP17A1 in the same locations as the corresponding α-carbons of 
P450BMP, the thermo- and molecular dynamic procedures shifted the CYP17A1 backbone significantly further restricting 
the size of the CYP17A1 substrate-binding pocket. (c) The conic space-filling diagram shows that although the steroid fills 
virtually the entire substrate-binding pocket, there is space above the steroid for water molecules. (d) A sagittal sectional 
view of the conic diagram (through Thr306, Fe-oxygen and C17 of the steroid), shows that three key components of the 
17α-hydroxylase reaction are in close proximity (reproduced from Auchus and Miller, 1999). 
Previously, it was also proposed that the substrate was positioned perpendicularly to the heme (Lin et 
al., 1994). However, the smaller substrate-binding pocket found in the human CYP17A1 model 
prevents this binding orientation and rather limits the substrate to a position where the planes of the 
steroid and heme ring are more or less parallel to one another (Auchus and Miller, 1999). This 
orientation restricts steroid substrates to a single orientation, which places C17 directly above the heme 
Fe. Additionally, this orientation facilitates hydrophobic interactions between the C18 and C19 methyl 
groups of the steroids and the side-chains of CYP17A1 residues Pro368, Val482, Val483 and Ala302. 
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3.3 Key residues involved in CYP17A1 activity 
Residues Ile344, Ser345, Asp346, Arg347, Asn348 and Arg358 are conserved in most species 
(particularly in baboon, bovine, chimpanzee, angora goat, macaques, porcine and sheep) with the 
exceptions of rat and mouse (see Addendum A). Lys89 is conserved in all species, including rat and 
mouse, and together with Arg347 and Arg358 are highlighted specifically to be involved with the redox 
binding proteins. These residues form positive charges on the proximal surface of the enzyme. 
Neutralizing these charges impairs 17,20-lyase activity without reduction in 17α-hydroxylase activity 
(Auchus et al., 2000).  
Substrate preferences for CYP17A1 have been shown to be species-specific. The ∆5 pathway is 
favoured in human, bovine, and pig adrenal glands and testes (Miller, 1988) and the ∆4 pathway is 
prevalent in rat testis (Fevold et al., 1989). Substrate preferences are also evident in transfected non-
steroidogenic COS-1 cell line, where the source of the differential ∆4 and ∆5 activity has been 
identified at the level of the lyase activity (Zuber et al., 1986). Bovine CYP17A1 has a specific 
reduction in the ∆4-lyase activity, but not expressed rat CYP17A1. The initial reactions catalyzed by 
human/bovine or rat species display comparable ∆4 and ∆5 17α-hydroxylase activities. Therefore, 
expression of human/bovine and rat CYP17A1 in non-steroidogenic cell lines (Zuber et al., 1988), can 
be distinguished on the basis of changes in ∆4-supported lyase activity (Fevold et al., 1989), and these 
changes may be related to the species-specific amino acid substitutions within the conserved domain 
(Chung et al., 1987).  
Arg346 forms part of a putative lyase domain (residues 343-348) in rat CYP17A1 and is essential for 
lyase activity (Picardo-Leonard and Miller, 1988; Kitamura et al., 1991). Site-directed mutagenesis 
generated rat CYP17A1 mutant, with substituted residues identical to bovine residues at those 
positions, to determine if the bovine-specific reduction in Δ4 lyase activity results from changes in the 
primary sequence that may influence substrate interaction and or specific transport of the Δ4 
intermediate out of the active-site domain. Expression and analysis of the ∆4-lyase activity of mutant 
rat CYP17A1 in COS-1 cells, revealed that rat mutation Phe343Ile resulted in a reduction in ∆4-lyase 
activity to levels approaching the range of the ∆5-reaction (Koh et al., 1993). Rat CYP17A1 with 
substitutions Asn344Ser, Ser347Asn and His348Arg, did not exhibit changes in ∆4-lyase activity or in 
∆4- and ∆5 17α-hydroxylase activities. Therefore, rat CYP17A1 with substitution at position 343 with 
bovine amino acid residue Ile, imitates the reduced activity of the bovine CYP17A1 Δ4 lyase reaction. 
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The rat Phe343 mutant exhibited a low level lyase activity that did not differentiate between Δ4- and 
Δ5 substrates. Results suggest that the occurrence of Phe343 enhances the Δ4 lyase activity potentially 
through stabilization of Δ4 specific interface and facilitating either the Δ4 lyase reaction or Δ4 
substrate binding (Koh et al., 1993). 
Figure 3-5 shows known mutations in the redox partner binding site of human CYP17A1. These 
mutations cause the characteristic loss in 17,20-lyase activity by neutralizing positively charged 
residues. Phe417 is not exposed to the protein surface but lies behind a loop between the meander 
region and the heme binding region (Gupta et al., 2001). 
 
Figure 3-5: Mutations in the redox partner binding pocket of human CYP17A1, causes the loss in 17,20-lyase activity 
(Gupta et al., 2001). 
Mutations that specifically impair the 17,20-lyase activity of CYP17A1 are mostly informative for 
structure-function studies of this protein and may also give insight into the development of adrenarche 
(Gupta et al., 2001). Geller et al. (1997) identified patients who were homozygous for the mutations 
Arg347His and Arg358Gln that neutralized single positive charges in the redox partner binding site 
(Geller et al., 1997). These two mutations are associated with isolated 17,20-lyase deficiency. They 
dramatically impair lyase activity in the presence or absence of CYB5, whilst 17α-hydroxylase activity 
remained preserved (Geller et al., 1997). Gupta et al. (2001), using molecular models and biochemical 
studies, described these mutations as impairing the interactions of CYP17A1 with redox partners CPR 
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and CYB5. They also concluded that neutralizing key positive charges in the redox partner binding site 
can cause the isolated loss of 17,20-lyase activity (Gupta et al., 2001). Lys89Asn (Auchus and Miller, 
1999) and Arg449Ala (Lee-Robichaud et al., 1999) are two other mutations that map to the redox 
binding site but cause a reduction in 17,20-lyase activity.  
Phe417Cys has been considered to cause 17,20-lyase deficiency, however it was suggested that this 
mutation does not lie within the redox partner binding site but adjacent to it. Amongst other possible 
mechanisms, this mutation may introduce changes to the structure of the protein that are propagated to 
the redox partner binding site. Gupta et al. (2001) found that although this mutant protein could be 
expressed, it was not active and the heme did not bind correctly nor did it exhibit 17α-hydroxylase 
activity (Gupta et al., 2001). Two prevalent CYP17A1 mutations in humans which cause 17α-
hydroxylase deficiency are Trp406Arg and Arg362Cys (Costa-Santos et al., 2004). 
The human CYP17A1 amino acid sequence has 66.7% sequence identity with the porcine protein. 
cDNA comparisons indicated that a central region (consisting of amino acids 160-268) is hypervariable 
in human, porcine and bovine proteins (Chung et al., 1987). Adrenal and testicular CYP17A1 mRNA 
are mostly indistinguishable (Chung et al., 1987), although minor differences have been reported in 
porcine adrenal or testicular CYP17A1 (Nakajin et al., 1984). These proteins were defined by 
molecular weight, amino acid composition and N-terminal amino acid sequence but were 
enzymologically and immunologically indistinguishable. This raised the possibility of tissue-specific 
isozymes, which to date, remains to be confirmed. Porcine adrenal CYP17A1 amino acid sequence 
differs from porcine testes CYP17A1 at a single position. Adrenal cDNA encodes a His407 residue 
(GenBank accession number AAA84419.1) and testes cDNA encodes a Leu407 residue (GenBank 
accession number NP_999593.1). 
The aim of this study is to compare the 17α-hydroxylase/17,20-lyase and 16α-hydroxylase activities of 
wt porcine CYP17A1 and to determine the influence of targeted amino acid substitutions on the 
catalytic activity of the wt. Adrenal porcine CYP17A1 cDNA (wt pCYP17A1) was obtained from 
collaborators at Edinburgh University, Scotland. Direct sequencing analysis of this clone revealed an 
amino acid sequence different to that obtained from porcine CYP17A1, cloned from cDNA isolated 
from porcine testicular cDNA (Conley et al., 1992). Sequence analysis of wt pCYP17A1 showed 
residues Val40 and His407 (designated -VH), whereas CYP17A1 purified from the porcine adrenal has 
Leu40 and His407 (designated -LH). CYP17A1 cloned from porcine testes has residues Leu40 and 
Leu407 (designated -LL). Although these differences may be due to PCR artifacts, it is interesting to 
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note that Chung et al. (1987) isolated and purified CYP17A1 protein from porcine adrenal tissue and 
subsequent amino acid analysis identified a His residue at position 407 (Chung et al., 1987). Human 
CYP17A1 (Picardo-Leonard and Miller, 1987) also has a Leu residue at position 40 and a His residue 
at position 407. Employing site-directed mutagenesis using wt pCYP17A1-VH as the template, single 
mutants (pCYP17A1-LH and -VL) and a double mutant (pCYP17A1-LL) at amino acid positions 40 
and 407, respectively, were prepared. This study also investigated the 16α-hydroxylase activity 
characteristic of human CYP17A1, which has an Ala residue at position 105 while wt pCYP17A1-VH 
has a Leu residue. A wt pCYP17A1 mutant construct (designated -LA), was thus prepared to 
investigate the 16α-hydroxylase activity, in which Leu105 was mutated to an Ala residue. All 
mutations were confirmed by direct sequence analysis. Catalytic studies were conducted using prog as 
substrate in non-steroidogenic mammalian cells expressing the recombinant enzymes.  
The integration of recombinant cDNA in plasmid vectors into specific cell lines is a very efficient 
method of examining enzyme function. Transformed (Simian Virus 40) African Green Monkey kidney 
fibroblast cells (COS-1) are non-steroidogenic cells and serve most useful in the investigation of 
enzyme activity with steroid substrate added to growth medium. COS-1 cells contain a single 
integrated copy of the complete early region of SV40 DNA and express the SV40 large tumour antigen, 
which enables transcription initiation at the SV40 origin site present in mammalian expression vectors 
such as pCMV5 and pcDNA3.2 (Gluzman, 1981; Strayer, 1996). This results in a high copy number of 
the vector in each transfected cell (Aruffo, 2001). Furthermore, COS-1 cells also have sufficient 
amounts of endogenous CPR to confer maximal 17α-hydroxylase activity in CYP17A1 (Lin et al., 
1993), making these cells ideal for the investigation of the influence of Val40Leu, His407Leu and 
Leu105Ala substitutions on the catalytic activity of porcine CYP17A1.   
3.4 Materials and methods 
3.4.1 Plasmids  
Porcine pCMV5_CYP17A1 (wt pCYP17A1-VH) plasmid (cloned via BamH1 in MCS) was a kind gift 
from Prof. Ian Mason of Edinburgh University, Scotland. pCI-neo (Promega) and angora CYP17A1 
(aCYP17A1) plasmids were available in the laboratory and included as experimental control plasmids. 
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3.4.2 Reagents 
3H-Prog was purchased from PerkinElmer Life Sciences (Boston, MA, USA). Prog, 17OHprog, 
16OHprog, A4 and Dulbecco’s modified Eagle’s medium (DMEM) were purchased from Sigma 
Chemical Company (St. Louis, MO, USA). COS-1 cells were obtained from the American Type Tissue 
Culture Collection (Manassas, VA, USA). Penicillin-streptomycin and trypsin-EDTA were purchased 
from Gibco-BRL (Gaithersburg, MD, USA). Fetal calf serum and bacterial culture media were 
purchased from Highveld Biological (Lyndhurst, RSA). GeneJuice transfection reagent was purchased 
from Novagen (Darmstadt, Germany). DNA marker, marker VI (digested pBR328 DNA/Bgl1 and 
pBR328 DNA/Hinf1) was purchased from Roche Applied Sciences (Mannheim, Germany). Plasmid 
pCI-neo, DNA markers λDNA/EcoR1+HindIII (digested lambda DNA/EcoR1+HindIII) and 1 kb DNA 
marker, ribonucleotide phosphates and Wizard® Plus SV Miniprep DNA Purification systems were 
purchased from Promega Biotech (Madison, WI, USA). Restriction endonucleases BamH1, Xho1 and 
EcoR1 were purchased from Fermentas (Burlington, Canada). Primers were purchased from Integrated 
DNA Technologies (Coralville, Iowa). Nucleobond® AX plasmid preparation kits were purchased 
from Machery-Nagal (Duran, Germany). Platinum Taq Polymerase PCR kits, SYBR®Safe DNA gel 
stain and GeneTailor™ Site-Directed Mutagenesis Systems were purchased from Invitrogen (Carlsbad, 
California). A Pierce BCA™ protein assay kit was purchased from Pierce Chemical (Rockford, IL, 
USA). All other chemicals were of the highest analytical grade and purchased from scientific supply 
houses.  
3.4.3 Wt pCYP17A1-VH preparation and plasmid integrity 
The plasmid construct was received blotted on filter paper. The circular centres, 3 mm x 3 mm, were 
cut out and resuspended in TRIS buffer (10 mM, pH 7.6), 50 µl. Resuspended plasmid, 2 µl, was added 
to freshly prepared E. coli JM109 competent cells, 200 µl, prepared using the CaCl2 (75 mM) method 
(Sambrook et al., 1989), placed on ice for 30 min, heat shocked at 42ºC for 90 sec and then placed on 
ice for 90 sec. SOC medium, 800 µl, was added to the transformed cells after which the cells were 
incubated at 37ºC for 1 hr at 225 rpm. Cells were plated on LB medium-agar containing ampicillin, 100 
µg/ml, and grown overnight at 37ºC with plates placed upside-down. 
LB medium, 5 ml, containing ampicillin, 100 µg/ml, was inoculated with a single colony of 
transformed E. coli cells and incubated overnight at 37ºC at 225 rpm. Plasmid DNA was isolated using 
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the Wizard® Plus SV Minipreps DNA Purification System, according to manufacturer’s instructions 
(Promega). After precipitation, the plasmid DNA pellet was redissolved in nuclease-free water, 100 µl, 
and the plasmid yield was calculated by UV spectrophotometry, 260/280 nm.  
Plasmid constructs were screened by restriction digestion analysis and positive clones were 
subsequently subjected to sequence analysis with primers listed in Table 3-1. All DNA sequencing was 
performed on an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster city, California). 
Table 3-1: Primer sequences used in the direct DNA sequencing of wt pCYP17A1-VH. First left and right primer pair (LP1 
and LP2) are complementary to the 5’ and 3’ ends of porcine CYP17A1 (GenBank accession number NM_214428.1), 
respectively. The second and third left and right primer pairs are complementary to the 5’and 3’ ends of wt pCYP17A1-VH, 
respectively and sequence the remaining length of DNA. 
Primer Oligonucleotide sequence 
LP1 (Sense) 5’-GGTCAATGCTATCCTGGATC-3’ 
RP1 (Antisense) 5’-CACTGGAGTGGCAACTTC-3’ 
LP2 (Sense) 5’-CTGCAGGCCATAGTGAAT-3’ 
RP2 (Antisense) 5’-ACTATGTTGGTCATCGCC-3’ 
LP3 (Sense) 5’-CACAGATGTCGTCGTCAA-3’ 
RP3 (Antisense) 5’-TGACGACGACATCTGTGT-3’ 
Plasmid DNA was subjected to single enzyme restriction digests in a reaction volume of 20 µl with 
nuclease-free water, including: appropriate single enzyme BSA-buffer (10X), 1X, 2 µl; plasmid DNA 
(1 µg/µl), 1 µl, and restriction enzyme BamH1 (10 U/µl), 5 U, 0.5 µl; Xho1 (10 U/µl), 5 U, 0.5 µl; or 
EcoR1 (10 U/µl), 5 U, 0.5 µl, respectively, for 1 hr at 37ºC. Plasmid DNA was subjected to a double 
enzyme restriction digest in a reaction volume of 20 µl with nuclease-free water, including: TangoTM 
BSA-buffer (10X), 2X, 4 µl; plasmid DNA (1 µg/µl), 1 µl, and restriction enzymes EcoR1 (10 U/µl), 
10 U, 1 µl and Xho1 (10 U/µl), 10 U, 1 µl for 1 hr at 37ºC. The products were separated by 1% agarose 
gel electrophoresis at 55 V with 1 kb DNA marker and stained with SYBR®Safe for UV visualization. 
3.4.4 Site-directed mutagenesis 
Site-directed mutagenesis of porcine CYP17A1 was carried out using the GeneTailor™ site-directed 
mutagenesis system (Invitrogen) according to manufactures instructions, using the primers listed in 
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Table 3-2. The wt pCYP17A1-VH clone was used as the template, which contains the cDNA encoding 
porcine CYP17A1. 
Table 3-2: Primer sequences used in the site directed mutagenesis of wt pCYP17A1-VH. Left and right mutagenesis primer 
pairs (V40L-LP, V40L-RP, H407L-LP, H407L-RP, L105A-LP and L105A-RP) are complementary to the 5’and 3’ ends of 
wt pCYP17A1-VH, respectively and incorporate the appropriate nucleotide substitutions encoding the desired amino acid 
change. The codons for the changed amino acid appear in bold characters and the substituted nucleotide is underlined. 
Primer   Oligonucleotide sequence     
V40L-LP (Sense)  5’- CTGCCCGTGGTGGGCAGCCTGCCATTCCTA-3’  
V40L-RP (Antisense) 5’- GCTGCCCACCACGGGCAGGACTGGGAGACT-3’  
H407L-LP (Sense) 5’- TCACAATGAGAAGGAGTGGCTCCGGCCCGAC-3’  
H407L-RP (Antisense) 5’-GCCACTCCTTCTCATTGTGATGCAGTGCCC-3’ 
L105A-LP (Sense) 5’-AGAGTGATGACTCTAGACATCGCGTCAGACAACC-3’ 
L105A-RP (Antisense) 5’-GATGTCTAGAGTCATCACTCTGGGCCGCC-3’ 
The DNA methylation reaction was carried out in a final volume of 16 µl using sterile RNA/DNA free 
water including: methylation buffer (10X), 1X, 1.6 µl; SAM (10X), 1X, 1.6 µl; plasmid DNA template 
(100 ng), 1 µl, and DNA methylase (4 U/µl), 4 U, 1 µl. This reaction mixture was placed in a water 
bath at 37ºC for 1 hr and then on ice. The mutagenesis reaction was made up to a volume of 50 µl using 
RNA/DNA-free sterile water: High Fidelity buffer (10X), 1X, 5 µl; dNTP (20 mM), 10 mM, 0.75 µl; 
MgSO4 (50 mM), 1 mM, 1 µl; left and right mutagenic primers (10 µM), 300 nM, 1.5 µl each; 
methylated DNA (12.5-31.25 ng), 3 µl, and Platinum Taq Polymerase (5 U/µl), 2.5 U, 0.5 µl. PCR 
amplification was performed as follows: 94ºC for 2.5 min, followed by 20 cycles 94ºC for 30 sec, 55ºC 
for 30 sec and 68 ºC for 7 min, with a final elongation step at 68 ºC for 7 min. The amplified mutant 
DNA fragments were separated on a 1% agarose gel by electrophoresis at 65 V with DNA marker 
λDNA/EcoR1 and HindIII. The gel was stained with ethidium bromide for visualization.  
PCR product, 2 µl, was added to One-Shot® MAX Efficiency® DH5α™-T1R E. coli competent cells, 
50 µl, on ice. The transformation reaction was placed in a water bath at 42ºC for 30 sec, followed by 1 
min incubation on ice. Room temperature SOC medium, 200 µl, was added to the cells after which the 
cells were incubated at 37º for 1 hr.  Cells were plated on LB medium-agar containing ampicillin, 100 
µg/ml, and grown overnight at 37ºC with plates placed upside-down. 
LB medium was inoculated with single colonies and incubated for 12-14 hr after which plasmid DNA 
was purified as previously described in section 3.4.3.  
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The desired mutations, Val40Leu, His407Leu and Leu105Ala were confirmed by direct DNA sequence 
analysis with primers listed in Table 3-1. Wt and mutant cDNA, at positions 40 and 407, will be 
referred to by single letter abbreviations of the amino acids they possess at those respective positions, 
listed in Table 3-3. Wt mutant containing Ala105, pCYP17A1-L105A, will be referred to as 
pCYP17A1-LA, which shows the single letter abbreviation for the amino acids substituted at position 
105. 
Table 3-3: Wt mutants are designated names based on one-letter abbreviations of amino acids present at respective positions 
and in comparison with the wt pCYP17A1-VH sequence. Double letter designations (-LH, -VL and -LL) refer to amino 
acids present at position 40 and 407, respectively and –LA refers to the amino acids substituted at position 105.  
wt/mutant Substitutions Positions of amino acid differences Designated name 
wt  Val40 Leu105 His407 wt pCYP17A1-VH 
wt mutant V40L Leu40 Leu105 His407 pCYP17A1-LH 
wt mutant H407L Val40 Leu105 Leu407 pCYP17A1-VL 
wt mutant V40L; H407L Leu40 Leu105 Leu407 pCYP17A1-LL 
wt mutant L105A Val40 Ala105 His407 pCYP17A1-LA 
3.4.5 Plasmid preparation 
LB medium, 100 ml, containing ampicillin, 100 µg/ml, was inoculated with freezer stocks of plasmid-
containing E. coli cells, 100 µl, and incubated overnight at 37ºC at 225 rpm. The plasmid DNA was 
isolated using the Nucleobond® AX100 DNA Isolation Kit, according to manufacturers’ instruction 
(Machery-Nagal). After precipitation, the plasmid DNA pellet was redissolved in deionized water, 200 
µl, and the plasmid yield was calculated by UV spectrophotometry, 260/280 nm.  
3.4.6 Conversion assays in non-steroidogenic mammalian COS-1 cells 
COS-1 cells were grown to confluence in 100 mm culture dishes at 37ºC and 5% CO2 in DMEM, 10 
ml; supplemented with 0.9 g/L glucose, 0.12% NaHCO3, 10% fetal calf serum and 1% penicillin–
streptomycin (stock containing 10 000 U/ml penicillin and 10 000 µg/ml streptomycin). Twenty-four 
hours prior to transfection, cells were plated into 12-well culture dishes with each well containing 
1×105 cells (1 ml/well). Cells were transfected by adding transfection reaction mix, 50 µl DMEM 
without fetal calf serum or penicillin–streptomycin, which contained plasmid DNA, 0.5 µg, and 
GeneJuice transfection reagent, 1.5 µl. Control transfection reactions were performed using the 
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mammalian expression vector pCI-neo (containing no cDNA insert) and a positive control plasmid, 
angora CYP17A1. The cells were incubated for 72 hr, after which enzyme activity was assayed by 
adding steroid substrate 1 µM prog with or without 3H-prog (100 000 cpm/50 µl) to fresh growth 
medium. Aliquots of 50 µl or 500 µl were removed at specific time intervals to assay substrate 
conversion and were analysed by high performance liquid chromatography (HPLC) or ultra 
performance liquid chromatography-mass spectrophotometry (UPLC-MS), respectively. Deionised 
water, 450 µl was added to the tritiated samples (50 µl) after which steroid metabolites were extracted 
in dichloromethane, 5 ml, for analyses by HPLC. Non-tritiated samples (500 µL) were extracted in 
dichloromethane, 5 ml and steroid metabolites for analyses by UPLC. The dichloromethane phase was 
evaporated under a stream of nitrogen. Dried steroid residue was redissolved in methanol, 120 µl, prior 
to analysis. After the last time-point, cells were washed with and collected in phosphate buffer (0.1 M, 
pH 7.4) and sonicated prior to determining the protein content by the Pierce BCA method (Pierce 
Chemical) according to the manufacturers’ instructions. 
3.4.7 Separation and quantification of steroid metabolites 
HPLC steroid separation was performed on a Waters (Milford, MA, USA) high performance liquid 
chromatograph coupled to a WISP™ automatic injector (Waters) and a Flo-One liquid scintillation 
spectrophotometer (Radiomatic, Tampa, FL). Prog, 17OHprog and A4 were separated on a Novapak® 
C18 column at a flow rate of 1 ml/min. The mobile phase consisted of solvent A (35% water and 65% 
methanol) and solvent B (100% methanol). The column was equilibrated for 10 min with solvent A, 
followed by a linear gradient from 100% solvent A to 100% solvent B in 5 min, after which an isocratic 
elution of solvent B ran for 2 min. 
UPLC-MS steroid separation was performed using a Waters UPLC BEH C18 (2.1 mm × 100 mm, 1.7 
µm) column (ACQUITY UPLC, Waters, Milford, USA) to separate and quantify prog, 17OHprog, 
16OHprog and A4. The mobile phases consisted of 0.1% formic acid (solvent A) and acetonitrile 
(solvent B). Steroids were eluted at a flow rate of 0.35 ml/min, starting with the mobile phase 85% 
solvent A and 15% solvent B for 3.5 min, followed by 20% solvent A and 80% solvent B for 2.1 min, 
followed by 100% solvent B for 1 minand finally 85% solvent A and 15% solvent B for 2 min. An API 
Quattro Micro tandem mass spectrometer (Waters, Milford, USA) was used for quantitative mass 
spectrometric detection. An Ion Sabre probe (Waters, Milford, USA) was used for the APCI interface 
in positive mode. The corona pin was set to 7 µA, the cone voltage to 30 V and APCI probe 
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temperature was 100ºC. All other settings were optimized to obtain the strongest signal possible. Data 
was collected with the MassLynx 4.0 software program. 
3.5 Results 
3.5.1 Plasmid yield, integrity and sequence 
Table 3-4 shows the absorbance values obtained from UV spectrophotometry analysis of isolated wt 
and mutant plasmid DNA samples. Concentration and purity of plasmid DNA was calculated using 
absorption values at 260 and 280 nm. OD values ranged between 0.1 and 0.8 for optimal measurement. 
Double strand plasmid DNA yield and concentration was calculated for 200 µl (wt) and 50 µl (mutant) 
plasmid DNA samples with 1 A260 Unit of dsDNA = 50 µg/ml H20 and purity was determined by 
A260/A280 ≥ 1.6. 
Table 3-4: Absorbance values of wt pCYP17A1-VH and mutant cDNA plasmids.  
Absorbance values 
Isolated DNA 
260 nm 280 nm 
Dilution 
Factor 
Concentration 
(µg/µl) 
dsDNA 
(µg) 
Purity 
260/280 
wt pCYP17A1-VH 0.65 0.40 150 4.88 975.0 1.65 
pCYP17A1-LH 0.70 0.43 8 0.28 14.0 1.64 
pCYP17A1-VL 0.42 0.22 10 0.21 10.5 1.93 
pCYP17A1-LL 0.57 0.29 8 0.23 11.5 1.95 
pCYP17A1-LA 0.73 0.37 20 0.73 36.5 1.98 
Direct sequence analysis of wt pCYP17A1-VH and mutants showed a total of 1786 bp. Table 3-5 
shows plasmid DNA sequence recognition sites for restriction enzymes EcoR1 (5’-G/AATTC-3’), 
Xho1 (5’-C/TCGAG-3’) and BamH1 (5’-G/GATCC-3’).  
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Table 3-5: Restriction enzyme recognition sites in (a) expression vector, pCMV5; (b) linear porcine CYP17A1 encoding 
cDNA sequence and (c) vector containing porcine CYP17A1 cDNA ligated into MCS in pCMV5 with BamH1 (wt 
pCYP17A1-VH). Restriction enzymes have one recognition site per sequence; except Xho1, which has only one recognition 
site in pCMV5 and EcoR1, which has two recognition sites in wt pCYP17A1–VH. 
 Sequence 
Total size 
(bp) 
EcoR1 
 bp position 
Xho1 
 bp position 
BamH1  
 bp position 
(a) pCMV5 (circular) 4657 920 1973 980 
(b) porcine CYP17A1 (linear) 1786 371  670 
(c) wt pCYP17A1-VH (circular) 6443 920; 1351 3759 1650 
Figure 3-6 shows the calculated fragment sizes of DNA products as a result of single/double 
endonuclease digestion of wt pCYP17A1-VH. Wt pCYP17A1-VH digested with BamH1 or Xho1, 
digesting at one site each, both result in linear DNA of 6443 bp. Wt pCYP17A1-VH digested with 
EcoR1 (Figure 3-6a), digesting at two positions, results in DNA lengths of 431 bp and 6012 bp, 
respectively. Wt pCYP17A1-VH digested with EcoR1 and Xho1 (Figure 3-6b), digesting at three sites, 
results in DNA lengths of 431, 2408 and 3604 bp, respectively. 
 
Figure 3-6: Calculated DNA fragment sizes after wt pCYP17A1-VH plasmid (pCMV5_pCYP17A1wt) was (a) digested 
using endonuclease EcoR1 and (b) double digested using endonucleases EcoR1 and Xho1. 
Figure 3-7 shows the analyses of DNA constructs using gel electrophoresis on a 1% agarose. 
Undigested plasmid wt pCYP17A1-VH (a); DNA products of plasmid enzyme digestion (b), as well as 
wt mutant PCR products (c-f) are shown in Figure 3-7. The λDNA/EcoR1+HindIII marker ranges in 
base pair lengths of DNA fragments from 564 bp to 21 227 bp and the 1 kb marker ranges from 250 bp 
to 10 000 bp. Wt pCYP17A1-VH plasmid DNA comprise mostly supercoiled conformations and to a 
lesser extent, nicked (Figure 3-7a). 
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Figure 3-7: Images of undigested and digested wt pCYP17A1-VH plasmid and site-directed mutagenic constructs. (a) Lane 
1 shows 1 kb marker and lane 2 shows undigested wt pCYP17A1-VH plasmid DNA. (b) Lane 1 shows 1 kb marker and wt 
pCYP17A1-VH single digested by EcoR1 (lane 2), Xho1 (lane 3), BamH1 (lane 4) and a double digested by EcoR1 and 
Xho1 (lane 5). (c-f) First lanes show λDNA/EcoR1+HindIII marker. Lanes 2 show mutagenic PCR products: pCYP17A1-
LH (c); pCYP17A1-VL (d); pCYP17A1-LL (e) and pCYP17A1-LA (f). DNA was separated by electrophoresis using a 1% 
agarose gel, subsequently stained with SYBR®Safe (a-b) or ethidium bromide (c-f) for UV visualization.  
The aligned amino acid sequence of wt pCYP17A1-VH, pCYP17A1-LH, pCYP17A1-VL, pCYP17A1-
LL and pCYP17A1-LA are shown in Addendum B with amino acid residue differences indicated at 
positions 40, 105 and 407.  
3.5.2 Analysis of prog conversion by wt pCYP17A1-VH 
Wt pCYP17A1-VH was expressed in COS-1 cells and the catalytic activity of the recombinant enzyme 
determined by assaying the metabolism of 1 µM prog. Steroid metabolites were analysed by HPLC and 
a typical chromatogram obtained from HPLC analysis is shown in Figure 3-8.  
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Figure 3-8: Typical HPLC chromatograms and elution profiles of A4 (8.93 min), 17OHprog (12.33 min) and prog (19.23 
min) on a Novapak® C18 column, as described in materials and methods. Steroid profiles of prog metabolism by wt 
pCYP17A1-VH are shown at (a) T0; (b) T2; (c) T12 and (d) T24. 
The retention times for the steroids separated by HPLC are depicted in Table 3-6. 
Table 3-6: Retention time (min) of Δ4 steroids separated by HPLC. 
Steroid retention time (min) 
A4 8.93 
17OHprog 12.33 
prog 19.23 
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A time-course conversion assay (Figure 3-9) shows prog conversion over a 24 hr time period with 
samples taken at 2, 4, 8, 12 and 24 hr intervals.  
 
Figure 3-9: Metabolism of prog substrate, 1 µM (2 000 000 cpm/ml 3H-prog), by wt pCYP17A1-VH. COS-1 cells were 
transfected with 0.5 µg wt pCYP17A1-VH and 17OHprog and A4 production was analysed. Results are representative of 
three independent experiments (n = 9). 
Within 3 hr, ~50% prog was metabolized to 17OHprog (~40%) and A4 (~10%). After 24 hr, negligible 
levels prog (~3.8%) remained with wt pCYP17A1-VH catalysing the production of ~70.9% 17OHprog 
and ~25.3% A4. No substrate conversion was detected in the assay in which COS-1 cells were 
transfected with pCI-neo containing no insert cDNA. Prog conversion by angora CYP17A1 was 50% at 
1.5 hr with no prog remaining after 24 hr. Table 3-7 shows the percentage steroids present at each time 
interval. 
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Table 3-7: The percentage steroids present at (a) various hourly time (T) intervals during 1 µM prog time-course conversion 
assay by wt pCYP17A1-VH and (b) 24 hr after 1 µM prog conversion assay by angora CYP17A1.  
 DNA Intervals 
(h) 
prog 
% 
17OHprog 
% 
A4 
% 
17OHprog:17OHprog+A4 
(a) wt pCYP17A1-VH T0 100 0.00 0.00 0.00 
  T2 61.0 34.1 4.90 0.87 
  T4 32.1 50.2 17.6 0.74 
  T8 26.5 52.9 16.8 0.76 
  T12 18.0 58.8 23.3 0.72 
  T24 3.80 70.9 25.3 0.74 
(b) angora CYP17A1 T24 0.00 90.1 9.90 0.91 
3.5.3 Analysis of prog conversion by wt pCYP17A1-VH with amino acid substitutions Val40Leu, 
His407Leu and Leu105Ala  
Mutant constructs were expressed in COS-1 cells and prog conversion was assayed after 24 hr.  UPLC-
MS analyses detected 17OHprog, 16OHprog and A4. Figure 3-10 shows typical chromatograms 
obtained from UPLC-MS analysis, which elutes steroids according to the specified time schedule, as 
listed in Table 3-8. 
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Figure 3-10: Selected ion chromatograms of Δ4 steroid standards separated, according to retention times listed in Table 3-8, 
on a Waters UPLC BEH C18 column (2.1 mm x 100 mm, 1.7 µm) at 50ºC, as described in Materials and methods. Total ion 
current (TIC) of m/z 200 to 400, for mixtures of standards, is also shown.  
Steroids separated by UPLC-MS have the specifications (m/z) and retention times as shown in Table 3-
8. 
Table 3-8: Peak identification, extracted ions and retention times of Δ4 steroids. 
Steroid Extracted ion (m/z) Retention time (min) 
16OHprog 331 2.12 
17OHprog 331 2.63 
A4 287 2.60 
prog 315 3.19 
After 24 hr, ~98% of the total prog substrate was converted by wt and mutant clones: wt pCYP17A1-
VH, pCYP17A1-LH, pCYP17A1-VL and pCYP17A1-LL (Figure 3-11). However, using UPLC-MS to 
detect the steroid metabolites, 17-, 16OHprog and A4 percentages showed to differ significantly. 
Subsequent analyses showed that there were no significant differences in 16OHprog production. 
Differences in the catalytic activity were evident when comparing the 17OHprog and A4, especially in 
the conversion by pCYP17A1-VL.  
Stellenbosch University  http://scholar.sun.ac.za
69 
 
Figure 3-11: Steroid profiles of 1 µM prog conversion after 24 hr by wt pCYP17A1-VH and mutants pCYP17A1-LH, -VL 
and -LL expressed in COS-1 cells. Results are representative of three independent experiments (n = 9). Individual steroids 
were compared, represented by matching alphabetical letters, by a one-way ANOVA, followed by a Dunnett’s multiple 
comparison test. Results are expressed as the mean ±SEM. Comparisons of 17OHprog (a,c,e) percentages between wt and -
LL (a); -VL and -LL (c); and between wt and -VL (e); as well as comparisons of A4 (b,d,f) percentages between wt and -LL 
(b); -VL and -LL (d); and between wt and -VL (f), were significantly (p<0.0001) different.  
The conversion of prog by wt pCYP17A1-VH and pCYP17A1-LH were similar, producing metabolite 
levels not significantly different from each other (Table 3-9). However, conversion by pCYP17A1-VL 
showed a steroid profile significantly (p<0.0001) different to that of wt, pCYP17A1-LH and 
pCYP17A1–LL. In the conversion by pCYP17A1-VL, the levels of A4 produced were 3.9-fold more 
than that produced by wt pCYP17A1-VH, with a concomitant decrease of 23.6-fold in the levels of 
17OHProg. Interestingly, a 2.3-fold increase in A4 was detected in the conversion by pCYP17A1-LL 
compared to wt.  
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Table 3-9: Percentage steroids present after 24 hr of 1 µM prog substrate conversion by (a) wt pCYP17A1-VH, (b) wt 
mutants and (c) angora CYP17A1.  
 DNA Time 
(h) 
prog 
% 
17OHprog 
% 
16OHprog 
% 
A4 
% 
17OHprog:17OHprog+A4 
(a) wt pCYP17A1-VH T24 1.90 66.1 9.10 22.9 0.74 
(b) pCYP17A1-LH T24 2.50 62.7 8.00 26.8 0.70 
 pCYP17A1-VL T24 0.10 2.80 7.30 89.8 0.03 
 pCYP17A1-LL T24 1.60 34.6 10.2 53.6 0.39 
 pCYP17A1-LA T24 71.7 15.3 10.3 2.70 0.85 
(c) angora CYP17A1 T24 0.0 86.4 2.96 10.6 0.89 
pCYP17A1-LA decreased the overall catalytic activity of expressed enzyme when compared to wt, 
with 71.7% prog substrate remaining after 24 hr, (Figure 3-12), however, it would appear that the 16α-
hydroxylase activity was not affected by the mutation to the extent that the 17α-hydroxylase was 
affected. 
 
Figure 3-12: Prog conversion catalysed by wt pCYP17A1-VH and -LA (wt with L105A substitution). COS-1 cells were 
transfected with 0.5 µg DNA and given 1 µM prog substrate medium. Assays were taken after 24 hr. Steroids were 
separated by UPLC-MS, with a method separating prog, 17-, 16OHprog and A4. Results are representative of three 
independent experiments (n = 9). Individual steroids were compared by a one-way ANOVA, followed by a Dunnett’s 
multiple comparison test. Results are expressed as the mean ±SEM. Comparisons between percentage prog (a), 17OHprog 
(b) and A4 (c) are significantly different (p<0.0001) from each other. 
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No substrate conversion was detected in the assay in which COS-1 cells were transfected with pCI-neo 
containing no insert cDNA. Prog was converted to steroid products by angora CYP17A1, with no prog 
remaining after 24 hr.  
3.6 Discussion 
In this study, three amino acid mutations were investigated, that at positions 40, 407 and 105. Sequence 
alignment of the deduced amino acid residues of wt pCYP17A1 differed from the published sequences 
for porcine adrenal and testes CYP17A1 proteins (see Addendum B). The amino acid sequences are 
identical, except for testes pCYP17A1 having a Leu407 residue and the adrenal protein having a 
His407 residue, while wt pCYP17A1-VH differs from these two sequences with residues Val40 and 
His407. Porcine wt CYP17A1 cDNA in the pCMV5 expression vector (wt pCYP17A1-VH) was used 
as template to construct four mutant pCYP17A1 constructs using site-directed mutagenesis and the 
plasmids were subsequently expressed in COS-1 cells. The catalytic activities, 17α-hydroxylase/17,20-
lyase and 16α-hydroxylase activities were assessed by assaying the conversion of prog and analysing 
end-product formation.  
In this study, mutants pCYP17A1-LL (testicular) and pCYP17A1-LH (adrenal) both have a Leu 
residue at position 40 and produce 17OHprog:A4 at a ratio of 0.64 and 2.33, respectively, after 24 hr. 
These enzymes differ only at position 407, with the testicular protein having a Leu residue and the 
adrenal protein having a His residue. However, maintaining the Leu residue at position 407 and 
replacing the Leu residue at position 40 with a Val residue (mutant pCYP17A1-VL) resulted in 
17OHprog:A4 at a ratio of 0.03 after 24 hr. It would therefore seem that not only does the Val residue 
at position 40 influence the lyase activity of wt pCYP17A1-VH but the loss of the charged residue at 
position 407 also plays a significant role in the production of A4. Redox binding of both CPR and 
CYB5 have been shown to be more important for the lyase reaction than for the hydroxylation reaction. 
Position 40 lies upstream to the A helix (A’ helix) and postion 407 lies as the start of the meander 
region, downstream to the K’ helix and just upstream of the heme-binding domain. The A-helix and K′-
helix, in the crystal structure protein model, lie in close proximity to each other. Noteworthy, perhaps,is 
that changes in side-chains, such as the loss of the bulky charged side-chain of a residue (at position 
407) and the insertion of a branched side-chain (at position 40), may: influence the conformation of the 
protein ― favouring the positioning of 17OHprog for the lyase reaction and thus involved in substrate 
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binding;  interfere with the transfer and propogation of electrons from redox partners to the CYP17A1 
heme center (specifically Cys442 and other neighbouring charged residues) and/or affect positioning of 
the heme-binding domain for inadequate acceptance of electrons ― as the meander region is suggested 
to be involved in appropriate positioning of this domain.  
Theoretical modelling of wt and mutants will show where the residues at positions 40 and 407 are in 
relation to secondary structural features, which are involved in-, essential to- and/or contribute to the 
redox partner binding sites of CYP17A1. A preliminary model shows that the His407 residue of wt and 
mutant porcine CYP17A1, is in fact positioned close to Arg residues, suggesting a possible interference 
with the redox partner as these charged residues have been shown to be vital for redox binding 
(Shimizu et al., 1991).   
End-products, 17OHprog and A4, of complete prog metabolism by CYP17A1 were measured after 24 
hr and it would appear that it is only the conversion of 17OHprog to A4 that is significantly influenced 
by these mutations as the conversion of prog to 17OHprog was not noticeably affected by the different 
residues, at positions 40 and 407, when compared to wt 17OHprog formation after the same time 
period. These mutagenesis data do not reflect the rate of prog conversion by porcine CYP17A1, as only 
end-product formation was analysed, without determining dual reaction rate constants for wt and 
mutants. Therefore, differences observed in end-product formation are attributed to site-directed 
changes in the protein sequence. 
Angora goat, which prefers the Δ5 steroid 17OHpreg as the substrate for the 17,20 lyase activity, 
expresses two CYP17A1 isoforms CYP17A1ACS+ and CYP17A1ACS- (Storbeck et al., 2007; 
Storbeck et al., 2008a), both with residues Leu40 and Gln407, with only the latter catalysing the 
production of negligible A4 from 17OHprog in the presence of CYB5. Interestingly, at position 41, 
CYP17A1ACS+ has a Leu residue and CYP17A1ACS- has a Pro residue. Mutating the Pro residue of 
CYP17A1ACS- to a Leu residue led to a loss of lyase activity towards 17OHprog in the presence of 
CYB5, while the Leu41Pro mutation of CYP17A1ACS+ reinstated this activity under the same 
conditions. Although the effect of the residues at position 41 on the lyase activity was more 
pronounced with 17OHpreg as substrate, the differences detected were, nevertheless, significant. It is 
apparent that, while residues at positions 40 and 41 influence the lyase activity, these may be 
responsible for conformational changes, in conjunction with other residues, affecting structure in other 
domains.  
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While porcine CYP17A1 catalysed the conversion of 50% prog at ~3 hr, the conversion by the angora 
CYP17A1 isoforms are similar. In addition, the levels of 16OHprog catalysed by wt pCYP17A1-VH 
were the same after 24 hr, 7.3–10.2%, in all the assays conducted with the different constructs. This 
activity was further investigated by mutating the residue at position 105 in wt pCYP17A1, namely 
residue Leu105, to the residue, which is shown to be responsible for this activity in human CYP17A1, 
the residue Ala (Swart et al., 1993; Swart et al., 2010). The Leu105Ala substitution, however, 
generated a less active clone of wt pCYP17A1, with the 17α-hydroxylase activity of the enzyme for 
prog significantly reduced. With more than 70% prog remaining after 24 hr, the 16α-hydroxylase 
activity seemed unaffected. However, further analysis of the data shows that the ratio of 
16OHprog:17OHP4+A4 does significantly change from 0.10 to 0.57 after the Leu105Ala mutation, 
which strongly suggests that the mutation itself is responsible for the increased change in this ratio and, 
with 16OHprog levels remaining unaffected, the mutation thus affected only the 17α-hydroxylase 
activity. 
The aim of chapter 3 was to assess the influences of three amino acid substitutions on the activity of 
porcine wt CYP17A1 towards prog. After complete prog metabolism at 24 hr, end-product 
comparisons indicated that the conversion of 17OHprog to A4 was significantly influenced by residues 
at positions 40 and 407, while the conversion of prog to 17OHprog was not affected. As CYB5 is 
known to influence the lyase activity, porcine CYB5 was subsequently cloned and its influence on the 
catalytic activity of wt pCYP17A1-VH was investigated and is described in the next chapter. 
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CHAPTER 4 
THE INFLUENCE OF SPECIES-SPECIFIC CYB5 ON THE 17,20 LYASE 
ACTIVITY OF PORCINE CYP17A1 
4.1 Introduction 
Membrane-bound CYB5 is a highly conserved hemeprotein consisting of 134 amino acids and has a 
predicted molecular weight of ~16 kDa. This small, electron transfer protein is widely expressed. 
Adrenal and testes expressed CYB5 serves as a modifier of the steroidogenic cytochrome P450, 
CYP17A1 (Schenkman and Janssom, 2003). Numerous structure based studies have provided a 
plethora of valuable information describing the precise mechanism by which CYB5 and CPR interact 
with and facilitate CYP17A1 activity (Omata et al., 1994a, Omata et al., 1994b; Dürr et al., 2007).  
CYP17A1 is capable of catalysing the transformation of four different C21 steroid substrates at a 
common active site (Miller and Auchus, 2011). After the first round of oxidation, either hydroxylated 
products are shunted towards other enzymes for the formation of corticoids or they are exposed to the 
second catalytic reaction of CYP17A1, which represents the first dedicated step in androgen synthesis. 
The specificity of this enzyme towards its substrates differs in various species and tissues with most 
variation being attributed to 16α-hydroxylase and 17,20-lyase activity (Swart et al., 1993; Swart et al., 
2010; Miller and Auchus, 2011). The chemical mechanisms of these reactions have evoked immense 
interest, particularly with the chemistry regarding the carbon-carbon cleavage and the structure-
function relationship of all the components enabling, facilitating or hampering this action (Mathieu et 
al., 2003; Gregory et al., 2013).  
Essentially, CYP17A1 activity is dependent on the initial reduction of the heme group by the 
acquisition of electrons from the readily available redox partner CPR (Shimada et al., 2005). The 
involvement of CYB5 is dependent on species, tissue-specific expression and the substrate involved. 
CYB5 has been shown to have considerable influence on the Δ5- and Δ4 pathways, stimulating the 
17,20-lyase activity of CYP17A1 as well as the activity of 3βHSD, while not influencing other 
steroidogenic enzymes (Akhtar et al., 2005; Goosen et al., 2011). For the insertion of molecular oxygen 
into a steroid substrate, CPR provides both the required electrons. Hydroxylation occurs primarily at 
C17 and in certain species, C16, due to the precise molecular alignment of CYP17A1 with the 
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substrate, which is achieved by the orientation of the CPR-P450 in complex with each other (Akhtar et 
al., 2005). In species susceptible to CYB5 stimulation, CYB5 facilitates the transfer of the second 
electron and the conformational change that is induced in the active site of CYP17A1, when CYB5 
interacts with this complex, is such that the oxidative attack by the iron-oxygen intermediate of 
CYP17A1 is redirected to C20 resulting in the scission of the C17-20 bond. At low concentrations, 
CYB5 may enhance the rate of enzyme catalysis up to 100-fold; however at high concentrations it 
inhibits catalysis by competing with CPR for a binding site on the P450 enzyme, thus preventing the 
transfer of the first electron and consequent reduction of heme (Im and Waskell, 2011).  
The molecular dynamics of hemeproteins in complex with substrates have been well documented, 
identifying structural motifs and amino acid residues crucial to proper complex formation and optimal 
enzyme functioning (Auchus and Miller, 1999; Ahuja et al., 2013). 
4.2 Structural domains of CYB5 determined by NMR spectroscopy 
To date, several NMR spectroscopy- and X-Ray crystallography based studies have elucidated the 3D 
tertiary and crystal structures, respectively, of various species truncated variants of microsomal 
membrane CYB5, including bovine CYB5 (pdb-id’s 1HKO, Muskett et al., 1996 and 1CYO, Durley 
and Mathews, 1996); rat CYB5 (1AW3, Arnesano et al., 1998), rabbit CYB5 (1DO9, Banci et al., 
2000) and human CYB5 (2I96, Nunez-Quintana et al., 2010). Recently, a 3D model of membrane-
bound mammalian CYB5, as well as its quaternary structure in complex with a P450, has been 
developed. Ahuja et al. (2013) reported the first structure of full-length rabbit ferric microsomal CYB5 
(pdb-id 2M33), incorporated in two different membrane types (detergent micelles and lipid bicelles) 
(Ahuja et al., 2013).  
The structure of the soluble heme domain of CYB5 contains five α-helices, five β-strands and one 310 
helix (Pro86-Arg89), which marks the end of this globular domain (Ahuja et al., 2013). Residues 
Lys10-Tyr12 form the first β-sheet (β1) and residues Leu14-His20 form the first α-helix (α1). The 
heme binding section consists of two helices in the lower cleft, shown as α4 (Thr60-Val66) and α5 
(Thr70-Phe79); two helices in the upper cleft, shown as α2 (Lys39-Glu43) and α3 (Glu49-Gln54) and 
three β-sheets at the bottom of the heme pocket, shown as β3 (Lys33-Asp36), β2 (Trp27-Leu30) and β4 
(Gly56-Asp58). Figure 4-1 shows the sequence and annotated secondary structures of full-length rabbit 
CYB5 aligned with sequences and NMR structures of truncated CYB5 from various other species. 
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Figure 4-1: Sequence and secondary structure comparison of full-length rabbit CYB5 with truncated variants from various 
species. The following species amino acid sequences are presented: rabbit full-length (pdb-id 2M33) and truncated rabbit 
(1DO9), human (2I96), bovine (1HKO), rat (1AW3) and reduced rat (1AQA). Amino acid sequences that are involved in 
the secondary structural elements α-helices (red) and β-sheets (blue) are highlighted. Heme association occurs above β-
sheets 2-4, and between α-helices 4 and 5 in the heme-binding domain (HBD). Conserved residues His44 and His68 
coordinate heme positioning. One side of the heme is exposed through the opening of the structural cleft between α-helices 
2 and 3. Domains and other structural features are also shown (reproduced from Ahuja et al., 2013, and supplementary 
data). 
The overall structure of the heme domain of full-length ferric CYB5, with residues His44 and His68 
shown to coordinate with the heme group, was found to be similar to the previously determined NMR 
structure of the heme domain of truncated ferric rabbit CYB5 (Banci et al., 2000; Ahuja et al., 2013). 
These two heme-orientating residues appear to be conserved for known sequences of species CYB5 
(see Addendum C). CYB5 exists as two isomers (major and minor), which differ by a 180º rotation of 
the heme axis that cuts through the meso-carbon atoms α and γ. The major/minor isomer ratio of full-
length rabbit CYB5 was determined to be 6.6:1 (Ahuja et al., 2013), which is similar to the 5:1 ratio 
determined for truncated rabbit CYB5 (Banci et al., 2000) and nearly identical to the 6.5:1 isomer ratio 
for truncated bovine CYB5 (Zhang et al., 2004). The isomer ratio depends on the CYB5 species and it 
has been reported to be as high as 1.5:1 for rat CYB5, despite sequence similarity between rabbit and 
rat CYB5 (Lee et al., 1990).  
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The linker domain (Ser90-Asp104) connects the cytosolic heme domain to the transmembrane domain 
(Ser105-Asp133) (Ahuja et al., 2013). The full-length CYB5 linker region appears unstructured; a 
random coil lacking any distinct secondary features. It has been shown that in this region, at least 6-8 
amino acids are necessary to enable formation of a functional complex between CYB5 and its full-
length redox partner cytochrome P450 (Clark et al., 2004). The transmembrane domain is conserved 
among vertebrates with sequence similarity of 78-96% and is essential for complex formation with 
redox partners (Vergeres and Waskell, 1992). With respect to perpendicular insertion in the bilayer, a 
15º average tilt angle has been calculated for the transmembrane α-helical anchor (Asn106-Met126) 
Ahuja et al., 2013). 
Figure 4-2 shows a ribbon diagram of the structural model of the 134 amino acid rabbit CYB5.  
 
Figure 4-2: Ribbon diagram of the 3D NMR structure of full-length rabbit CYB5 with α-helices (blue) and β-sheets 
(orange). The N-terminal soluble heme domain (residues 1-Arg89); flexible linker and angled C-terminal transmembrane 
domain, with α-helix anchor (Asn106-Met126), are shown. Residues (green) His44 and His68 coordinate heme group (red) 
positioning (reproduced from Ahuja et al., 2013). 
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4.3 Redox partner binding site and CYP17A1 activity 
Human CYP17A1 favours Δ5- and Δ4 steroid 17α-hydroxylation that occurs at the most reactive C-H 
bond in the steroid substrate and is relatively insensitive to changes in the P450-CPR conformation. 
The more intricate reaction of C-C cleavage, that few species catalyse, can only occur in a narrow 
range of P450-CPR geometries. Allosteric action by CYB5 optimizes the topology of this complex, 
thus markedly stimulating scission of the bond.  
The redox-partner binding lies on the opposite side of the heme group away from the substrate-binding 
site (Ravichandran et al., 1993). There are many basic residues situated in this region (mostly Arg 
residues in CYP17A1), which yield a surface charge distribution that is predominantly positive. The 
surfaces of the FMN domain of CPR and CYB5, which interact with the P450, contain a collection of 
acidic residues. CYB5 and CPR thus compete for an overlapping binding site on the P450 molecule, 
rather than having separate functional binding sites (Bridges et al., 1998). The protein surfaces 
interacting remain separated by several angstroms and so the interactions between these oppositely 
charged residue clusters are weak and indirect (Ahuja et al., 2013).  
CYP17A1 residues Lys89, Arg347 and Arg358 are highlighted specifically to be involved with the 
redox binding proteins (Auchus et al., 2000). Neutralizing these Arg residues in the CYP17A1 redox 
binding site, individually result in selective loss of 17,20-lyase activity (Geller et al., 1997). Although 
there is a subtle disturbance in the CYP17A1-CPR complex, electron transfer can still take place when 
these basic residues are neutralized (Auchus and Miller, 1999).  
CYP17A1 mutation Pro342Thr, which is located upstream of Arg347 in the Jʹ-helix, causes partial loss 
of both 17α-hydroxylase and 17,20-lyase activities (Ahlgren et al., 1992). The resulting Thr-Thr-Thr- 
motif is suggested to extend and misdirect the Jʹ-helix, ultimately creating a significant change in the 
structure of the redox-binding site (Auchus and Miller, 1999). 
CYP17A1 Phe417 lies adjacent to, and not within, the redox partner binding site (Miller and Auchus, 
1999). However, mutations at this position (Phe417Cys) also selectively disrupt 17,20-lyase activity 
(Biason-Lauber et al., 1997). The human CYP17A1 model (pdb-id 2C17) shows that Phe417 lies C-
terminal of the meander sequence (His407-Arg416), which can not be accessed by solvent and thus 
cannot form part of the redox-binding site. The authors suggested that although Phe417 is not a 
component of the redox-binding site, it does form an edge for the redox-binding site by contributing to 
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hydrophobic interactions that assists in stabilizing the “flap” (sequence adjacent to Arg358 and lacking 
basic residues) between the heme-binding domain and the meander (Auchus and Miller, 1999).  
Human CYB5 with double mutation Glu48Gly and Glu49Gly, which introduces a very flexible 
sequence of four Gly residues, has been shown to be deficient in its ability to stimulate the activity of 
human CYP17A1 (Naffin-Olivos and Auchus, 2006). This observation was consistent with the 
presence of Glu48 and Glu49 in the interaction interface of cluster II and considerable line broadening 
NMR data was observed for CYB5 Glu48 and Glu49 upon complex formation with the CYP2B4 
(Ahuja et al., 2013). 
Remarkable differences in CYP17A1 activities occur among species and conserved key residues have 
been identified to be involved in- and are essential to hemeprotein interactions and activity. Current 
experimental procedures, the extent of data obtained and the accuracy of tested prediction models of 
hemeproteins, all provide a strong foundation for attributing structure/function similarities to different 
species of the same protein.  
There is modest amino acid sequence identitiy occurring between the ~500 amino acids of various 
species CYP17A1s and a greater identity occurring between the 134 amino acids of various species 
CYB5s. Therefore, the aim of this chapter will be to observe whether there is a specific relationship or 
interaction between same species CYP17A1 and CYB5 in conferring maximal activity by that species 
CYP17A1 protein. This will be achieved by investigating whether or not wt pCYP17A1-VH activity is 
amplified in a similar manner when co-expressed with alternative species CYB5 cDNA.  
Porcine CYB5 cDNA will be cloned from porcine liver homogenates by reverse transcribing cDNA 
from mRNA. Co-expression assays of wt pCYP17A1-VH with porcine CYB5 (pCYB5), human CYB5 
(hCYB5), angora CYB5 (aCYB5) and rat CYB5 (rCYB5) will be conducted in COS-1 cells with prog 
metabolism assayed. Testicular pCYP17A1 (-LL) will also be assayed with pCYB5 and end-products 
will be compared to those assayed with adrenal pCYP17A1 (-VH). 
Porcine CYB5 shares 86.5% amino acid sequence identity with human CYB5 (18 amino acid 
differences), 90.2% with angora CYB5 (13 amino acid differences) and 91.7% with rat CYB5 (11 
amino acid differences). Figure 4-3 shows the full-length amino acid sequence alignments of porcine-, 
human-, angora- and rat- CYB5 annotated with inferred secondary structural features.  
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Figure 4-3: Amino acid sequence alignments of full-length species CYB5 used in the co-expression assays with wt porcine 
CYP17A1. The GenBank accession numbers for species CYB5 are: porcine CYB5 (pCYB5) P00172.3; human CYB5 
(hCYB5) P00167.2; angora CYB5 (aCYB5) ABQ12619.1 and rat CYB5 (rCYB5) P00173.2. hCYB5, aCYB5 and rCYB5 
are aligned with regards to the pCYB5 sequence. Secondary structure elements are shown by barrels (α-helices) and arrows 
(β-sheets) (inferences from Ahuja et al., 2013). 
4.4 Materials and methods 
4.4.1 Plasmids  
Human pCMW_CYB5 (hCYB5), angora pCMW_CYB5 (aCYB5) and rat pCW_CYB5 (rCYB5) and 
control plasmids, pCI-neo and angora CYP17A1 (aCYP17A1), were available for use in the laboratory. 
Their sequences correspond to their GenBank counterparts (protein identification numbers): 
aCYP17A1 (ABQ12616.1) and hCYB5 (P00167.2), aCYB5 (ABQ12619.1), rCYB5 (P00173.2) are 
aligned in Figure 4-3. 
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4.4.2 Reagents 
3H-Prog was purchased from PerkinElmer Life Sciences (Boston, MA, USA). Prog, 17OHprog, 
16OHprog, A4 and DMEM were purchased from Sigma Chemical Company (St. Louis, MO, USA). 
COS-1 cells were obtained from the American Type Tissue Culture Collection (Manassas, VA, USA). 
Penicillin-streptomycin and trypsin-EDTA were purchased from Gibco-BRL (Gaithersburg, MD, 
USA). Fetal calf serum and bacterial culture media were purchased from Highveld Biological 
(Lyndhurst, RSA). GeneJuice transfection reagent was purchased from Novagen (Darmstadt, 
Germany). Wizard® Plus SV Minipreps DNA Purification system and DNA markers 
(λDNA/EcoR1+HindIII and 1 kb marker) were purchased from Promega Biotech (Madison, WI, USA). 
TRI-Reagent® Kit and nuclease-free water were purchased from Ambion, an Applied Biosystems 
Business (Austin, Texas, USA). RNase-free plasticware, oligoDT (deoxythymidine), ribonucleotide 
phosphates and primers were purchased from Whitehead Scientific (Pty) Ltd (Bellville, RSA). 1st 
Strand cDNA Synthesis kit for RT-PCR (AMV), PWO DNA Polymerase High Fidelity, restriction 
endonuclease Acs1 and DNA marker, marker VI (digested pBR328 DNA/Bgl1 and pBR328 
DNA/Hinf1) were purchased from Roche-Applied Sciences (Mannheim, Germany). pcDNA™ 
Gateway® Directional TOPO® Expression kits and One shot® TOP10 E. coli cells were purchased 
from Invitrogen (Carlsbad, USA). Nucleobond® AX plasmid preparation kits were purchased from 
Machery-Nagal (Duran, Germany). PCR machines, electrophoresis apparatus and spectrophotometers 
are of the highest laboratory standards. All other chemicals were of the highest analytical grade and 
purchased from scientific supply houses.  
4.4.3 RNA isolation and cDNA cloning  
Porcine livers were obtained at Winelands Pork, Stikland, abbatoire facility (Mr. Fredi Williams). 
Multiple 5 x 3 cm Landros porcine liver sections were collected 20 min after slaughtering, using the 
necessary sterile precautions. Sections were immediately contained in sterile RNase-free 50 ml falcon 
tubes and stored in liquid nitrogen.  
Extraction and purification of porcine liver RNA was conducted at 4ºC, with the necessary precautions 
taken in handling RNA and avoiding RNase contamination (Ausubel et al., 1991). Upon thawing, liver 
sections, ~50 mg, were sliced and placed into 1.5 ml RNase-free centrifuge tubes containing Tri-
Reagent®, 500 µl. Samples were homogenized at 4ºC using a glass homogenizer after which the 
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homogenate was transferred into RNAase-free 1.5 ml centrifuge tubes containing equal volume Tri-
Reagent®. Total RNA isolation was performed at room temperature using the TRI-Reagent® total 
RNA isolation kit, according to manufactures instructions and was quantified by absorbance at 260/280 
nm. 
Reverse transcriptase PCR was performed with a RNA reaction mixture containing RNA, 2 µg, 
oligodT’s (0.5 µg/µl), 2 µl, and nuclease-free water, in a total volume of 11 µl. Samples were incubated 
on a heating-block at 70ºC for 5 min to denature RNA secondary structures. Thereafter, samples were 
placed on ice for 5 min to allow annealing of the dT primer to mRNA. The components of the 1st strand 
cDNA synthesis RT-PCR: AMV-RT buffer (5X), 1X, 5 µl, RNase inhibitor (50 U/µl), 50 U, 1 µl, 
AMV reverse transcriptase, 3 µl, and nuclease-free water were added together in a total reaction 
volume of 14 µl. The reverse transcriptase reaction mixture was added to the RNA reaction mixture 
and was placed on the heating-block at 42 ºC for 1 hr.   
The cDNA obtained was used as template DNA in the PCR amplification to generate double stranded 
porcine DNA using primers listed in Table 4-1. Proof reading polymerase (PWO DNA Polymerase 
High Fidelity) was used, according to manufacturers’ instructions in the amplification reaction to 
ensure that incorrect nucleotides were not incorporated into the amplified DNA. 
Table 4-1: Primer sequences used in the PCR amplification and direct DNA sequencing of pCYB5. First left and right 
primer pair (LP1 and LP2) are complementary to the 5’ and 3’ ends of porcine CYB5 (GenBank protein identification 
number P00172.3), respectively. The CACC sequence (underlined) was incorporated in LP1, which was required for 
subsequent TOPO cloning. 
Primer Oligonucleotide sequence 
LP1 (Sense) 5’-CACCCTCGCTGAGTTAAGAAATG-3’ 
RP1 (Antisense)  5’-CTGCTTTGGTCCAGGGAG-3’ 
The PCR components were combined to a total reaction mixture of 100 µl with nuclease-free water: 
MgS04-PCR buffer (10X), 1X, 10 µl; dNTPs (10 mM), 400 µM, 4 µl; each primer (20 µM), 300 nM, 
1.5 µl; PWO (5 U/µl), 2.5 U, 0.5 µl, and RT-PCR product, 3 µl. PCR amplification was performed 
under the following conditions: denaturation at 94ºC for 2 min; annealing at 94ºC for 30 sec, 55ºC for 
30 sec, 70ºC for 1 min (35 cycles) and the extension stage at 70ºC for 10 min.  
A pcDNA™ Gateway® Directional TOPO® expression kit was used, according to manufacturers’ 
instructions. PCR product, porcine CYB5 cDNA, 4 µl, was ligated into the mammalian expression 
vector TOPO® (pcDNA3.2/V5/GW/D-TOPO®) (15-20 ng/µl), 1 µl, in a salt solution (1.2 M NaCl; 
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0.06 M MgCl2), 1 µl. The reaction was incubated at room temperature for 30 min and then placed on 
ice. One shot® TOP10 E. coli cells were transformed with the addition of PCR amplification mixture, 
2 µl, and incubated on ice for 30 min. Thereafter, the reaction was heat shocked in a water bath at 42ºC 
for 30 sec and placed back on ice for 1 min. Room temperature SOC medium, 250 µl, was added after 
which the cells were incubated at 125 rpm at 37ºC for 1 hr.  Cells were plated on LB medium-agar 
containing ampicillin, 100 µg/ml, and grown overnight at 37ºC with petri dishes placed upside-down. 
LB medium, 5 ml, containing ampicillin, 100 µg/ml, was inoculated with a single colony of 
transformed TOP10 E. coli cells and incubated overnight at 37ºC at 225 rpm. Plasmid DNA was 
isolated using the Wizard® Plus SV minipreps DNA purification system, according to manufacturers’ 
instructions. Plasmid DNA, 10 µl, was subjected to a restriction digest for 1.5 hr in a 50ºC warm bath, 
with 10 U restriction enzyme Acs1 (10 U/µl), according to manufactures instructions. The products 
were separated by 1% agarose gel electrophoresis at 55 V with a DNA marker, 1 kb marker (Promega) 
and stained with ethidium bromide for UV visualization. Positive clones were subsequently subjected 
to sequence analysis with universal primer T7 (5’-TAA TAC GAC TCA CTA TAG GG-3’) and 
primers listed in Table 4-1. All DNA sequencing was performed on an ABI Prism 3100 Genetic 
Analyzer (Applied Biosystems, Foster city, California).  
LB medium, 100 ml, containing ampicillin, 100 µg/ml, was inoculated with freezer stocks of pcDNA-
CYB5, 100 µl, and incubated overnight at 37ºC at 225 rpm. The plasmid DNA was isolated using the 
Nucleobond® AX100 DNA Isolation Kit, according to manufacturers’ instructions (Machery-Nagal). 
After precipitation, the plasmid DNA pellet was redissolved in deionized water, 200 µl, and the 
plasmid yield was calculated by UV spectrophotometry, 260/280 nm.  
4.4.4 Enzymatic assays in non-steroidogenic mammalian COS-1 cells 
COS-1 cells were grown to confluence in 100 mm culture dishes at 37ºC and 5% CO2 in DMEM, 10 
ml; supplemented with 0.9 g/L glucose, 0.12% NaHCO3, 10% fetal calf serum and 1% penicillin–
streptomycin (stock containing 10 000 U/ml penicillin and 10 000 µg/ml streptomycin). Twenty four 
hours prior to transfection, cells were plated into 12-well culture dishes with each well containing 
1×105 cells (1 ml/well). For co-transfection experiments, cells were transfected with medium 
containing transfection reaction mix (1 ml/well), 50 µl, which contained total plasmid DNA of 0.5 µg 
(two different cDNAs of 0.25 µg each) and GeneJuice transfection reagent, 1.5 µl. Control transfection 
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reactions were performed using the mammalian expression vector pCI-neo (containing no gene insert) 
and a positive control plasmid, angora CYP17A1. The cells were incubated for 72 hr, after which 
enzyme activity was assayed by adding steroid substrate 1 µM prog with or without 3H-prog (100 000 
cpm/50 µl) to fresh growth medium. Aliquots of 50 µl or 500 µl were removed at specific time 
intervals to assay substrate conversion and were analysed by HPLC or UPLC-MS, respectively. 
Deionised water, 450 µl was added to the tritiated samples after which steroid metabolites were 
extracted in dichloromethane, 5 ml, for analyses by HPLC. Non-tritiated samples were extracted in 
dichloromethane, 5 ml and steroid metabolites analysed by UPLC-MS. The dichloromethane phase was 
evaporated under a stream of nitrogen. Dried steroid residue was redissolved in methanol, 120 µl, prior 
to analysis. After the last time-point, cells were washed with and collected in phosphate buffer (0.1 M, 
pH 7.4) and sonicated prior to determining the protein content by the Pierce BCA method (Pierce 
Chemical) according to the manufacturers’ instructions. 
4.4.6 Separation and quantification of steroid metabolites 
The chromatographic separation of steroids was performed on a Waters (Milford, MA, USA) HPLC 
coupled to a WISP™ automatic injector (Waters) and a Flo-One liquid scintillation spectrophotometer 
(Radiomatic, Tampa, FL). Prog, 17OHprog and A4 were separated on a Novapak® C18 column at a 
flow rate of 1 ml/min. The mobile phase consisted of solvent A (35% water and 65% methanol) and 
solvent B (100% methanol). The column was equilibrated for 10 min with solvent A, followed by a 
linear gradient from 100% solvent A to 100% solvent B in 5 min, after which an isocratic elution of 
solvent B ran for 2 min. 
Steroid metabolites, prog, 17OHprog, 16OHprog and A4 were separated and quantified using UPLC-
MS on a Waters UPLC BEH C18 (2.1 mm × 100 mm, 1.7 µm) column (ACQUITY UPLC, Waters, 
Milford, USA). The mobile phases consisted of 0.1% formic acid (solvent A) and acetonitrile (solvent 
B). Steroids were eluted at a flow rate of 0.35 ml/min, starting with the mobile phase 85% solvent A 
and 15% solvent B for 3.5 min, followed by 20% solvent A and 80% solvent B for 2.1 min, followed 
by 100% solvent B for 1 min and finally 85% solvent A and 15% solvent B for 2 min. An API Quattro 
Micro tandem mass spectrometer (Waters, Milford, USA) was used for quantitative mass spectrometric 
detection. An Ion Sabre probe (Waters, Milford, USA) was used for the APCI interface in positive 
mode. The corona pin was set to 7 µA, the cone voltage to 30 V and APCI probe temperature was 
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100ºC. All other settings were optimized to obtain the strongest signal possible. Data was collected 
with the MassLynx 4.0 software program. 
4.5 Results 
4.5.1 Cloning and analyses of pCYB5  
Total RNA was isolated from porcine liver homogenates after which RNA was reverse transcribed 
using oligodT primers and porcine cDNA encoding CYB5 was amplified by RT-PCR. The RT-PCR 
product was subsequently cloned into the pcDNA3.2/V5/GW/D-TOPO® vector and transformed into E. 
coli cells. Isolated plasmid DNA of clones were subjected to digestion by restriction enzyme Acs1. The 
size of vector containing porcine CYB5 cDNA is shown in Table 4-2, as well as the sequence 
recognition sites for restriction enzyme Acs1. 
Table 4-2: Recognition sites of endonuclease Acs1 recognition sites in (a) expression vector, pcDNA3.2/V5/GW/D-
TOPO®; (b) linear porcine CYB5 cDNA and (c) porcine CYB5 cDNA ligated into the vector at the TOPO® site (pCYB5 
initiation codon ATG inserted at base pair position 970 of vector). 
 Sequence Total size (bp) Acs1 5’-A(G)/AATTC(T)-3’ (bp) 
(a) pcDNA3.2/V5/GW/D-TOPO® (circular) 5532 128; 1811; 3256 
(b) porcine CYB5 cDNA (linear) 470* 48; 116 
(c) vector with pCYB5 insert (circular) 6002 128; 1087; 1155; 2281; 3726 
* Porcine cDNA spanning the ATG initiation site at position 78 and the TAA termination site at position 482 of the 
transcribed mRNA (1724 bp). Sixty-six additional base pairs were PCR amplified downstream of the termination codon in 
the mRNA nucleotide sequence. 
Figure 4-4 shows the calculated base pairs of DNA products as a result of AcsI endonuclease digestion 
of plasmid pCYB5. Five digest sites yield DNA fragments of 68, 959, 1126, 1445 and 2404 bp. 
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Figure 4-4: Vector diagram of (a) the pcDNA3.2/V5/GW/D-TOPO® vector without and b) with the porcine CYB5 insert 
(green broken line indicates the position of insertion in the vector). Vector, 5532 bp, has three Acs1 recognition sites at base 
pair positions 128, 1811 and 3256. The vector containing DNA insert, 6002 bp, has two additional Acs1 recognition sites. 
Plasmid digestion by Acs1 yields estimated DNA fragments of 68, 959, 1126, 1445 and 2404 bp.  
Figure 4-5 shows the analyses of isolated plasmids and DNA products resulting from AcsI digestion, 
using gel electrophoresis on a 1% agarose. The 1 kb marker ranges from 250 bp to 10 000 bp.  
 
Figure 4-5: Restriction digest of isolated plasmids. Lane 1, 1 kb DNA marker (Roche); lanes 2 and 3, Acs1 digest of positive 
clones, pcDNA3.2_ pCYB5; lanes 4 and 5, Acs1 digest of clones containing vector only; and lane 6, undigested plasmid 
cDNA. Fragments were separated by gel electrophoresis using a 1% agarose, stained with ethidium bromide for UV 
visualization. 
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Lanes 2 and 3 show DNA fragments with sizes that were calculated for the Acs1 digest of the circular 
vector containing the porcine CYB5 cDNA insert. Sequence analysis, confirmed that the DNA 
sequence of clones 1 and 2 were identical to porcine CYB5 (GenBank protein identification number 
P00172.3). 
Table 4-3 shows the absorbance values obtained from UV spectrophotometry analysis of isolated 
porcine liver mRNA and porcine CYB5 (pCYB5) DNA. Concentration and purity of DNA was 
calculated via OD measurements at 260 and 280 nm. OD values ranged between 0.1 and 0.8 for 
optimal measurement. mRNA and DNA yield and concentration were calculated for 50 µl and 200 µl 
sample volumes, respectively, and 1 A260 Unit of ssDNA = 33 µg/ml H20 and 1 A260 Unit of dsDNA = 
50 µg/ml H20, respectively. Purity was determined by A260/A280 ≥ 1.6. 
Table 4-3: Absorbance values of (a) isolated porcine liver mRNA and (b) purified pCYB5 plasmid DNA. 
 absorbance values 
 
Isolated  
260 nm 280 nm 
dilution  
factor 
concentration 
(µg/µl) 
dsDNA 
(µg) 
purity 
260:280 
a) mRNA1 0.65 0.39 40 0.86 42.9 1.66 
 mRNA2 0.46 0.29 40 0.59 29.7 1.59 
b) pCYB51  0.72 0.46 100 3.61 722 1.59 
 pCYB52 0.72 0.46 100 3.60 720 1.56 
4.5.2 Analyses of prog conversion by CYP17A1 
4.5.2.1 Prog conversion by wt pCYP17A1-VH co-expressed with different species of CYB5 
The expression of wt pCYP17A1-VH (0.25 µg) in COS-1 cells without CYB5 resulted in prog 
conversion yielding 80.2 % 17OHprog and 16.4% A4, with negligible (3.4%) substrate remaining (see 
Figure 4-6 and Table 4-4). In the presence of equimolar ratios of pCYB5 (0.25 µg), the catalytic 
activity of wt pCYP17A1-VH was significantly influenced, shifting the formation of A4 to 85.6%, with 
only 13.0% 17OHprog remaining. It has previously been shown that co-transfecting CYP17A1 and 
CYB5 at a 1:1 ratio (0.25 µg plasmid of each) achieves optimal catalytic conditions. 
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Figure 4-6: Steroid profiles of 1 µM prog conversion after 24 hr by wt porcine CYP17A1 (wt pCYP17A1-VH) without and 
in the presence of different species CYB5: porcine (pCYB5), rat (rCYB5), angora (aCYB5) and human (hCYB5), expressed 
in COS-1 cells. Results are representative of three independent experiments (n = 9). Individual steroids were compared, 
represented by matching alphabetical letters, by a one-way ANOVA, followed by a Dunnett’s multiple comparison test. 
Results are expressed as the mean ±SEM. Comparisons of 17OHprog (a,b,c,d) formation between wt and wt in the presence 
of porcine- (a), rat- (b), angora- (c) and human (d) CYB5, respectively, as well as comparisions of A4 (e,f) production 
between wt and wt in the presence of porcine- (e) and rat (f) CYB5, respectively, were significantly (p<0.0001) different 
from each other. Comparison of A4 (g) formation between wt and wt with angora CYB5, was also significantly different 
with p=0.0480. Human CYB5 significantly (p<0.0001) reduced wt pCYP17A1 17α-hydroxylase and 17OHprog (d) 
formation, with the concomitant and significantly (p<0.0001) higher levels of prog (i) remaining. Comparisons between A4 
(h) formation by wt and wt in the presence of human CYB5, were not significantly different to each other. Comparisons 
between porcine CYB5 and human CYB5 activities and their effects on wt pCYP17A1 17OHprog (j) and A4 (k) formation, 
were significantly (p<0.0001) different to each other. 
Co-expression of porcine CYP17A1 with CYB5 from a species other than porcine, did not enhance 
porcine CYP17A1 17,20-lyase activity to the degree that porcine CYB5 did. Comparisons of steroid 
product formation by wt porcine CYP17A1 expressed without and with different species CYB5 clearly 
shows (Table 4-4) that while pCYB5 enhanced the lyase reaction and increased the A4 production 5.2-
fold, the effect on the lyase activity in the presence of different species CYB5 is less favourable. A 
lesser increase is shown in the production of A4 by rat CYB5, rCYB5 (3.7-fold) and angora CYB5, 
aCYB5 (1.5-fold) In the presence of human CYB5, hCYB5, although not significant, produced less A4 
(1.4-fold). In addition, expression of CYP17A1 in the presence of human CYB5 also influenced the 
hydroxylase activity and after 24 hr, nearly half the substrate remained (47.5%). with 2-fold less 17α-
hydroxylated product than in wt. 
As CYB5 influences 17,20-lyase activity, ratios of A4:17OHprog+A4 obtained in the conversion of 
prog by porcine CYP17A1 in the presence of the different CYB5 were determined (Table 4-4).  
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Table 4-4: Percentage steroids present after 24 hr of 1 µM prog conversion and ratios of 17,20-lyase:17α-hydroxylase 
products after wt pCYP17A1-VH expression in the presence of CYB5 from different species. 
 prog % 17OHprog%  A4% A4:17OHprog+A4 
wt pCYP17A1-VH 3.4 80.2 16.4 0.17 
+ pCYB5 1.4 13.0 85.6 0.87 
+ rCYB5 2.6 36.8 60.6 0.62 
+ aCYB5 9.5 66.4 24.1 0.27 
+ hCYB5 47.5 40.9 11.6 0.22 
Porcine CYB5 affects porcine 17,20-lyase activity in that the production of A4 is more efficient (5.2-
fold increase) than rat- (3.7-fold increase), angora- (1.5-fold increase) and human CYB5 (1.4-fold 
reduction) A4 production. It is quite apparent that same species co-expression achieves optimal 
activity. 
4.5.2.2 Analyses of 16OHprog production by wt pCYP17A1-VH in the presence of pCYB5 and rCYB5 
16α-Hydroxylase activity was investigated by co-expressing wt pCYP17A1-VH, pCYB5 and rCYB5. 
Figure 4-7 shows the steroid profiles, analysed by UPLC-MS, for the prog conversion assays after 24 
hr.  
 
Figure 4-7: Effect of CYB5 on 16OHprog formation after 24 hr. Results are representative of three independent experiments 
(n = 9). Individual steroids were compared by a one-way ANOVA, followed by a Dunnett’s multiple comparison test. 
Results are expressed as the mean ±SEM. Comparisons of 16OHprog formation between wt without and in the presence of 
porcine- (a) or rat CYB5 (b) were not significantly different to each other.  
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Levels of 16OHprog were negligible, neither porcine CYB5 nor rat CYB5 influences the formation of 
this steroid (Table 4-5). The change in ratio of products formed via C17 hydroxylation and C16 
hydroxylation are not significantly different. 
Table 4-5: Analyses of CYB5 influence on 16α-hydroxylase activity of wt pCYP17A1-VH. 
Plasmid cDNA prog % 17OHprog % 16OHprog % A4 % 16OHprog:17OHprog+A4 
wt pCYP17A1-VH 1.9 66.1 9.1 22.9 0.10 
+ pCYB5 0.0 2.0 7.7 90.3 0.08 
+ rCYB5 0.0 24.8 10.1 65.1 0.11 
4.5.2.3 Analyses of prog conversion by wt pCYP17A1-VH and mutant pCYP17A1-LL co-expressed 
with pCYB5  
pCYP17A1-LL, is a double mutant of wt pCYP17A1, containing the Val40Leu and His407Leu 
substitutions. In the absence of CYB5, they have quite different activities (Figure 4-8).  
 
Figure 4-8: Similar steroid profiles at 24 hr after wt (Val40/His407) and double mutant pCYP17A1-LL (Leu40/Leu407) 
amplification by pCYB5. As seen in wt, there is a significant change (p<0.0001) in both 17OHprog (a) and A4 (b) 
production upon addition of pCYB5 with mutant pCYP17A1-LL. There are no significant differences in steroid product 
percentages between the co-expression steroid profiles of wt+pCYB5 and LL+pCYB5.  
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Compared to wt ratio (0.74), see Table 4-6, the double mutation of pCYP17A1-LL favours the catalysis 
of the lyase reaction and has a ratio of 0.39 for products formed via C17 hydroxylation and C17,20- 
lyase in the total products formed. Interestingly, the effect of pCYB5 on the lyase reaction is more 
prominent in the wt pCYP17A1-VH conversion of prog, which results in a 3.9-fold increase in A4 
production, when compared to the 1.6-fold increase in the case of the double mutant. 
Table 4-6: Steroid analyses of prog conversion by double mutant pCYP17A1-LL and wt pCYP17A1-VH in the presence of, 
and without CYB5.  
Plasmid cDNA prog % 17OHprog % 16OHprog % A4 % 17OHprog:17OHprog+A4 
wt pCYP17A1-VH 1.9 66.1 9.1 22.9 0.74 
+ pCYB5 0.0 2.0 7.7 90.3 0.02 
pCYP17A1-LL 1.6 34.6 10.2 53.6 0.39 
+ pCYB5 0.6 2.6 9.9 86.9 0.03 
Wt pCYP17A1-VH (Val40/His407) differs from porcine testes CYP17A1 (Leu40/Leu407) at two 
positions. Wt double mutant –LL comprise both V40L and H407L substitutions (Leu40/Leu407); thus 
representative of the testicular protein. pCYP17A1-LL produces higher levels of  A4 than wt 
pCYP17A1-VH, as is reflected in the ratios 0.61 and 0.26, respectively, regardless of the presence of 
CYB5, a 2.3-fold difference in formed A4. 
The production of 16OHprog remained negligible and unchanged for both wt and -LL, regardless of the 
presence of pCYB5.  
4.6 Discussion 
In this study, pCYB5 was cloned in order to investigate the effect of pCYB5 on A4 production by 
porcine CYP17A1. Other species CYB5 were included in the study to determine whether optimal 
activity was achieved when expressing wt pCYP17A1 with human-, rat- and angora CYB5. It was 
found that co-transfecting CYP17A1 and CYB5 at a 1:1 ratio achieved  
After 24 hr, the co-expression of wt pCYP17A1-VH with the four species CYB5s resulted in 
significant differences in steroid profiles, although no significant changes were observed in 16α-
hydroxylase activity. The greatest stimulation of the lyase reaction was obtained when porcine 
CYP17A1 was expressed with porcine CYB5 and a 6-fold increase in A4 levels was measured, while 
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rat CYB5, on the other hand, yielded a 2-fold increase in A4 levels. The conversion of prog by wt 
pCYP17A1-VH in the presence of angora CYB5 yielded significantly less A4 than in the presence of 
porcine and rat CYB5; with a concomitant increase in 17OHprog levels. While the A4 produced in the 
presence of angora CYB5 was also significantly less than the levels detected in the presence of porcine 
CYB5, it was nevertheless more than that produced by wt in the absence of CYB5. In contrast, human 
CYB5 not only resulted in significantly lower A4 levels but also hampered the hydroxylase activity.  
The CYB5 and CYP17A1 gene sequences comprise 402 bp and 1786 bp nucleotides, respectively, 
which encode the 134- and 508 amino acid proteins, respectively. Interactions between specific 
residues of same species CYP17A1 and CYB5 are dependent on the conformation of the proteins 
within the enzyme/redox partner complex, which probably allow for species-specific optimal enzyme 
activity. Single residues or mutations have been attributed to CYB5 potential to maximally 
amplify/reduce CYP17A1 activity, as well as being responsible for appropriate interaction between the 
hemeproteins. Although the amino acids in the P450 substrate binding site define the substrate 
specificity of the individual forms of P450, other undefined regions on the P450 surface are also 
functionally active as they interact with NADPH-CPR and CYB5 (Omata et al., 1994).  
Sequence alignment and analysis shows that although porcine, rat and angora CYB5 share a high 
degree of sequence identity; their redox partner CYP17A1 sequences do not (Table 4-7).  
Table 4-7: Amino acid residue differences (number) and percentage identities (in parenthesis) between porcine CYB5 and 
CYP17A1 and the human, rat and angora homologs.  
  human  rat  angora 
CYB5 (134 residues) porcine 18 (86.5%) 11(91.7%) 13 (90.2%) 
CYP17A1 (508 residues) porcine 173(66.0%) 393 (22.7%) 111 (78.1%) 
An alignment of various species CYB5 (Addendum C), shows that there is a conserved region of amino 
acid residues, ~35-74, with variations occurring near the N- and C- terminals (Hagihara and Furuya, 
1978). Secondary structural features obtained for a few of the species CYB5 (see Figure 4-1) show that 
in the heme-binding domain (amino acid residues ~60-80), residues His44 and His68 co-ordinate heme 
positioning (Aono et al., 2010), and residues Glu48, Glu49, Glu64, Asp65, Val66, Thr70-Ser76 are 
shown to specifically interact with P450 residues in the CYB5-P450 interface (Ahuja et al., 2013). 
These residues appear to be conserved for current known sequences of mammalian CYB5. The 
alignment of the species CYB5 investigated in this study (Figure 4-3); show the same residues in these 
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structural domains, with all of the conserved residues being identical with published data (Musket et 
al., 1996; Arnesano et al., 1998; Banci et al., 2000; Nunez-Quintana et al., 2010, Ahuja et al., 2013).  
In accordance with the literature, cloned porcine CYB5 amplified the production of A4 by wt 
pCYP17A1-VH, which ranged from 16.4% without CYB5 to 85.6% with CYB5, with no apparent 
influence on hydroxylase activity. This mechanism of allosteric behaviour of enhancing 17,20-lyase 
activity, has been widely reported. It is interesting to note that even though porcine and rat CYP17A1 
share the least sequence identity (22.7%) it is rat CYB5 which yields a greater stimulation of the 
porcine CYP17A1 lyase reaction than did angora and human CYB5, which have far higher CYP17A1 
sequence identity. In addition, it is only when human CYB5 forms the redox/partner enzyme complex 
that there is a negative effect on wt pCYP17A1-VH hydroxylase activity, with only 48% of the 
substrate being metabolised after 24 hr.   
The influence of the sequence identity of CYB5 on the ratio of A4 production by wt porcine CYP17A1 
in the presence of and without porcine CYB5, rat CYB5, angora CYB5 and human CYB5 is shown in 
Figure 4-9. 
 
Figure 4-9: Influence of sequence identity on the ratio of A4 production by wt pCYP17A1 in the presence of- and without 
porcine CYB5 (p), rat CYB5 (r), angora CYB5 (a) and human CYB5 (h).  
The linker domain spanning residues Ser90 to Asp104 of CYB5 connects the cytosolic heme domain to 
the α-helical transmembrane anchor and it is the linker region that appears to lack distinct structure 
(Ahuja et al., 2013). Residues within this region, 96 to 103, are essential in the formation of a 
functional complex between CYB5 and CYP17A1 (Clark et al., 2004). Residues 96 to 103 of porcine 
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and rat CYB5 are identical. In this region, human has a Pro at position 96 (porcine, rat and angora have 
a Ser residue) possibly resulting in a bend in the polypeptide chain. Porcine and rat have a Val103 and 
a Glu104, while human and angora exhibit conservative changes, Ile and Asp, respectively. The 
influence of human CYB5 on porcine wt CYP17A1 however, cannot be attributed solely to the Pro 
residue at position 96 with residues in pCYP17A1 also affecting structure and interaction within the 
enzyme/redox partner complex. 
The specificity of CYP17A1 towards its substrates differs in various species and tissues. In human 
adrenals and testes, CYP17A1 17α-hydroxylates both preg and prog but selectively produces DHEA in 
greater quantities than A4 (Chung et al., 1987). CYP17A1 is not expressed in rat or mice adrenal 
glands (van Weerden et al., 1992) but the gonadal CYP17A1 in these species preferentially produces 
A4 (Fevold et al., 1989). CYP17A1 is however, expressed in guinea pig (Tremblay et al., 1994) and 
hamster (LeHoux and Lefebvre, 1980) adrenal glands, producing both DHEA and A4 but favouring A4 
production. In this study, porcine CYP17A1 (wt pCYP17A1-VH), with Val40 and His407, catalysed 
the conversion of prog (>90%) with and without CYB5. The porcine testes pCYP17A1 variant (with 
sequence including Leu40 and Leu407) was prepared from wt pCYP17A1-VH and is represented by 
the double mutant construct pCYP17A1-LL, with both Val40Leu and His407Leu substitutions.  
With the aim to increase ∆5-lyase activity in hamster, mutation Asp407His replaced the Asp residue 
(suggested to contribute to high ∆4-lyase activity in small animals) with the His residue (suggested to 
contribute to high ∆5-lyase activity in larger animals), which substituted a negatively charged side-
chain with a positive charge (Mathieu et al., 2002). Activity assays of wt hamster CYP17A1 and 
mutant Asp407His, in transiently transfected COS-1 cells, show that substrate (2.5 µM preg or prog) 
utilization was linear with time (1 hr). Compared to wt, the Asp407His mutant only showed a selective 
decrease in 17α-hydroxylase activity for the Δ4 pathway by 46%, leading to a comparable decrease in 
A4 formation, which was attributed to the reduced production of 17OHprog. The Trp406Arg mutation 
in CYP17A1 resulted in two adjacent positive charges (Arg406/His407) in the meander region and led 
to 17α-hydroxylase deficiency in prog metabolism (Costa-Santos et al., 2004). In this study, the 
mutation His407Leu in wt pCYP17A1-VH, which resulted in the loss of a positive charge at the start of 
the meander region, led to a 2-fold increase in A4 production inferring stimulation of wt lyase activity. 
There is modest sequence identity occurring between the ~500 amino acids of various species 
CYP17A1s and a greater sequence identity occurring between the 134 amino acids of various species 
CYB5s. Therefore, the aim of this chapter was to observe whether there was a specific relationship or 
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interaction between same species CYP17A1 and CYB5 in conferring maximal activity by that species 
CYP17A1 protein. This was achieved by investigating whether or not wt pCYP17A1-VH activity was 
amplified in a similar manner when co-expressed with alternative species CYB5 cDNA. In comparison 
with isolated porcine testes CYP17A1 (Leu40 and Leu407) and the partial amino acid sequence of 
porcine CYP17A1 (Leu40 and His407) derived from adrenal cDNA (GenBank accession numbers 
NP_999593.1 and AAA84419.1 respectively), porcine wt CYP17A1 used in this study, exhibited 
Val40 and His407 (wt pCYP17A1-VH) and showed typical enzyme characteristics with minimal 
17,20-lyase activity. It was rigorously stimulated (6-fold) by porcine CYB5, to a lesser extent by rat 
CYB5 (above 90% sequence identity) and to even lesser and no extent with angora and human CYB5 
(90.2% and 86.5%, respectively). It appears that porcine CYP17A1 with Val40 and His407 was 
stimulated by porcine CYB5 more intensely than porcine CYP17A1 with Leu40 and Leu407 residues 
(representing the testes variant).  
With regards to how single amino acid substitutions affect- or why other species CYB5 do not similarly 
affect porcine CYP17A1 activity, speculations that are based solely on end-product formation and 
steroid profiles are ultimately deemed limited. Therefore, to have a more complete understanding of the 
effects of the site-directed mutagenesis, future studies would include characterizing wt- and mutant 
proteins with respect to the rates of their dual catalytic reactions in prog metabolism, with and without 
the various species CYB5. Furthermore, elaborated 3D models of wt and mutant porcine CYP17A1 
with and without various species CYB5, would accurately predict the structural consequences of such 
mutations and any related restructuring in heme, redox-partner and substrate binding sites. 
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CHAPTER 5 
CONCLUSION 
The central aim of this study was to investigate the structure/function relationship of CYP17A1, a key 
enzyme in adrenal and gonad steroidogenesis. Sequence alignments of the deduced amino acid residues 
of CYP17A1 from various species have allowed for the prediction of ligand binding domains (Auchus 
and Miller, 1999; DeVore and Scott, 2012), while site-directed mutagenesis and kinetic studies have 
identified potential active pocket residues (Lin et al., 1991; Monno et al., 1993; Koh et al., 1993; 
Fardella et al., 1994; Lee-Robichaud et al., 1998; Di Cerbo et al., 2002; Sherbet  et al., 2003; Pandey 
and Miller, 2005; Lin et al., 2005a; Sahakitrungruang et al., 2009; Kok et al., 2010). The homology 
models of mammalian P450 that are currently available have been generated based mostly on the 
crystal structures of bacterial enzymes and although they share less than 20% amino acid sequence 
identity, they share a common structural core even though these proteins differ with regards to 
solubility, sequence identity, redox partner and substrate specificity (Auchus and Miller, 1999; Kemp et 
al., 2005). The recent determinination of the crystal structures for several of mammailian P450 have 
enhanced the accuracy of homology modeling. In an effort to promote insight into the 
structure/function relationship of CYP17A1, the aims of this study were to investigate the catalytic 
activity of porcine CYP17A1 and the effects of the amino acid residues at positions 40 and 407 on the 
catalytic activity of porcine CYP17A1; to clone porcine cDNA encoding CYB5 from mRNA isolated 
from porcine liver and to investigate the influence of CYB5 on the catalytic activity of the enzyme. The 
influence of porcine CYB5 on the lyase activity of porcine CYP17A1 was subsequently compared to 
that of human, rat and angora CYB5.  
The amino acid sequence of a protein and the reactive side-chain groups determine the manner and 
frequency in which the protein forms α-helices and β-sheets and ultimately folds into its 3D structure. 
It is this unique protein conformation that is responsible for defining the catalytic activity of the 
enzyme. Changes to one or more of amino acid residues do not necessarily result in changes in the 
catalytic activity even though they may impact on the conformation of the protein. Changes within the 
active site, substrate docking site and redox partner binding site will to a great extent influence the 
ability of an enzyme to function in its typical catalytic manner. 
Stellenbosch University  http://scholar.sun.ac.za
97 
Single base-pair changes in human CYP17A1 cDNA have led to mutations in key amino acid residues, 
reducing the C17,20-lyase activity. These residues (i.e. Arg347His, Arg358Gln and Arg449Ala) have 
been well documented and shown to be essential for CYP17A1 interaction with CYB5 (Lee-Robichaud 
et al., 1998; Lee-Robichaud et al., 1999; Geller et al., 1999). Mutation Trp406Arg abolishes both 
hydroxylase and lyase activities of human CYP17A1 rendering the enzyme inactive (Costas-Santos et 
al., 2004). Human CYP17A1 consists of eight exons, which spans 6.6 kb, is located on chromosome 
10q24.3, and is transcribed into the same 2.1 kb mRNA species in the adrenal and gonads, of which 1.6 
kb contains coding DNA (Matteson et al., 1986; Chung et al., 1987; Picado-Leonard and Miller, 1987). 
In general, it is understood that CYP17A1 protein is encoded by a single gene (Miller and Auchus, 
2011). However, recent publications have reported that in sheep, a single gene exists as two sequences, 
which differ by two nucleotides (Storbeck et al., 2008b).  Furthermore, two CYP17A1 isoforms were 
found to be the product of two separate CYP17A1 genes (available on GenBank) encoding two unique 
CYP17A1 isoforms (Storbeck et al., 2008b) rather than the product of two alleles of the same gene. To 
date, no SNP’s affecting CYP17A1 activities have been detected in the coding region of porcine 
CYP17A1 cDNA from a variety of different breeds (Yorkshire, Duroc, Landrace, Pietrain) (Lin et al., 
2005; Moe et al., 2007; Grindflek et al., 2010). 
In this study, the amino acid sequence of porcine wt CYP17A1 (adrenal) differed from the published 
sequences of porcine adrenal (Chung et al., 1987) and porcine testes (Conley et al., 1992) CYP17A1 
cDNA. Sequence analysis of wt identified Val40 and His407 amino acid residues, with the adrenal 
CYP17A1 protein having Leu40 and His407 residues and the testicular protein having Leu40 and 
Leu407 residues. Mutant constructs were thus prepared, using wt (Val40 and His407) to include 
constructs encoding both the porcine adrenal and the testicular protein sequences, pCYP17A1-LH and 
pCYP17A1-LL, respectively, as well as a mutant incorporating Val40 and Leu407 (pCYP17A1-VL). 
Amino acid residues at positions 40 and 407 have not been the focus of earlier investigations in any 
specie CYP17A1 sequence. Sequence alignments between human and porcine CYP17A1, together with 
the secondary structural features obtained from the human CYP17A1 crystallized structure (Auchus 
and Miller, 1999; DeVore and Scott, 2012), showed the residue at position 40 to lie in the A′-helix and 
the residue at position 407 to lie at the start of the meander region between K′-helix and the highly 
conserved heme-binding domain. Substitutions at these two positions in wt pCYP17A1-VH ‒ Leu40 
and Val40, neutral residues, and His407, a positively charged residue ‒ appear to affect the catalytic 
activity of the enzyme.  
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Differences are evident when comparing the levels of 17OHprog and A4, especially in the conversion 
by the Val40/Leu407 construct. The conversion of prog in the case of Val40/His407 (wt adrenal) and 
Leu40/His407 (GenBank adrenal) were similar, producing metabolite levels not significantly different 
from each other. This was expected as they are both adrenal proteins and noteworthy, perhaps, is that a 
conservative substitution at position 40 had an effect on enzyme activity.  
Conversion by Val40/Leu407 and the Leu40/Leu407 constructs resulted in significantly higher A4 
levels with conversion by Val40/Leu407 showing a steroid profile significantly different (p<0.0001) to 
that of wt, as well as the two other constructs. In the conversion of prog by Val40/Leu407, the levels of 
A4 produced was 3.9-fold more than that produced by wt –Val40/His407, with a concomitant decrease 
of 23.6-fold in the level of 17OHProg, clearly indicating that the His residue at position 407, resulted in 
a decrease in the lyase activity. Interestingly, compared to wt, a 2.3-fold increase in A4 was detected in 
the conversion by the construct encoding the published testicular Leu40/Leu407 protein sequence, 
which is corroborated by reports that porcine testes has a high potential for C17,20-cleaved steroids. It 
is also interesting to note that the testicular construct (encoding Leu40/Leu407 residues) produced 
significantly more A4 than the construct encoding the published sequence for the adrenal protein 
(encoding Leu40/His407 residues), which is also corroborated by reports that although porcine adrenal 
is capable of Δ4 androgen production, more is produced by the testes. This tissue specific activity, 
which according to observations obtained in this study, could possibly be related to the single amino 
acid differences shown between the published sequences of adrenal and testes CYP17A1. However, the 
possibility of either the same gene existing as two sequences (as was found in sheep) or two distinct 
genes (as was found in angora) encoding porcine CYP17A1 adrenal and testes proteins would require 
further investigation. 
Subsequent analyses of the data also showed that there were no significant differences in 16OHprog 
production, underlying the findings that these substitutions at positions 40 and 407 did not influence 
the hydroxylase activities. In addtition, these data also suggest that, while maintaining the Leu residue 
at position 407, mutating the Leu40 residue of porcine testicular CYP17A1 to a Val residue led to a 
significant increase in A4 production. Although this is a conservative change, the bulkier side chain of 
Leu in the A′-helix may influence the conformation of the protein with the shorter branched chain of 
Val leading to a more favourable positioning of the substrate and subsequent interaction with the redox 
partners.  
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Substitutions at these two positions in wt pCYP17A1, affected predominantly the lyase activity of the 
enzyme. Comparing the sequences of porcine and human CYP17A1, identified a His407 residue in the 
human protein, while also showing that the porcine sequence has a Leu residue at position 105. Human 
CYP17A1 has an Ala105 residue, which is associated with the 16α-hydroxylase activity. Although 
porcine CYP17A1 catalyses 16α-hydroxylation reactions, 16OHprog formation is relatively low 
(~10%) in comparison with 17OHprog (~70%) and A4 (~20%) formation, therefore the mutation 
Leu105Ala was constructed (pCYP17A1-LA) to investigate associated changes in 16α-hydroxylase 
activity. This mutant decreased the overall catalytic activity of expressed enzyme, with 71.7% prog 
substrate remaining after 24 hr, a 5-fold decrease when compared to wt. Interestingly, there was a 
significant change in the ratio of 16OHprog:17OHprog+A4 from 0.10 for the wt to 0.57 for the mutant 
indicating that the increased change in this ratio was due to the mutation itself and that it was only the 
17α-hydroxylase activity, which was influenced by the mutation and not the 16α-hydroxylase activity. 
In the human adrenal, CYP17A1 produces significant levels of 16OHprog. Prog metabolism was 
assayed in COS-1 cells transiently transfected with wt human CYP17A1, which produced a 
17OHprog:16OHprog ratio of ~3:1, regardless of the presence of CYB5. The mutation Ala105Leu 
resulted in the production of negligible 16OHprog levels, with no apparent influence on 17α-
hydroxylase activity, regardless of the presence of CYB5 (Swart et al., 2010). Co-expression with 
CYB5 significantly decreased the ratio of 17OHprog:16OHprog in the proteins with Leu105, while 
effects were negligible with Ala at this position (Swart et al., 2010). Baboon CYP17A1 (Leu105) with 
mutation, Leu105Ala, exhibited the same 17OHprog:16OHprog ratio (~3:1) observed in wt human 
CYP17A1 (His407); although the rate of prog conversion was reduced. In this study, the Leu105Ala 
mutation in wt pCYP17A1 (His407) showed to significantly reduce wt 17OHprog formation. 
Homology models showed that Ala105 faced towards the active pocket in the predicted Bʹ–C domain 
of CYP17A1 (Swart et al., 2010). It was suggested that this smaller residue allows more flexibility of 
movement in the active pocket than Leu does, presenting both the C16 and C17 of prog to the iron-
oxygen complex. With regards to species investigated for 16α-hydroxylase activity, human CYP17A1 
is the only protein with a His residue at position 407 and although porcine CYP17A1 (Chung et al., 
1987) and porcine CYP17A1 assayed in this study, have a His residue at position 407, both exhibit low 
16α-hydroxylase activity with the 16OHprog produced being negligible. The low levels could not be 
quantified accurately as these fall below the lowest levels of quantification of the analytical methods, 
which were used.  
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Different species of CYB5, sharing high degrees of amino acid sequence identity, were co-expressed 
with wt pCYP17A1 in COS-1 cells to investigate the influence of CYB5 on the catalytic activity of 
porcine CYP17A1. Porcine CYB5 was also co-expressed with the double mutant pCYP17A1-LL 
(representing the testicular protein). The expression of wt pCYP17A1-VH in COS-1 cells without 
CYB5 resulted in prog conversion yielding 80.2 % 17OHprog and 16.4% A4, with negligible (3.4%) 
substrate remaining. In the presence of equimolar ratios of pCYB5, the catalytic activity of wt 
pCYP17A1-VH was significantly influenced, shifting the formation of A4 to 85.6%, with only 13.0% 
17OHprog remaining. Co-expression of porcine CYP17A1 with CYB5 from a species other than 
porcine, did not enhance porcine CYP17A1 17,20-lyase activity to the degree that porcine CYB5 did. 
Comparisons of steroid product formation by wt porcine CYP17A1 expressed without and with 
different species CYB5 clearly shows that while porcine CYB5 enhanced the lyase reaction and 
increased the A4 production 5.2-fold, the effect on the lyase activity in the presence of different species 
CYB5 was less favourable. A smaller increase is shown in the production of A4 by rat CYB5 (3.7-fold) 
and angora CYB5 (1.5-fold). In the presence of human CYB5, lower levels of A4 were detected than 
was produced by wt pCYP17A1 in the absence of CYB5, although not significant. In addition, 
expression of wt pCYP17A1 in the presence of human CYB5 also influenced the hydroxylase activity 
and after 24 hr, nearly half the substrate remained (47.5%). with 2-fold less 17α-hydroxylated product 
being produced in comparison to wt pCYP17A1 in the absence of CYB5. As CYB5 influences 17,20-
lyase activity, ratios of A4:17OHprog+A4 obtained in the conversion of prog by porcine CYP17A1 in 
the presence of the different CYB5 were determined. Porcine CYB5 affects porcine 17,20-lyase 
activity in the production of A4 and is more efficient (5.2-fold increase) than rat CYB5 (3.7-fold 
increase), angora CYB5 (1.5-fold increase) and human CYB5 (1.4-fold reduction) in stimulating A4 
production. It is quite apparent that same species co-expression achieves optimal activity. It would, 
therefore, appear that while optimal lyase conversion may be achieved by co-expression of CYP17A1 
with the same species CYB5, expression in the presence of CYB5 of different species may impede the 
conversion of the substrate in that the hydroxylase reaction is affected.  
The 16α-hydroxylase activity was subsequently investigated by co-expressing wt pCYP17A1-VH with 
porcine CYB5 and rat CYB5. Levels of 16OHprog were negligible, with neither porcine nor rat CYB5 
influencing the formation of this steroid, as the change in ratio of products formed via C17 
hydroxylation and C16 hydroxylation were not significantly different. It is, however, possible that if wt 
pCYP17A1-VH was co-expressed with human CYB5, the 16OHprog levels may have been reduced, 
indicating that human CYB5 hinders the hydroxylase activity of CYP17A1. To investigate the effect of 
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CYB5 on CYP17A1 lyase activity, wt pCYP17A1-VH and pCYP17A1-LL (containing both Val40Leu 
and His407Leu substitutions), were co-expressed with porcine CYB5. In the absence of CYB5, they 
have quite different activities with pCYP17A1-LL favouring the catalysis of the lyase reaction with a 
ratio of 0.39 for products formed via C17 hydroxylation and C17,20- lyase while a 0.74 ratio was 
obtained with wt pCYP17A1. Interestingly, the effect of porcine CYB5 on the lyase reaction is more 
prominent in the wt pCYP17A1-VH conversion of prog, which results in a 3.9-fold increase in A4 
production, when compared to the 1.6-fold increase in the case of pCYP17A1-LL. Porcine CYP17A1-
LL, representing testicular CYP17A1, produces 2.3-fold more A4 than wt pCYP17A1-VH (adrenal), 
regardless of the presence of CYB5, suggesting the possible significance of residues at position 40 
and/or 407. The production of 16OHprog remained negligible and unchanged for both wt and -LL, 
regardless of the presence of pCYB5.  
CYP17A1 exhibits a dual catalytic activity in terms of its hydroxylase and lyase activities, with the 
enzyme being species-specific regarding the preg and prog substrates, and the hydroxylated 
intermediates. Numerous studies have been conducted investigating the preferred pathway for porcine 
androgen production via Δ5 CYP17A1 activity. Furthermore, contributions towards the characterisation 
of these activities have been achieved by clinical cases describing mutations, as well as mutations 
engineered by site-directed mutagenesis, which influence the enzymes behaviour.  
Residues at position 407 in CYP17A1 from most small laboratory animals (species with preferred Δ4 
lyase activity) are Asp407 in hamster and guinea pig (adrenal and testes enzymes) and Gln407 in rat 
and mouse (testicular protein only). Adrenal and testes CYP17A1 from larger animals (species with 
preferred Δ5 lyase activity) have residues His407 in human, His/Leu407 in porcine, respectively, and 
Gln407 in bovine, angora and sheep (Miller and Auchus, 2011). In human testes, enzyme kinetics data 
indicate a >10-fold higher preference for testosterone formation via the Δ5 pathway than the Δ4 
pathway (Fluck et al., 2003). Production of A4, by expressed wt pCYP17A1-VH and -LL (porcine 
testes), both increased to ~90 % in the presence of CYB5. Accurate stimulation of the lyase reaction by 
wt pCYP17A1-VH and pCYP17A1-LL can only be assessed once the catalytic parameters have been 
determined. However, conclusions from studies relating CYP17A1 activity to amino acid residues in a 
protein sequence, allow for inferences regarding the activity of proteins with high acid sequence 
identity. 
Positively charged residues on the proximal face of CYP17A1 generally contribute to the lyase activity 
as it has been shown that substitutions of these basic proteins result in a loss of lyase activity; but not 
Stellenbosch University  http://scholar.sun.ac.za
102 
the hydroxylase activity. Mutations which neutralize these positively charged residues cause the 
characteristic loss in 17,20-lyase activity. It is, however, not only surface residues that influence 
catalytic activity. The Phe417Cys mutation, which resulted in the loss of lyase activity, does not lie at 
the protein surface but behind a loop between the meander region and the heme binding region; which 
suggests that changes to the structure of the protein affects the redox partner binding site (Biason-
Lauber et al., 1997).  
The addition of CYB5 may have also influenced the catalytic rates of the CYP17A1 reactions; 
however, in this study, only the end-products were analysed. Future studies would include investigating 
the effects of the substitutions at positions 40 and 407, as well as the influence of various species 
CYB5 on the rate of porcine CYP17A1 catalysis by determining the apparent Michaelis constant (Km) 
and maximum velocities (Vmax) for the dual reactions. 
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ADDENDUM A 
Sequence alignment of the 510 amino acids of various species CYP17A1 enzymes relative to the human form. GenBank 
accession numbers: human (Homo sapiens) NP_000093.1; cape baboon (Papio ursinus) AAG10599.1 and yellow baboon 
(Papio cynocephalus) Q8HYN0.1; bison (Bison bison) Q9GMC7.1; bovine (Bos taurus) NP_776729.1; chimpanzee (Pan 
troglodyte) Q8HYN1.1; angora goat (Capra hircus) ABQ12616.1 (ACS-: Ala6, Pro41, Val213) and ABQ12617.1 (ACS+: 
Gly6, Leu41, Ile213); crab-eating macaque (Macaca fascicularis) ABB76808.1 and rhesus macaque (Macaca mulatta) 
Q8HYM9.1; porcine (Sus scrofa) AAA84419.1 (His407) and NP_999593.1 (Leu407); sheep (Ovis aries) NP_001009483.1, 
black bear (Ursus thibetanus japonicas) BAH82843.1; cat (Felis catus) NP_001009371.1; guinea pig (Cavia porcellus) 
Q64410; horse (Equus caballus) BAA13551.1; hamster (Mesocricetus auratus) NP_001268860.1; house mouse (Mus 
musculus) NP_031835.3 and white-footed mouse (Peromyscus leucopus) Q91Z85.1, and brown rat (Rattus norvegicus) 
NP_036885.1.  
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ADDENDUM B 
Deduced amino acid sequences of wt porcine CYP17A1 cDNA (wt pCYP17A1-VH) and mutant constructs (pCYP17A1-
LH, -VL, -LL and -LA) are shown in alignment. Reference amino acid sequences are also shown. Porcine testes CYP17A1 
cDNA (Tes. pCYP17A1-LL) was published by Conley et al. (1992) (GenBank accession number NP_999593.1) (Conley et. 
al., 1992). Porcine adrenal CYP17A1 mRNA (Adr. pCYP17A1-LH) was published by Chung et al. (1987) (GenBank 
accession number AAA84419.1) (Chung et. al., 1987). In comparison with the wt, different amino acids are visible at 
positions 40, 105 and 407.  
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ADDENDUM C 
Sequence alignment of the 134 amino acids of various mammalian CYB5 enzymes relative to the human form. GenBank 
accession numbers: human (Homo sapiens) AAA35729.1; chimpanzee (Pan troglodyte) JAA42572.1; crab-eating macaque 
(Macaca fascicularis) EHH58972.1 and rhesus macaque (Macaca mulatta) AFH31257.1 and AFJ70408.1, respectively; 
marmoset (Callithrix jacchus) JAB11986.1; dog (Canis lupus familiaris) ADJ67811.1; porcine (Sus scrofa) AAC48779.1; 
shrew (Tupaia chinensis) ELV10907.1; rat (Rattus norvegicus) AAB67610.1; house mouse (Mus musculus) AAH24341.1; 
angora (Capra hircus) ABQ12619.1 and AEJ84155.1, respectively; sheep (Ovis aries) ACV53659.1; bovine (Bos taurus) 
AAI08114.1; yak (Bos mutus) ELR50125.1; mole (Heterocephalus glaber) EHB06367.1 and hamster (Cricetulus griseus) 
EGW12916.1. 
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